Study Accession	Suppl Concept	Modifier	Disease Background/Stratification, Phenotype/Biomarker, Treatment Response/Side_Effect or Interactions
GCST000004		phenotype	qt interval
GCST000006		phenotype	wet
GCST000007		phenotype	memory performance
GCST000010		phenotype	nicotine dependence
GCST000018		phenotype	late onset
GCST000021		phenotype	nicotine dependence
GCST000026		biomarker	triglyceride
GCST000034		response, biomarker	ximelagatran, alanine aminotransferase
GCST000037		background	er-positive
GCST000037		stratified	ER-positive
GCST000046		phenotype	late onset
GCST000059		phenotype	setpoint viral load
GCST000064		background	type 2 diabetes
GCST000069		biomarker	fetal hemoglobin
GCST000077		biomarker	fasting blood insulin
GCST000077		biomarker	glycated hemoglobin levels
GCST000077		phenotype	insulin sensitivity
GCST000078		biomarker	lipid traits
GCST000079		multiple disease	prostate cancer
GCST000080		biomarker	hemoglobin
GCST000080		biomarker	plasminogen activator inhibitor 1
GCST000080		biomarker	plat
GCST000080		phenotype	mean corpuscular hemoglobin
GCST000080		phenotype	platelet aggregation
GCST000081		phenotype	related phenotypes
GCST000082		biomarker	factor vii
GCST000083		biomarker	alkaline phosphatase
GCST000083		biomarker	atrial natriuretic factor
GCST000083		biomarker	bilirubin
GCST000083		biomarker	ccl2
GCST000083		biomarker	cd40lg (cd40 ligand)
GCST000083		biomarker	c-reactive protein
GCST000083		biomarker	gpt
GCST000083		biomarker	tnf
GCST000083		biomarker	vitamin d
GCST000083		biomarker	vitamin k
GCST000086		phenotype	heart rate
GCST000087		phenotype	ankle brachial index
GCST000087		phenotype	common carotid intimal medial thickness
GCST000087		phenotype	internal carotid intimal medial thickness
GCST000087		phenotype	subclinical atherosclerosis traits
GCST000088		phenotype	volumetric brain mri
GCST000091		biomarker	cystatin c
GCST000096		phenotype	age at death
GCST000096		phenotype	age at menopause
GCST000096		phenotype	exercise test
GCST000097		phenotype	calcification
GCST000099		phenotype	fvc (2 exams)
GCST000100		biomarker	tshb
GCST000101		phenotype	hip geometry
GCST000102		phenotype	endothelial function
GCST000106		phenotype	pulmonary function
GCST000110		phenotype	left atrial function
GCST000110		phenotype	left ventricular function
GCST000111		phenotype	pr interval
GCST000111		phenotype	qt interval
GCST000115		phenotype	red vs non-red hair color
GCST000116		phenotype	skin sensitivity to sun
GCST000117		phenotype	blue vs. green eyes
GCST000118		phenotype	blond vs. brown hair color
GCST000120		phenotype	blue vs. brown eyes
GCST000123		biomarker	urate
GCST000129		phenotype	early onset extreme
GCST000130		biomarker	urate
GCST000131		biomarker	ldl
GCST000132		biomarker	ldl
GCST000133		biomarker	hdl
GCST000134		biomarker	ldl
GCST000135		biomarker	hdl
GCST000137		biomarker	triglyceride
GCST000138		biomarker	triglyceride
GCST000139		biomarker	triglyceride
GCST000140		response	interferon beta for multiple sclerosis
GCST000145		phenotype	general cognitive ability
GCST000147		phenotype	nicotine dependence
GCST000148		background	males
GCST000149		background	females
GCST000150		biomarker	fetal hemoglobin
GCST000151		biomarker	ldl
GCST000156		phenotype	methamphetamine dependence
GCST000160		biomarker	urate
GCST000161		biomarker	urate
GCST000166		phenotype	environmental confusion in the home
GCST000171		phenotype	nicotine dependence
GCST000177		biomarker	chi3l1 (ykl40)
GCST000178		biomarker	c-reactive protein
GCST000179		biomarker	c-reactive protein
GCST000180		phenotype	spine bmd
GCST000181		phenotype	hip bmd
GCST000184		biomarker	triglyceride
GCST000184		phenotype, biomarker	waist circumference, hdl
GCST000187		background	early-onset
GCST000187		stratified	early-onset
GCST000189		biomarker	adipoq
GCST000189		biomarker	alb
GCST000189		biomarker	alkaline phosphatase
GCST000189		biomarker	alpha globulin
GCST000189		biomarker	alpha macroglobulin
GCST000189		biomarker	apolipoprotein a1 levels
GCST000189		biomarker	aspartate aminotransferase
GCST000189		biomarker	ccl2
GCST000189		biomarker	ccl4
GCST000189		biomarker	c-reactive protein
GCST000189		biomarker	erythropoetin
GCST000189		biomarker	ferritin
GCST000189		biomarker	fibrinogen
GCST000189		biomarker	fructose-bisphosphate aldolase
GCST000189		biomarker	gamma-glutamyl transferase
GCST000189		biomarker	glycoprotein
GCST000189		biomarker	hemoglobin
GCST000189		biomarker	insulin
GCST000189		biomarker	insulin like growth factor
GCST000189		biomarker	interleukin 10
GCST000189		biomarker	interleukin 12
GCST000189		biomarker	interleukin 18
GCST000189		biomarker	interleukin-1 beta
GCST000189		biomarker	interleukin 1 receptor antagonist
GCST000189		biomarker	interleukin-6
GCST000189		biomarker	interleukin-6 receptor
GCST000189		biomarker	interleukin-8
GCST000189		biomarker	leptin
GCST000189		biomarker	l lactate dehydrogenase
GCST000189		biomarker	myoglobin
GCST000189		biomarker	parathyroid hormone
GCST000189		biomarker	resistin
GCST000189		biomarker	shgb
GCST000189		biomarker	tfrc, soluble
GCST000189		biomarker	tgfb1
GCST000189		biomarker	thyroxine
GCST000189		biomarker	tnf
GCST000189		biomarker	triiodothyronine
GCST000189		biomarker	tshb
GCST000190		phenotype	black vs. blond hair color
GCST000191		phenotype	black vs. red hair color
GCST000192		phenotype	blue vs. green eyes
GCST000193		phenotype	red vs. non-red hair color
GCST000194		phenotype	blond vs. brown hair color
GCST000195		phenotype	skin sensitivity to sun
GCST000199		biomarker	tshb
GCST000200		response	iloperidone treatment (panss-t score)
GCST000201		side effect, phenotype	iloperidone for schizophrenia, qt prolongation
GCST000204		response	warfarin maintenance dose
GCST000208		response	thiazide diuretic
GCST000210		biomarker	icam-1
GCST000211		response	tnf antagonist treatment
GCST000212		phenotype	sarcoidosis
GCST000213		side effect	statin
GCST000222		biomarker	ige
GCST000227		biomarker	uric acid
GCST000228		biomarker	vitamin b12
GCST000229		phenotype	bone size (hip)
GCST000234		biomarker	ldl
GCST000236		phenotype	narcolepsy with cataplexy
GCST000239		phenotype	ischemic stroke
GCST000240		biomarker	hdl
GCST000241		biomarker	lipid traits
GCST000242		biomarker	urate
GCST000245		interaction	maternal expressed emotions
GCST000247		interaction	maternal expressed emotions
GCST000248		biomarker	alkaline phosphatase
GCST000248		biomarker	serum alanine aminotransferase
GCST000248		biomarker	serum gamma-glutamyl transferase
GCST000249		background	cutaneous
GCST000249		stratified	cutaneous
GCST000253		phenotype	attention deficit hyperactivity disorder and conduct disorder
GCST000261		phenotype	familial
GCST000264		phenotype	nicotine dependence
GCST000266		phenotype	severity
GCST000267		phenotype	age of onset
GCST000268		background, phenotype	multiple sclerosis, normalized brain volume
GCST000271		interaction, phenotype	dorsolateral prefrontal cortex, brain imaging
GCST000274		biomarker	acylcarnitine
GCST000274		biomarker	carbohydrate
GCST000274		biomarker	lipid metabolites
GCST000274		biomarker	lysine
GCST000274		biomarker	phenylalanine
GCST000274		biomarker	phospholipid
GCST000274		biomarker	serotonin
GCST000274		biomarker	sphingolipid
GCST000274		biomarker	tyrosine
GCST000278		phenotype	hyperactive-impulsive symptoms
GCST000279		phenotype	inattentive symptoms
GCST000280		phenotype	time to onset
GCST000282		biomarker	ldl
GCST000283		biomarker	ldl
GCST000284		biomarker	hdl
GCST000285		biomarker	total cholesterol
GCST000286		biomarker	triglyceride
GCST000287		biomarker	ldl
GCST000288		biomarker	hdl
GCST000289		biomarker	triglyceride
GCST000290		biomarker	hdl
GCST000292		biomarker	glucose
GCST000292		biomarker	insulin
GCST000292		biomarker	triglyceride
GCST000295		phenotype	spine bmd
GCST000297		phenotype	hip bmd
GCST000300		biomarker	triglyceride
GCST000301		biomarker	iron
GCST000302		biomarker	iron
GCST000303		biomarker	glycated hemoglobin levels
GCST000305		phenotype	mean platelet volume
GCST000308		phenotype	progression
GCST000312		biomarker	apolipoprotein a1 levels
GCST000316		biomarker	polyunsaturated fatty acid
GCST000319		biomarker	adipoq
GCST000323		response	antineoplastic agent
GCST000324		biomarker	carotenoid and tocopherol levels
GCST000327		phenotype	brachial circumference
GCST000327		phenotype	hip circumference
GCST000328		biomarker	alb
GCST000328		biomarker	fibrinogen
GCST000328		biomarker	hdl
GCST000328		biomarker	ldl
GCST000328		biomarker	total cholesterol
GCST000328		biomarker	triglyceride
GCST000328		biomarker	uric acid
GCST000330		phenotype	toluene diisocyanate-induced
GCST000331		biomarker	hdl
GCST000337		biomarker	c-reactive protein
GCST000337		biomarker	hdl
GCST000337		biomarker	ldl
GCST000337		biomarker	total cholesterol
GCST000337		biomarker	triglyceride
GCST000337		biomarker	tshb
GCST000337		phenotype	body fat distribution
GCST000339		phenotype	eosinophil count
GCST000340		phenotype	early onset
GCST000342		phenotype	mean platelet volume
GCST000344		phenotype	pr interval
GCST000344		phenotype	pr segment
GCST000344		phenotype	p wave duration
GCST000352		phenotype	lean body mass
GCST000353		phenotype	orofacial clefts
GCST000355		phenotype	age at onset
GCST000356		response	autoantibody against cyclic citrullinated peptide
GCST000358		biomarker	vitamin b
GCST000358		biomarker	vitamin b12
GCST000358		biomarker	vitamin b6
GCST000360		response	warfarin maintenance dose
GCST000362		phenotype	pulmonary function
GCST000363		phenotype	qt interval
GCST000364		phenotype	qt interval
GCST000366		biomarker	fibrinogen
GCST000367		biomarker	homocysteine
GCST000368		biomarker	fibrinogen
GCST000369		response	atorvastatin
GCST000370		phenotype	arterial stiffness
GCST000373		phenotype	ischemic stroke
GCST000377		biomarker	hdl
GCST000381		phenotype	heart rate
GCST000384		phenotype	high-risk
GCST000384		stratified	high-risk
GCST000385		phenotype	narcolepsy with cataplexy
GCST000386		biomarker	bilirubin
GCST000388		biomarker	bilirubin
GCST000390		phenotype	early onset
GCST000400		phenotype	age at onset
GCST000401		phenotype	age at onset
GCST000402		response	lithium treatment
GCST000403		phenotype	menarche and menopause (age at onset)
GCST000404		phenotype	age at onset
GCST000405		phenotype	age at onset
GCST000407		phenotype	left ventricular mass
GCST000409		phenotype	adipose tissue measurement
GCST000414	C563236	phenotype	testicular germ cell tumor
GCST000414	C563236	stratified	testicular germ cell tumor
GCST000415		side effect	flucloxacillin
GCST000416	C563236	phenotype	testicular germ cell tumor
GCST000416		stratified	Testicular Germ Cell Tumor (C563236)
GCST000418		biomarker	uric acid
GCST000423		biomarker	homocysteine
GCST000426		phenotype	extreme
GCST000430		biomarker	c-reactive protein
GCST000436		response	acenocoumarol maintenance dose
GCST000438		background	cutaneous
GCST000438		stratified	cutaneous
GCST000440		background	high-grade
GCST000440		stratified	high-grade
GCST000442		phenotype	aortic root size
GCST000443		phenotype	body mass index and fat mass
GCST000444		phenotype	qt interval
GCST000450		biomarker	matrix metalloproteinase
GCST000452		phenotype	qt interval
GCST000453		response	interferon beta for multiple sclerosis
GCST000458		phenotype	orofacial clefts
GCST000461		phenotype	hippocampal atrophy
GCST000462		response	antipsychotic
GCST000463		background	childhood
GCST000463		stratified	childhood
GCST000464		background	childhood
GCST000464		stratified	childhood
GCST000465		response	chronic hepatitis c infection
GCST000466		interaction or exposure	alcohol and smoking
GCST000467		response	clopidogrel therapy in healthy amish
GCST000468		phenotype	childhood onset
GCST000469		pleiotropy	osteoporosis
GCST000470		response	antidepressants
GCST000471		response	antidepressants
GCST000473		response	olanzapine
GCST000473		response	risperidone
GCST000473		response	ziprasidone
GCST000476		biomarker	e-selectin
GCST000482	C531617	interaction, phenotype	snp x snp, sporadic
GCST000483		biomarker	homocysteine
GCST000483		biomarker	vitamin b12
GCST000483		biomarker	vitamin b6
GCST000485		response	interferon-alpha and ribavirin therapy
GCST000486		response	pegylated interferon-alpha and ribavirin therapy
GCST000490		phenotype	age of onset
GCST000491		phenotype	pathological
GCST000492		background	dyslexia
GCST000493		biomarker	sphingolipid
GCST000494		phenotype	spine bmd
GCST000495		phenotype	hip bmd
GCST000497		phenotype	mean platelet volume
GCST000498		phenotype	mean corpuscular hemoglobin
GCST000498		phenotype	mean corpuscular volume
GCST000499		biomarker	hemoglobin
GCST000500		phenotype	mean corpuscular hemoglobin concentration
GCST000501		biomarker	hemoglobin
GCST000503		phenotype	mean corpuscular volume
GCST000504		phenotype	mean corpuscular hemoglobin
GCST000505		biomarker	iron
GCST000509		response	citalopram
GCST000510		phenotype	mean corpuscular hemoglobin
GCST000510		phenotype	mean corpuscular volume
GCST000513		phenotype	severity
GCST000514		side effect	antipsychotic for schizophrenia
GCST000516		biomarker	glycated hemoglobin levels
GCST000517		biomarker	iron
GCST000519		phenotype	hair morphology
GCST000523		drug metabolism	methotrexate for acute lymphoblastic leukemia
GCST000524		phenotype	mathematical ability
GCST000526		biomarker	insulin
GCST000531		phenotype	early onset
GCST000533		phenotype	lipid metabolism phenotypes
GCST000537		biomarker	adipoq
GCST000538		biomarker	adipoq
GCST000541		phenotype	femoral neck bone geometry
GCST000542		phenotype	pulmonary function
GCST000543		phenotype	social and non-social autistic-like traits
GCST000544		phenotype	pulmonary function
GCST000545		biomarker	fetal hemoglobin
GCST000547		phenotype	orofacial clefts
GCST000550		biomarker	metabolite
GCST000551		phenotype	broad
GCST000553		biomarker	cd4:cd8 lymphocyte ratio
GCST000554		phenotype	subclinical
GCST000555		background	hiv infection
GCST000556		phenotype	functional mri
GCST000559		biomarker	total cholesterol
GCST000561		phenotype	heart rate
GCST000561		phenotype	pr interval
GCST000561		phenotype	qrs complex
GCST000561		phenotype	qrs duration
GCST000561		phenotype	qt interval
GCST000562		phenotype	pr interval
GCST000564		phenotype	pr interval
GCST000564		phenotype	qt interval
GCST000565		biomarker	angiotensin-converting enzyme
GCST000570		phenotype	major mood disorders
GCST000571		biomarker	fasting blood insulin
GCST000575		phenotype	related phenotypes
GCST000577		phenotype	severity
GCST000581		biomarker	urate
GCST000582		biomarker	mean corpuscular hemoglobin concentration
GCST000583		biomarker	alb
GCST000583		biomarker	alkaline phosphatase
GCST000583		biomarker	alkaline phosphatase, uric acid
GCST000583		biomarker	aspartate aminotransferase
GCST000583		biomarker	creatine kinase
GCST000583		biomarker	creatinine
GCST000583		biomarker	gamma-glutamyl transferase
GCST000583		biomarker	gpt
GCST000583		biomarker	hdl
GCST000583		biomarker	hemoglobin
GCST000583		biomarker	protein
GCST000583		biomarker	uric acid
GCST000584		biomarker	triglyceride
GCST000585		phenotype	mean corpuscular volume
GCST000587		biomarker	mean corpuscular hemoglobin
GCST000590		biomarker	interleukin 18
GCST000594		biomarker	homocysteine
GCST000596		phenotype	progression
GCST000597		phenotype	brain structure
GCST000599		biomarker	icam1
GCST000599		biomarker	p-selectin
GCST000600		phenotype	neutrophil count
GCST000605		biomarker	leptin receptor
GCST000606		biomarker	e-selectin
GCST000608		background	childhood
GCST000609		phenotype	primary tooth development (time to first tooth eruption)
GCST000610		phenotype	primary tooth development (number of teeth)
GCST000613		phenotype	hiv mother to child transmission
GCST000614		phenotype	temporal lobe volume
GCST000615		phenotype	brain structure (hippocampal volume)
GCST000618		side effect	clozapine for schizophrenia, metabolic side effects
GCST000618		side effect	olanzapine for schizophrenia, metabolic side effects
GCST000618		side effect	perphenazine for schizophrenia, metabolic side effects
GCST000618		side effect	quetiapine for schizophrenia, metabolic side effects
GCST000618		side effect	risperidone for schizophrenia, metabolic side effects
GCST000618		side effect	ziprasidone for schizophrenia, metabolic side effects
GCST000620		phenotype	pediatric
GCST000621		biomarker	c4b binding protein levels
GCST000622		biomarker	creatinine
GCST000625		biomarker	factor vii
GCST000626		biomarker	factor viii
GCST000627		biomarker	vwf
GCST000628		biomarker	chemerin
GCST000630		phenotype	digit length ratio
GCST000631		phenotype	partial thromboplastin time
GCST000634		phenotype	cognitive ability
GCST000635		response	statin
GCST000636		phenotype	prefrontal cortex cytoarchtiecture
GCST000637		phenotype	prognosis
GCST000640		interaction or exposure	radiation-related
GCST000641		background	bipolar disorder
GCST000643		response	antidepressants
GCST000647		biomarker	total cholesterol
GCST000649		biomarker	cystatin c
GCST000649		biomarker	serum creatinine
GCST000651		biomarker	creatinine
GCST000655		phenotype	optic cup-to-disc ratio
GCST000656		phenotype	setpoint viral load
GCST000657		phenotype	optic disc area
GCST000658		phenotype	rim area
GCST000659		phenotype	optic cup area
GCST000661		phenotype	mortality
GCST000663		phenotype	early onset extreme
GCST000664		biomarker	vitamin d
GCST000671		biomarker	lppla2
GCST000683		phenotype	central corneal thickness
GCST000688		response	platinum-based chemotherapy
GCST000693		phenotype	platelet aggregation
GCST000694		biomarker	phytosterol
GCST000695		background	bipolar disorder
GCST000696		phenotype	non-diabetic
GCST000698		phenotype	related phenotypes
GCST000699		phenotype	optic disc parameters
GCST000700		phenotype	vertical cup-disc ratio
GCST000701	C563236	phenotype	testicular germ cell tumor
GCST000701		stratified	Testicular Germ Cell Tumor (C563236)
GCST000703		biomarker	phosphorus
GCST000704		biomarker	hemoglobin
GCST000706		phenotype	attached earlobe
GCST000706		phenotype	braces
GCST000706		phenotype	common traits (other)
GCST000707		phenotype	hair color
GCST000711		biomarker	vitamin d
GCST000715		side effect	peg-asparaginase for acute lymphoblastic leukemia
GCST000717		background	type 2 diabetes
GCST000724		interaction	age
GCST000729		side effect	ribavirin
GCST000730		biomarker	bilirubin
GCST000731		phenotype	resting heart rate
GCST000735		side effect	lumiracoxib
GCST000736		biomarker	calcium level
GCST000737		biomarker	triglyceride
GCST000738		background	neonatal
GCST000739		phenotype	serologic markers
GCST000742		biomarker	serum creatinine
GCST000746		phenotype	bitter
GCST000748		response	anti-tnf alpha
GCST000749		background	childhood
GCST000753		biomarker	hdl
GCST000753		phenotype	metabolic syndrome
GCST000755		biomarker	hdl
GCST000756		biomarker	magnesium
GCST000758		biomarker	triglyceride
GCST000759		biomarker	ldl
GCST000760		biomarker	total cholesterol
GCST000763		biomarker	protein
GCST000765		biomarker	gpt
GCST000765		phenotype	histology (other)
GCST000766		phenotype	histology (lobular)
GCST000767		phenotype	histology (ast)
GCST000769		biomarker	calcium level
GCST000771		phenotype	narcolepsy with cataplexy
GCST000774		phenotype	schizophrenia, bipolar disorder and depression (combined)
GCST000775		phenotype	central corneal thickness
GCST000777		multiple disease	gastric adenocarcinoma
GCST000777		phenotype	esophageal cancer and gastric cancer
GCST000777		pleiotropy	gastric cancer
GCST000780		biomarker	protein c
GCST000783		biomarker	brian glutamate
GCST000784		phenotype	pseudoexfoliation syndrome
GCST000789		interaction, phenotype	age, multiple
GCST000791		phenotype	thyroid function
GCST000792		response	warfarin maintenance dose
GCST000798		biomarker	glycated hemoglobin levels
GCST000801		background	hormone-receptor negative
GCST000801		stratified	hormone-receptor negative
GCST000803		biomarker	glycated hemoglobin levels
GCST000805		biomarker	hdl
GCST000807		biomarker	ldl
GCST000808		phenotype	late onset
GCST000809		biomarker	triglyceride
GCST000812		biomarker	adipoq
GCST000813		side effect	aromatase inhibitors for early breast cancer
GCST000814		phenotype	mean corpuscular hemoglobin
GCST000814		phenotype	mean corpuscular hemoglobin concentration
GCST000814		phenotype	mean corpuscular volume
GCST000818		biomarker	urate
GCST000818		phenotype	urate levels
GCST000821		phenotype	bipolar disorder and schizophrenia
GCST000822		side effect, phenotype	quetiapine, interval prolongation
GCST000822		side effect, phenotype	risperidone, interval prolongation
GCST000823		response	radiation
GCST000824		side effect	radiotherapy for prostate cancer
GCST000824		treatment side effect	prostate cancer - radiotherapy (erectile dysfunction)
GCST000825		biomarker	cerebrospinal p-tau181p levels
GCST000826		biomarker	t-tau (csf)
GCST000827		biomarker	cerebrospinal fluid ab1-42 levels
GCST000828		biomarker	adipoq
GCST000831		background	schizophrenia
GCST000844		phenotype	survival time
GCST000845		background	males
GCST000846		background	brca2 mutation carriers
GCST000846		stratified	BRCA2 positive
GCST000847		phenotype	retinal vascular caliber
GCST000848		background	females
GCST000850		background	chronic obstructive pulmonary disease
GCST000852		phenotype	atrioventricular conduction
GCST000857		phenotype	event-related brain oscillation
GCST000862		phenotype	bipolar disorder and schizophrenia
GCST000865		response	etanercept (anti-tnf)
GCST000866		biomarker	ldl
GCST000867		background	estrogen-receptor negative
GCST000868		biomarker	handedness
GCST000871		phenotype	survival
GCST000871		treatment response	carboplatin and paclitaxel
GCST000872		phenotype	qrs duration
GCST000876		biomarker	amyloid a protein
GCST000878		phenotype	pathological
GCST000880		phenotype	age at onset
GCST000882		response, phenotype	bleomycin, chromatid breaks
GCST000883		response, phenotype	antipsychotic for schizophrenia, short-term memory
GCST000884		response	antipsychotic
GCST000885		response	antipsychotic, reasoning
GCST000889		interaction	cortical thickness
GCST000890		phenotype	hippocampal volume
GCST000891		phenotype	whole-brain volume
GCST000892		interaction	brain volume
GCST000893		interaction	entorhinal cortical volume
GCST000894		phenotype	cortical thickness
GCST000895		interaction	whole-brain volume
GCST000896		phenotype	survival
GCST000896		survival	
GCST000897		interaction	hippocampal volume
GCST000898		phenotype	total ventricular volume
GCST000899		phenotype	entorhinal cortical volume
GCST000900		biomarker	beta-amyloid 1-42
GCST000900		biomarker	beta-amyloid 1-42 measurement, t-tau measurement
GCST000900		biomarker	p-tau measurement, beta-amyloid 1-42 measurement, t-tau measurement
GCST000900		biomarker	t-tau
GCST000903		side effect	methylphenidate for attention-deficit/hyperactivity disorder
GCST000905		phenotype	information processing speed
GCST000908		background	ileal
GCST000908		stratified	ileal
GCST000911		biomarker	progranulin
GCST000912		side effect	carbamazepine
GCST000913		biomarker	ferritin
GCST000913		biomarker	tfrc, soluble, iron
GCST000918		phenotype	susceptibility
GCST000919		biomarker	
GCST000922		phenotype	openness
GCST000924		side effect	acetaminophen
GCST000925		biomarker	n-glycan
GCST000926		phenotype	maximal oxygen uptake response
GCST000927		response	metformin
GCST000928		interaction	sex
GCST000930		interaction	sex
GCST000931		interaction	sex
GCST000933		biomarker	c-reactive protein
GCST000934		interaction, pleiotropy	farm exposure, atopy
GCST000935		biomarker	ferritin
GCST000935		biomarker	iron
GCST000935		biomarker	tf (transferrin)
GCST000936		phenotype	left ventricular hypertrophy
GCST000937		biomarker	igf-1
GCST000937		biomarker	igfbp-3
GCST000938		phenotype	adolescent idiopathic
GCST000941		phenotype	ischemic stroke
GCST000942		side effect	drug-induced
GCST000943		phenotype	aortic root size
GCST000944		response	chronic hepatitis c infection
GCST000946		background	coronary artery disease
GCST000947		phenotype	clinical stage
GCST000948		stratified	distal
GCST000953		side effect	lapatinib in breat canacer
GCST000955		background	crohn's disease
GCST000957		biomarker	nt-probnp
GCST000963		biomarker	uric acid
GCST000965		biomarker	c-reactive protein
GCST000967		response	platinum-based chemotherapy
GCST000968		response	platinum-based chemotherapy
GCST000969		phenotype	psychotic symptoms
GCST000969		phenotype	psychotic symptoms, age of onset
GCST000970		phenotype	optic disc area
GCST000971		phenotype	pr interval
GCST000974		biomarker	hdl
GCST000975		biomarker	ldl
GCST000978		biomarker	cortisol secretion
GCST000979		phenotype	childhood onset
GCST000980		phenotype	late onset
GCST000982		biomarker	f-cell distribution
GCST000983		biomarker	slc6a4
GCST000986		phenotype	late onset
GCST000987		phenotype	celiac disease or rheumatoid arthritis
GCST000991		phenotype	language delay
GCST000992		phenotype	coffee consumption
GCST000995		background	bipolar disorder
GCST001002		side effect	cerivastatin
GCST001004		biomarker	blood pressure, triglycerides
GCST001005		biomarker	hdl, triglyceride
GCST001006		phenotype, biomarker	waist circumference, triglycerides
GCST001011		phenotype	oral cavity and pharyngeal cancer
GCST001014		side effect	carbamazepine
GCST001015		background	bipolar disorder
GCST001016		side effect	vaccine
GCST001018		phenotype	acquired
GCST001021		biomarker	ferritin
GCST001021		biomarker	iron
GCST001021		biomarker	total iron binding capacity
GCST001021		biomarker	transferrin saturation
GCST001026		phenotype	late onset
GCST001027		phenotype	uterine fibroid
GCST001030		phenotype	motor coordination
GCST001031		phenotype	large
GCST001032		phenotype	caffeine consumption
GCST001034		background	cutaneous
GCST001034		stratified	cutaneous
GCST001035		response	platinum-based chemotherapy
GCST001035		treatment response	platinum-based chemotherapy
GCST001036		side effect	amoxicillin-clavulanate
GCST001037		phenotype	neurocognition, neuranatomic
GCST001038		biomarker	dehydroepiandrosterone sulphate
GCST001043		response	interferon beta for multiple sclerosis
GCST001044		phenotype	pathological
GCST001045		phenotype	caudate nucleus volume
GCST001047		biomarker	icam-1
GCST001048		phenotype	monocyte early outgrowth colony forming unit
GCST001049		biomarker	d-dimer
GCST001052		phenotype	heaviness of drinking
GCST001053		phenotype	alcohol use disorder factor score
GCST001054		phenotype	alcohol dependence factor score
GCST001055		phenotype	12-month weekly alcohol consumption
GCST001059		phenotype	neutrophil count
GCST001060		phenotype	progression
GCST001065		phenotype	platelet function and related traits
GCST001067	C563236	phenotype	testicular germ cell tumor
GCST001067		stratified	Testicular Germ Cell Tumor (C563236)
GCST001069		phenotype	thyroid volume
GCST001073		biomarker	urinary metabolite
GCST001076		side effect	ifn
GCST001082		interaction	alcohol consumption
GCST001084		interaction	snp x snp
GCST001085		interaction	snp x snp
GCST001088		phenotype	pathological
GCST001091		biomarker	bilirubin
GCST001093		biomarker	c-reactive protein
GCST001094		side effect	pegylated interferon and ribavirin for hepatitis c
GCST001095		response	chemotherapeutic susceptibility
GCST001098		phenotype	peripartum cardiomyopathy
GCST001101		phenotype	corneal curvature
GCST001103		phenotype	transferrin glycosylation
GCST001108		background	chronic obstructive pulmonary disease
GCST001109		phenotype	white matter hyperintensity burden
GCST001111		background	chronic obstructive pulmonary disease
GCST001112		background	chronic obstructive pulmonary disease
GCST001113		background	chronic obstructive pulmonary disease
GCST001114		interaction, phenotype	sex, age at onset
GCST001115		phenotype	age at onset
GCST001117		phenotype	childhood onset
GCST001118		phenotype	ulcerative colitis or crohn's disease
GCST001122		biomarker	adipoq
GCST001127		response	oxaliplatin
GCST001134		phenotype	eosinophil count
GCST001134		phenotype	monocyte count
GCST001134		phenotype	neutrophil count
GCST001137		phenotype	monocyte count
GCST001137		phenotype	neutrophil count
GCST001142		biomarker	vitamin e
GCST001143		biomarker	hdl
GCST001145		response	chemotherapeutic susceptibility
GCST001155		biomarker	vegfa
GCST001157		phenotype	risk factors
GCST001158		biomarker	fibrinogen
GCST001162		response	hepatitis b vaccine
GCST001163		biomarker	urate
GCST001165		biomarker	adipoq
GCST001166		phenotype	time to event
GCST001167		phenotype	time to death
GCST001169		response	platinum-based chemotherapy
GCST001170		biomarker	lipid traits
GCST001171		phenotype	progression
GCST001174		biomarker	hepicidin
GCST001175		side effect	epirubicin-induced
GCST001177		biomarker	omega-3 pufa (docosahexaenoic acid)
GCST001178		biomarker	omega-3 pufa (eicosapentaenoic acid)
GCST001179		biomarker	omega-3 pufa (docosapentaenoic acid)
GCST001180		biomarker	omega-3 pufa (alphalinolenic acid)
GCST001181		side effect	drug-induced
GCST001186		side effect, phenotype	nevirapine, rash
GCST001187		phenotype	cortical thickness
GCST001188		biomarker	factor viii measurement, coagulation factor measurement
GCST001188		biomarker	vwf, coagulation factor
GCST001192		side effect	atorvastatin
GCST001201		response	cisplatin
GCST001204		response	carboplatin
GCST001205		interaction	coffee consumption
GCST001206		interaction	snp x snp
GCST001207	C537417	biomarker	butyrylcholinesterase
GCST001212		biomarker	insulin
GCST001215		phenotype	coffee consumption
GCST001216		biomarker	vitamin a
GCST001217		biomarker	metabolite
GCST001218		biomarker	apolipoprotein a1 levels
GCST001220		biomarker	metabolite
GCST001221		phenotype	permanent tooth development
GCST001222		biomarker	aspartate aminotransferase
GCST001225		phenotype	seropositive for hpv
GCST001230		biomarker	triglyceride
GCST001231		phenotype	intima media thickness
GCST001233		biomarker	alb
GCST001233		biomarker	gpt
GCST001233		biomarker	ldl
GCST001233		biomarker	uric acid
GCST001234		biomarker	gamma-glutamyl transferase
GCST001235		phenotype	pulse pressure
GCST001236		phenotype	mean arterial pressure
GCST001237		biomarker	hdl
GCST001239		side effect	drug-induced
GCST001240		phenotype	extreme
GCST001247		biomarker	aspartate aminotransferase
GCST001247		biomarker	c-reactive protein
GCST001247		biomarker	ferritin
GCST001247		biomarker	gamma-glutamyl transferase
GCST001247		biomarker	hdl
GCST001247		biomarker	ldl
GCST001247		biomarker	triglyceride
GCST001247		biomarker	uric acid
GCST001247	C537417	biomarker	butyrylcholinesterase
GCST001248		phenotype	pulmonary function
GCST001249		phenotype	bone size (spine)
GCST001251		phenotype	pulmonary function
GCST001252		response	glucocorticoid
GCST001256		side effect	surgery
GCST001259		response	lithium treatment
GCST001262		biomarker	ldl
GCST001264		biomarker	testosterone
GCST001269		biomarker	uric acid
GCST001271		side effect	antipsychotic for schizophrenia
GCST001272		phenotype	antibody response
GCST001273		biomarker	lppla2
GCST001275		biomarker	gpt
GCST001276		biomarker	alkaline phosphatase
GCST001277		biomarker	gamma-glutamyl transferase
GCST001280		phenotype	age of onset
GCST001282		background	alzheimer's disease
GCST001285		phenotype	psychosis and alzheimer's disease
GCST001289		biomarker	total cholesterol
GCST001291		side effect	oxaliplatin for colon cancer
GCST001298		background	er-negative
GCST001298		stratified	ER-negative
GCST001300		background	non-cardia
GCST001300		stratified	non-cardia
GCST001303		phenotype	ige grass sensitization
GCST001304		phenotype	renal sinus adipose tissue
GCST001307		biomarker	gamma-glutamyl transferase
GCST001308		response	anti-depressant treatment
GCST001308		response	bupropion
GCST001308		response	citalopram
GCST001308		response	sertraline
GCST001308		response	venlafaxine
GCST001310		phenotype	allergic rhinitis
GCST001313		background	depression
GCST001314		biomarker	adipoq
GCST001315		phenotype	femoral neck bone geometry
GCST001316		biomarker	ige
GCST001317		phenotype	carotid-femoral pulse wave velocity
GCST001318		biomarker	ceruloplasmin
GCST001320		background	childhood
GCST001320		stratified	childhood
GCST001323		background	nodular sclerosis
GCST001323		stratified	nodular sclerosis
GCST001324		biomarker	bilirubin
GCST001325		response	pegylated interferon-alpha and ribavirin therapy
GCST001327		phenotype	memory performance
GCST001333		biomarker	bilirubin
GCST001335		phenotype	mean platelet volume
GCST001336		phenotype	menarche and menopause (age at onset)
GCST001339		phenotype	corneal
GCST001344	C537770	phenotype	testicular dysgenesis syndrome
GCST001346		response	gemcitabine
GCST001346		treatment response	gemcitabine
GCST001347		phenotype	calcification
GCST001349		background, phenotype	infant head circumference
GCST001352		phenotype	setpoint viral load
GCST001353		phenotype	susceptibility
GCST001354		phenotype	heart rate
GCST001357		response	tamoxifen
GCST001357		treatment response	adjuvant tamoxifen therapy
GCST001361		phenotype	ankle brachial index
GCST001362		phenotype	non-obstructive
GCST001365		biomarker	protein c
GCST001365		biomarker	protein s
GCST001367		biomarker	triglyceride
GCST001368		side effect	capecitabine
GCST001370		interaction or exposure	Snp-SNP interactions
GCST001370		interaction	snp x snp
GCST001371		response	fenofibrate, inflammatory biomarkers
GCST001373		phenotype	survival
GCST001373		phenotype	survival time
GCST001373		survival	
GCST001374		biomarker	uric acid
GCST001378		biomarker	protein c
GCST001378		biomarker	protein s
GCST001381		phenotype	age at onset
GCST001385		biomarker	ccl2
GCST001385		biomarker	c-reactive protein
GCST001385		biomarker	interleukin-6
GCST001390		response	gemcitabine
GCST001390		treatment side effect	pancreatic cancer - gemcitabine (hematological toxicities)
GCST001391		biomarker	metabolite
GCST001392		phenotype	lipid metabolism phenotypes
GCST001393		biomarker	glycated hemoglobin levels
GCST001399		phenotype	infantile
GCST001402		response	epirubicin
GCST001403		response	5' fluorouracil
GCST001405		background	short sleep duration
GCST001408		response, biomarker	statin, ldl
GCST001409		interaction	snp x snp
GCST001410		phenotype	tpe interval
GCST001411		interaction, phenotype	total cortical area, occipital cortical area
GCST001412		phenotype	facial morphology
GCST001413		biomarker	sphingolipid
GCST001414		biomarker	phospholipid
GCST001416		interaction	snp x snp
GCST001418		background	hepatitis c treatment
GCST001421		biomarker	urinary arsenic
GCST001424		biomarker	vitamin b12
GCST001425		response	atorvastatin
GCST001426		interaction	snp x snp
GCST001427		phenotype	nicotine dependence
GCST001431		side effect	lamotrigine and phenytoin
GCST001434		biomarker	naphthyl-keratin adduct
GCST001435		biomarker	haptoglobin
GCST001437		phenotype	thyrotoxic
GCST001439		phenotype	mean platelet volume
GCST001440		response, phenotype, biomarker	psychopharmacological treatment, bmi, cholesterol
GCST001442		phenotype	orofacial cleft
GCST001444		phenotype	fev1
GCST001444		phenotype	fev1/fec ratio
GCST001446		phenotype	white matter integrity
GCST001450		response	vitamin e supplementation
GCST001452		phenotype	pemphigus vulgaris
GCST001453		side effect	ssri/snri-related
GCST001458		phenotype	treatment refractory
GCST001462		phenotype	brachial circumference
GCST001463		biomarker	adipoq
GCST001465		biomarker	adipoq
GCST001468		background	cystic fibrosis
GCST001471		phenotype	alcohol and nicotine co-dependence
GCST001472		biomarker	c-reactive protein
GCST001473		phenotype	crohn's disease
GCST001476		response	tocilizumab
GCST001477		phenotype	female
GCST001478		biomarker	circulating cell-free dna
GCST001479		phenotype	autoantibody type 1 diabetes
GCST001480		biomarker	matrix metalloproteinase
GCST001481		phenotype	hippocampal volume
GCST001481		phenotype	intracranial volume
GCST001482		phenotype	spine bmd (lumbar)
GCST001483		phenotype	intracranial volume
GCST001484		background, phenotype	infant head circumference
GCST001485		phenotype	hippocampal volume
GCST001487		phenotype	thyroid function
GCST001490		phenotype	nicotine dependence
GCST001491		response, biomarker	smallpox vaccine, il-6
GCST001494		phenotype	non-obstructive
GCST001496		biomarker	alb
GCST001496		biomarker	protein
GCST001496		biomarker	serum non-albumin protein
GCST001497		background, phenotype	sickle cell anemia, related traits
GCST001501		phenotype	platelet thrombus formation
GCST001502		phenotype	childhood onset
GCST001503		background, phenotype	alcoholism, frontal theta oscillation
GCST001507		phenotype	hair color
GCST001510		response	tnf-alpha inhibitors
GCST001511		phenotype	economic and political preferences (time)
GCST001512		phenotype	economic and political preferences (environmentalism)
GCST001513		phenotype	economic and political preferences (fairness)
GCST001514		phenotype	economic and political preferences (feminism/equality)
GCST001515		phenotype	economic and political preferences (immigration/crime)
GCST001517		side effect	antipsychotic drug
GCST001518		response	candesartan
GCST001519		phenotype	economic and political preferences
GCST001520		response	candesartan
GCST001521		phenotype	subcutaneous adipose tissue
GCST001522		phenotype	pericardial adipose tissue
GCST001523		phenotype	visceral adipose tissue, bmi adjusted
GCST001524		phenotype	visceral:subcutaneous adipose tissue ratio
GCST001525		phenotype	visceral adipose tissue
GCST001526		interaction	body mass index
GCST001527		interaction	body mass index
GCST001528		response	antidepressants
GCST001530		phenotype	hippocampal atrophy
GCST001532		response, biomarker	smallpox vaccine, il-6
GCST001533		response, biomarker	smallpox vaccine, il-1beta
GCST001534		response, biomarker	smallpox vaccine, il-10
GCST001535		response, biomarker	smallpox vaccine, il-2
GCST001536		response, biomarker	smallpox vaccine, tnf-alpha
GCST001537		response, biomarker	smallpox vaccine, il-12p40
GCST001538		response, biomarker	smallpox vaccine, ifn-alpha
GCST001540		phenotype	male fertility
GCST001543		interaction	asbestos exposure
GCST001543		interaction or exposure	asbestos
GCST001545		interaction	pravastatin
GCST001546		phenotype	motor and cognition
GCST001547		response	anthrax vaccine
GCST001549		phenotype	formal thought disorder
GCST001551		phenotype	amygdala reactivity
GCST001552		phenotype	central corneal thickness
GCST001553		background, biomarker	in postmenopausal women, estradiol
GCST001553		biomarker	in postmenopausal women
GCST001554		biomarker	shgb
GCST001555		biomarker	testosterone
GCST001558		response	irinotecan
GCST001558		treatment side effect	advanced non-small-cell lung cancer - irinotecan (severe toxicity)
GCST001560		biomarker	vitamin d
GCST001561		phenotype	pathological
GCST001566		interaction	sex
GCST001567		phenotype	schizophrenia and bipolar disorder
GCST001568		phenotype	severity
GCST001572		background	type 1 diabetes
GCST001573		phenotype	prothrombin time
GCST001574		phenotype	partial thromboplastin time
GCST001575		biomarker	factor xi
GCST001577		phenotype	cnv vs ga
GCST001579		phenotype	choroidal neovascularisation
GCST001580		phenotype	qt interval
GCST001582		phenotype	viral clearance
GCST001584		background	lean body mass and age at menarche (combined)
GCST001585		phenotype	breast size
GCST001586		phenotype	caffeine-induced
GCST001588		phenotype	microbiota
GCST001591		response	citalopram
GCST001593		phenotype	cortical thickness
GCST001597		response	bronchodilator
GCST001600		biomarker	igg
GCST001604		biomarker	fasting blood insulin
GCST001605		phenotype, biomarker	wbc count and c-reactive protein
GCST001606		biomarker	scr
GCST001607		biomarker	egrf crea
GCST001608		biomarker	uric acid
GCST001610		phenotype	bun
GCST001612		biomarker	shgb
GCST001614		phenotype	central corneal thickness
GCST001615		phenotype	sclerosing cholangitis and ulcerative colitis
GCST001616		phenotype	cannabis use (initiation)
GCST001620		biomarker	resistin
GCST001621		phenotype	airflow obstruction
GCST001623		background	hepatitis c infection
GCST001624		side effect	paclitaxel
GCST001626		biomarker	iga
GCST001627		phenotype	thyrotoxic
GCST001628		phenotype	orofacial cleft
GCST001629		response	platinum-based chemotherapy
GCST001629		treatment response	platinum-based chemotherapy
GCST001632		response	fenofibrate
GCST001639		phenotype	calcification
GCST001640		phenotype	lentiform nucleus
GCST001641		response	antidepressants
GCST001642		biomarker	serpina12
GCST001643		phenotype	age of onset
GCST001645		biomarker	ldl
GCST001649		phenotype	primary angle closure
GCST001650		biomarker	c-reactive protein
GCST001651		background	healthy volunteers
GCST001653		biomarker	dihydrotestosterone
GCST001653		biomarker	testosterone
GCST001658		phenotype	late onset
GCST001659		phenotype	ischemic stroke
GCST001661		biomarker	cyp3a4
GCST001662		phenotype	generalized
GCST001663		phenotype	age of onset
GCST001667		background	hormone receptor-positive
GCST001667		stratified	hormone receptor-positive
GCST001671		biomarker	igg
GCST001672		interaction	alcohol
GCST001672		interaction or exposure	alcohol
GCST001673		side effect	drug
GCST001677		biomarker	paraoxonase activity
GCST001678		phenotype	facial morphology
GCST001679		biomarker	complement c3
GCST001679		biomarker	complement c4
GCST001680		phenotype	corneal curvature
GCST001684		biomarker	plasminogen activator inhibitor 1
GCST001687		phenotype	disc degeneration (lumbar)
GCST001688		background	type 1 diabetes
GCST001689		phenotype	pediatric
GCST001691		biomarker	ccl2
GCST001692		response	docetaxel
GCST001693		background	childhood
GCST001693		stratified	childhood
GCST001694		response	paclitaxel
GCST001695		phenotype	negative mood delusions
GCST001698		phenotype	total protein
GCST001699		biomarker	alb
GCST001700		side effect	radiotherapy for prostate cancer
GCST001703		biomarker	apolipoprotein
GCST001704		biomarker	cholesterol and triglycerides
GCST001705		phenotype	platelet reactivity
GCST001706		phenotype	ischemic stroke
GCST001710		biomarker	hba2
GCST001711		biomarker	protein
GCST001712		phenotype	pathological
GCST001715		phenotype	with mood-incongruent psychosis
GCST001716		response	simvastatin
GCST001717		phenotype	chronic/recurrent
GCST001718		phenotype	lung cancer, gastric cancer, and squamous cell carcinoma
GCST001721		phenotype	dna repair capacity
GCST001721		stratified	lung cancer
GCST001722		phenotype	lean body mass
GCST001724		biomarker	igm
GCST001726		response, biomarker	rosuvastatin, lppla2
GCST001727		biomarker	lppla2
GCST001730		response	temozolomide
GCST001731		interaction	environment
GCST001735		phenotype	pr interval
GCST001736		background	type 2 diabetes
GCST001737		background, biomarker	copd, tnf
GCST001737		biomarker	c-reactive protein measurement
GCST001737		biomarker	fibrinogen measurement
GCST001737		biomarker	interleukin-6
GCST001737		biomarker	interleukin-8 measurement
GCST001737		biomarker	surfactant protein d
GCST001738		response	fenofibrate, adiponectin levels
GCST001739		biomarker	ige
GCST001744		drug metabolism	tamsulosin hydrochloride
GCST001746		phenotype	qt interval
GCST001748		phenotype	resting heart rate
GCST001749		survival stratified	adenocarcinoma
GCST001751		response	opiate
GCST001753		interaction	alcohol intake
GCST001754		interaction	smoking (ever vs never)
GCST001755		side effect	paclitaxel
GCST001756		phenotype	bone size (spine)
GCST001760		phenotype	white matter integrity
GCST001762		biomarker	adipoq
GCST001762		biomarker	antioxidant
GCST001762		biomarker	aspartate aminotransferase
GCST001762		biomarker	aspartate aminotransferase, alanine aminotransferase
GCST001762		biomarker	ccl11
GCST001762		biomarker	ccl2
GCST001762		biomarker	ccl5
GCST001762		biomarker	cortisol secretion
GCST001762		biomarker	c-peptide
GCST001762		biomarker	c-reactive protein
GCST001762		biomarker	estradiol
GCST001762		biomarker	fasting blood insulin
GCST001762		biomarker	fatty acid measurement
GCST001762		biomarker	folic acid
GCST001762		biomarker	gpt
GCST001762		biomarker	hdl
GCST001762		biomarker	hdl, triglyceride
GCST001762		biomarker	homocysteine
GCST001762		biomarker	hormone
GCST001762		biomarker	icam-1
GCST001762		biomarker	igf-1
GCST001762		biomarker	igfbp-1
GCST001762		biomarker	igfbp-3
GCST001762		biomarker	interleukin-6
GCST001762		biomarker	ldl
GCST001762		biomarker	leptin
GCST001762		biomarker	testosterone
GCST001762		biomarker	tgfb1
GCST001762		biomarker	tnf
GCST001762		biomarker	total cholesterol
GCST001762		biomarker	triglyceride
GCST001762		biomarker	tshb
GCST001762		biomarker	urinary metabolite
GCST001762		biomarker	urinary nitrogen
GCST001762		biomarker	vitamin b12
GCST001762		phenotype	arm span
GCST001762		phenotype	bmd
GCST001762		phenotype	head circumference
GCST001762		phenotype	heart rate
GCST001762		phenotype	hip circumference
GCST001762		phenotype	homeostasis model assessment of insulin resistance adjusted for bmi
GCST001762		phenotype	insulin sensitivity
GCST001762		phenotype	lean body mass
GCST001762		phenotype	maximal oxygen uptake response
GCST001762		phenotype	metabolic rate
GCST001762		phenotype	obesity-related traits
GCST001762		phenotype	physical activity
GCST001762		phenotype	related traits
GCST001762		phenotype	respiratory quotient
GCST001764		interaction, phenotype	bipolar disorder risk, white matter integrity
GCST001765		biomarker	hemoglobin
GCST001765		phenotype	mean corpuscular hemoglobin
GCST001765		phenotype	mean corpuscular hemoglobin concentration
GCST001765		phenotype	mean corpuscular volume
GCST001767		phenotype	facial
GCST001769		phenotype	alcohol and nicotine co-dependence
GCST001770		drug metabolism	methotrexate for acute lymphoblastic leukemia
GCST001772		response	tnf-alpha inhibitors
GCST001773		response	olanzapine
GCST001773		response	quetiapine
GCST001773		response	risperidone
GCST001773		response	ziprasidone
GCST001774		phenotype	stressful life event
GCST001775		associated disease	hepatitis B
GCST001775		background	hepatitis b infection
GCST001776		biomarker	cardiac troponin-t
GCST001777		biomarker	ldl (oxidized)
GCST001779		biomarker	hemoglobin
GCST001780		phenotype	mean corpuscular hemoglobin
GCST001781		phenotype	mean corpuscular volume
GCST001782		phenotype	mean corpuscular hemoglobin concentration
GCST001784		interaction, phenotype	smoking, pulmonary function
GCST001788		phenotype	digit length ratio
GCST001791		biomarker	urate
GCST001793		biomarker	coagulation factor
GCST001794		interaction or exposure	Snp-SNP interactions
GCST001794		interaction	snp x snp
GCST001796		biomarker	
GCST001798		biomarker	coagulation factor
GCST001798		biomarker	factor viii
GCST001798		biomarker	vwf
GCST001799		biomarker	
GCST001800		biomarker	apoh (beta-2-glycoprotein 1)
GCST001801		biomarker	uric acid
GCST001803		phenotype	corneal curvature
GCST001806		phenotype	corneal structure
GCST001810		phenotype	age at onset
GCST001811		phenotype	mania
GCST001812		response	antidody status, anti-epstein-barr virus (ebna-1)
GCST001813		biomarker	albumin-globulin ratio
GCST001815		background	hepatitis c infection
GCST001816		phenotype	prognosis
GCST001816		stratified	early-onset
GCST001817		biomarker	hva-5-hiaa factor score
GCST001818		biomarker	hva/5-hiaa ratio
GCST001819		phenotype	corneal
GCST001820		biomarker	metabolite levels (5-hiaa)
GCST001821		biomarker	metabolite levels (5-hiaa/ mhpg ratio)
GCST001822		biomarker	metabolite levels (mhpg)
GCST001823		biomarker	hva/mhpg ratio
GCST001824		biomarker	hva
GCST001825		phenotype	beta-trace
GCST001827		background	lung
GCST001827		stratified	lung
GCST001828		phenotype	vascular constriction
GCST001829		phenotype	fat intake
GCST001831		background	brca1/2 negative
GCST001831		stratified	BRCA1/2 negative
GCST001833		interaction	cytomegalovirus infection
GCST001834		biomarker	oleic acid (18:1n-9) levels
GCST001835		response	cholinesterase inhibitors
GCST001836		phenotype	negative symptoms
GCST001837		phenotype	childhood
GCST001838		biomarker	palmitic acid (16:0) levels
GCST001840		biomarker	stearic acid (18:0) levels
GCST001841		biomarker	palmitoleic acid (16:1n-7) levels
GCST001843		interaction	dietary heme iron intake
GCST001844		phenotype	dietary macronutrient intake
GCST001846		biomarker	bilirubin
GCST001847		side effect, phenotype	radiotherapy for prostate cancer, urinary symptoms
GCST001847		treatment side effect	prostate cancer - radiotherapy (urinary symptoms)
GCST001848		biomarker	igg glycosylation
GCST001849		biomarker	igg glycosylation
GCST001852		phenotype	insulin sensitivity
GCST001853		biomarker	vip
GCST001854		background	non-diabetics
GCST001855		response	antiplatelet therapy
GCST001856		biomarker	thyroid stimulating hormone
GCST001856		biomarker	thyroxine
GCST001857		phenotype	susceptibility
GCST001859		side effect	thiazide for hypertensive patients
GCST001861		phenotype	confectionary intake
GCST001862		phenotype	haemolysis
GCST001863		biomarker	beta-2 microglobulin
GCST001864		phenotype	mitral annular calcification
GCST001865		phenotype	aortic valve calcification
GCST001866		background, phenotype	children with dyslexia, mathematical ability
GCST001868		biomarker	amyloid-beta
GCST001869		interaction	menopausal hormone therapy
GCST001871		background	kidney transplantation
GCST001872		phenotype	autoantibody against phospholipid
GCST001873		biomarker	hemoglobin
GCST001873		phenotype	mean corpuscular hemoglobin
GCST001873		phenotype	mean corpuscular hemoglobin concentration
GCST001873		phenotype	mean corpuscular volume
GCST001873		phenotype	red blood cell distribution width
GCST001876		phenotype	anthropometrics
GCST001877		phenotype	attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder
GCST001878		background	kawasaki disease
GCST001881		phenotype	pathological
GCST001882		biomarker	metabolite
GCST001887		phenotype	monocyte count
GCST001889		phenotype	brain connectivity
GCST001890		interaction, phenotype	drug, qt interval
GCST001890		interaction, phenotype	sulfonylurea, qt interval
GCST001890		interaction, phenotype	thiazide, qt interval
GCST001890		side effect, phenotype	tricyclic antidepressant, qt interval
GCST001891		phenotype	ocb status
GCST001892		phenotype	ocb status
GCST001893		phenotype	qrs duration
GCST001895		response	dabigatran etexilate for stroke
GCST001896		phenotype	smooth surface dental caries
GCST001897		phenotype	pit and fissure surface dental caries
GCST001899		phenotype	glaucoma, age-related macular degeneration
GCST001901		response	irinotecan and platinum-based chemotherapy
GCST001901		treatment response	irinotecan plus cisplatin
GCST001902		phenotype	calcification
GCST001903		phenotype	central corneal thickness
GCST001904		biomarker	hdl
GCST001905		biomarker	triglyceride
GCST001906		background	igh translocation
GCST001906		stratified	IgH translocation
GCST001907		background	hyperdiploidy
GCST001907		stratified	hyperdiploidy
GCST001908		background	without bmpr2 mutations
GCST001909		phenotype	narcolepsy with cataplexy
GCST001910		drug metabolism	aspirin
GCST001911		response	bronchodilator
GCST001912		background	childhood
GCST001912		stratified	childhood
GCST001913		interaction	snp x snp
GCST001914		biomarker	estradiol
GCST001914		stratified	plasma estradiol concentrations and aromatase expression
GCST001915		phenotype	cognitive decline
GCST001916		background	brca1 mutation carriers
GCST001916		stratified	BRCA1 positive
GCST001917		background	brca1 mutation carriers
GCST001917		stratified	BRCA1 positive
GCST001918		phenotype	pulmonary function
GCST001920		phenotype	qrs duration
GCST001921		phenotype	heart rate
GCST001922		phenotype	qt interval
GCST001923		biomarker	glomerular filtration rate
GCST001925		phenotype	pr interval
GCST001926		response	etanercept (anti-tnf)
GCST001927		response	anti-tnf therapy
GCST001928		background	pediatric, disease activity score
GCST001930		background	er-negative
GCST001930		stratified	ER-negative
GCST001931		phenotype	combined symptoms
GCST001932		phenotype	hair color
GCST001935		background	non-asthmatics
GCST001940		phenotype	non-melanoma skin cancer
GCST001943		phenotype	inattention symptoms
GCST001944		phenotype	hyperactivity-impulsivity symptoms
GCST001945		background	asthmatics
GCST001946		biomarker	pca3 expression level
GCST001947		phenotype	late onset
GCST001950		phenotype	femoral neck bone geometry and menarche (age at onset)
GCST001951		biomarker	p-tau
GCST001951		biomarker	t-tau
GCST001957		phenotype	early onset extreme
GCST001959		phenotype	eating disorders (purging via substances)
GCST001960		phenotype	eating disorders
GCST001963		phenotype	late onset
GCST001964		background	newborns
GCST001966		phenotype	rhegmatogenous
GCST001969		phenotype	heart rate
GCST001970		phenotype	age at onset
GCST001971		background	hla-dqb1*06:02 negative
GCST001972		phenotype	methamphetamine dependence
GCST001973		phenotype	age at onset
GCST001975		side effect	methamphetamine-induced
GCST001976		biomarker	bilirubin
GCST001978	C562839	phenotype	malignant pleural mesothelioma
GCST001979		biomarker	myeloperoxidase
GCST001980		biomarker	myeloperoxidase
GCST001983		phenotype	occupation-related stress disorder
GCST001985		background	gastric bypass
GCST001987		phenotype	extreme sampling
GCST001988		phenotype	dietary macronutrient intake
GCST001989		phenotype	dietary macronutrient intake
GCST001990		interaction	smoking status
GCST001991		background	gastric bypass
GCST001992		phenotype	non-segmental
GCST001993		side effect	camptothecin
GCST001994		side effect	topoisomerase inhibitors for cancer
GCST001995		side effect	docetaxel
GCST001996		side effect	epirubicin
GCST001997		side effect	5' fluorouracil for cancer
GCST001998		side effect	platinum-based drugs
GCST001999		side effect	paclitaxel
GCST002000		side effect	etoposide
GCST002001		side effect	all antimicrotubule drugs
GCST002002		side effect	cyclophosphamide
GCST002003		side effect	gemcitabine
GCST002004		side effect	carboplatin
GCST002005		side effect	all antimetabolite drugs
GCST002006		side effect	carboplatin
GCST002007		side effect	cisplatin
GCST002008		side effect	all anthracycline-based drugs
GCST002009		side effect	doxorubicin
GCST002010		phenotype	survival time
GCST002010		survival	
GCST002013		phenotype	age at onset
GCST002014		response	igg levels, anti-helicobacter pylori
GCST002017		phenotype	need for surgery
GCST002018		phenotype	time to surgery
GCST002019		biomarker	ige
GCST002022	C563236	phenotype	testicular germ cell tumor
GCST002022	C563236	stratified	testicular germ cell tumor
GCST002023	C563236	phenotype	testicular germ cell tumor
GCST002023	C563236	stratified	testicular germ cell tumor
GCST002025		phenotype	type 2 diabetes
GCST002026		background	kawasaki disease
GCST002027		phenotype	mean corpuscular hemoglobin
GCST002027		phenotype	mean corpuscular hemoglobin concentration
GCST002027		phenotype	mean corpuscular volume
GCST002028		biomarker	selenium
GCST002030		phenotype	primary tooth development (time to first tooth eruption)
GCST002031		phenotype	primary tooth development (number of teeth)
GCST002032		phenotype	survival time
GCST002034		side effect	radiation therapy for prostate cancer
GCST002037		phenotype	adjusted for relateness
GCST002039		biomarker	selenium
GCST002040		biomarker	zinc
GCST002041		biomarker	copper
GCST002042		biomarker	ldl
GCST002043		biomarker	hdl
GCST002044		biomarker	triglyceride
GCST002046		response	citalopram
GCST002049		phenotype	sleep quality
GCST002050		phenotype	sleep time
GCST002051		phenotype	sleep latency
GCST002053		phenotype	sleep duration
GCST002054		phenotype	sleep depth
GCST002059		phenotype	non-word reading
GCST002060		phenotype	word reading
GCST002061		response	warfarin maintenance dose
GCST002062		phenotype	reading and spelling
GCST002063		background	waist circumference
GCST002063		background	waist-hip ratio
GCST002064		phenotype	corneal
GCST002067		response	hydrochlorothiazide
GCST002069		phenotype	systemic lupus erythematosus
GCST002071		phenotype	retinal arteriolar caliber
GCST002072		phenotype	ocb status
GCST002074		side effect	paclitaxel
GCST002075		biomarker	cytokine level
GCST002076		background, phenotype	schizophrenia, hippocampal volume
GCST002083		phenotype	self-reported
GCST002085	C562839	phenotype	malignant mesothelioma
GCST002086		biomarker	c-reactive protein
GCST002087		biomarker	homocysteine
GCST002088		phenotype	childhood onset
GCST002090		side effect	bilateral sagittal split ramus osteotomy
GCST002091		side effect	angiotensin-converting enzyme inhibitor
GCST002092		phenotype	callous-unemotional behaviour
GCST002097		phenotype	calcification
GCST002101		phenotype	susceptibility
GCST002105		phenotype	isobutyraldehyde
GCST002106		phenotype	beta-damascenone
GCST002107		phenotype	beta-ionone
GCST002108		phenotype	due to nickel
GCST002109		phenotype	mean corpuscular hemoglobin
GCST002109		phenotype	mean corpuscular volume
GCST002110		biomarker	c-peptide
GCST002110		biomarker	glycemic traits (pregnancy)
GCST002113		phenotype	pulmonary function
GCST002114		phenotype	molar-incisor hypomineralization
GCST002115		phenotype	axial length
GCST002117		phenotype	severe
GCST002118		biomarker	pyroglutamine
GCST002119		biomarker	hydroxy-leucine
GCST002120		biomarker	dihydroxy docosatrienoic acid
GCST002122		background, biomarker	asthmatics, ige
GCST002124		background, biomarker	asthmatics (d.p. specific mite), ige
GCST002125		background, biomarker	asthmatics (d.f. specific mite), ige
GCST002131		interaction	generation
GCST002132		phenotype	non-substance related disinhibited behaviour
GCST002133		phenotype	illegal drug consumption
GCST002135		phenotype	nicotine use
GCST002139		background, phenotype	joint damage progression in acpa-positive rheumatoid arthritis
GCST002141		response, phenotype, biomarker	treatment, remission
GCST002144		phenotype	bitter
GCST002145		phenotype	infantile
GCST002146		biomarker	alpha-1-antitrypsin
GCST002147		biomarker	fibrinogen
GCST002148		phenotype	chronic/recurrent
GCST002153		background	diabetics
GCST002154		response	bronchodilator
GCST002156		response	mtor inhibitor (rapamycin)
GCST002157		response	mtor inhibitor (everolimus)
GCST002161		phenotype	neuritic plaque pathology
GCST002162		phenotype	fvc
GCST002163		phenotype	maximal midexpiratory flow rate
GCST002164		phenotype	fev1/fec ratio
GCST002165		phenotype	fev1
GCST002166		biomarker	il1rl1
GCST002167		phenotype	mean arterial pressure
GCST002167		phenotype	pulse pressure
GCST002169		phenotype	severe
GCST002170	C566903	phenotype	mesial temporal lobe epilepsy with hippocampal sclerosis
GCST002173		biomarker	hdl
GCST002173		biomarker	ldl
GCST002173		biomarker	triglyceride
GCST002174		biomarker	hdl
GCST002174		biomarker	ldl
GCST002174		biomarker	total cholesterol
GCST002174		biomarker	triglyceride
GCST002175		phenotype	reading disability and language impairment
GCST002176		side effect	cyclophosphamide+epirubicin+/-5fu for breast cancer
GCST002176		treatment side effect	breast cancer - cyclophosphamide+epirubicin+/-5FU (alopecia)
GCST002177		side effect	anti-microtubule for breast cancer
GCST002177		treatment side effect	breast cancer - anti-microtubule chemotherapy (alopecia)
GCST002178		side effect	cyclophosphamide+doxorubicin+/-5fu for breast cancer
GCST002178		treatment side effect	breast cancer - cyclophosphamide+doxorubicin+/-5FU (alopecia)
GCST002179		side effect	paclitaxel for breast cancer
GCST002179		treatment side effect	breast cancer - paclitaxel (alopecia)
GCST002180		side effect	docetaxel for breast cancer
GCST002180		treatment side effect	breast cancer - docetaxel (alopecia)
GCST002181		side effect	chemotherapy for breast cancer
GCST002181		treatment side effect	breast cancer - chemotherapy (alopecia)
GCST002182		background, phenotype	type 1 diabetes, end-stage renal disease
GCST002183		biomarker	relative hand skill
GCST002184		phenotype	mean platelet volume
GCST002185		phenotype	relative hand skill
GCST002187		background	sickle cell anemia
GCST002188		phenotype	functional impairment in major depressive disorder, bipolar disorder and schizophrenia
GCST002191		phenotype	age at onset
GCST002192		phenotype	age at onset
GCST002195		biomarker	estradiol
GCST002195		biomarker	shgb
GCST002195		biomarker	testosterone
GCST002196		biomarker	homoarginine
GCST002199		biomarker	follicle stimulating hormone
GCST002200		phenotype	major depressive disorder
GCST002201		biomarker	calcium level
GCST002202		background	major depressive disorder
GCST002203		interaction, phenotype	schizophrenia, gray matter volume
GCST002204		background	chronic hepatitis b
GCST002205		phenotype	handedness
GCST002206		phenotype	handedness
GCST002207		biomarker	gpt
GCST002208		biomarker	aspartate aminotransferase
GCST002211		phenotype	atypical
GCST002212		phenotype	advanced colorectal adenoma
GCST002213		interaction	smoking status, coronary artery calcification
GCST002214		biomarker	alkaline phosphatase
GCST002216		biomarker	triglyceride
GCST002219		biomarker	triglyceride
GCST002220		biomarker	ldl
GCST002221		biomarker	total cholesterol
GCST002222		biomarker	ldl
GCST002223		biomarker	hdl
GCST002225		phenotype	disc degeneration (lumbar)
GCST002228		phenotype	social autistic-like traits
GCST002229		phenotype	severe teenage
GCST002231		phenotype	barrett's esophagus and esophageal adenocarcinoma
GCST002232	C562730		
GCST002232		stratified	adenocarcinoma
GCST002233		biomarker	adipoq
GCST002235		response	opiate
GCST002236		background	childhood
GCST002238		phenotype	contrast sensitivity
GCST002239		biomarker	dimethylarginine
GCST002241		biomarker	asymmetrical dimethylarginine
GCST002242		biomarker	dimethylarginine
GCST002245		phenotype	late onset
GCST002247		phenotype	cold pressor
GCST002247		phenotype	mean arterial pressure (cold pressor test)
GCST002248		interaction	dietary factor
GCST002249		response	high sodium
GCST002249		response	high sodium diet
GCST002249		response, phenotype	high sodium intervention, mean arterial pressure
GCST002250		response	low sodium
GCST002250		response	low sodium diet
GCST002250		response, phenotype	low sodium intervention, mean arterial pressure
GCST002251		interaction	dietary factor
GCST002252		response	high sodium and potassium intervention
GCST002252		response	high sodium diet, dietary potassium supplementation
GCST002252		response, phenotype	high sodium and potassium intervention, mean arterial pressure
GCST002253		interaction	dietary factor
GCST002254		phenotype	schizophrenia, schizoaffective disorder or bipolar disorder
GCST002255		biomarker	interleukin-1 beta
GCST002255		biomarker	interleukin 1 receptor antagonist
GCST002256		phenotype	tooth agenesis (third molar)
GCST002257		phenotype	tooth agenesis (maxillary third molar)
GCST002258		phenotype	tooth agenesis (mandibular third molar)
GCST002259		phenotype	narcolepsy with cataplexy
GCST002260		phenotype	narcolepsy with cataplexy
GCST002261		phenotype	narcolepsy with cataplexy, age at onset
GCST002262		response	antihypertensive
GCST002263		side effect, phenotype	nsaid, acute urticaria
GCST002265		interaction	menopausal hormone therapy
GCST002265		treatment response	menopausal hormone replacement therapy
GCST002266		interaction	menopausal hormone therapy
GCST002266		treatment response	menopausal hormone replacement therapy
GCST002270		biomarker	glycated hemoglobin levels
GCST002271		phenotype	delayed encephalopathy
GCST002274		pleiotropy	amyotrophic lateral sclerosis
GCST002275		phenotype	childhood onset
GCST002278		background, phenotype	seropositive for tripanosoma cruzi, qt interval
GCST002279		background, phenotype	seropositive for tripanosoma cruzi, pr interval
GCST002280		phenotype	antibody status, seropositive for tripanosoma cruzi
GCST002281		phenotype	seropositive for tripanosoma cruzi, ejection fraction
GCST002282		background	seropositive for tripanosoma cruzi
GCST002283	C531617	phenotype	sporadic
GCST002284		background, phenotype	seropositive for tripanosoma cruzi, qrs duration
GCST002285		background	seropositive for tripanosoma cruzi
GCST002287		phenotype	ischemic stroke
GCST002288		phenotype	large artery
GCST002290		phenotype	large artery, coronary artery
GCST002291		interaction, response	inhaled corticosteroid treatment, bronchodilator
GCST002292		response	alcohol consumption
GCST002294		phenotype	max drinks
GCST002295		phenotype	schizophrenia or bipolar disorder
GCST002296		interaction	educational attainment (years of education)
GCST002297		response	hepatitis b vaccine
GCST002302		biomarker	ige
GCST002303		biomarker	glycated hemoglobin levels
GCST002304		phenotype	nitric oxide exhalation
GCST002306		interaction	body mass index
GCST002307		interaction	alcohol consumption
GCST002308		interaction, phenotype	alcohol consumption, mean arterial pressure
GCST002309		interaction	alcohol consumption
GCST002310		interaction, phenotype	alcohol consumption, pulse pressure
GCST002311		biomarker	uric acid
GCST002312		phenotype	related phenotypes
GCST002314		biomarker	glomerular filtration rate
GCST002315		phenotype	thrombin generation potential
GCST002319	C566973	phenotype	musician's dystonia
GCST002321		biomarker	hdl
GCST002321		biomarker	ldl
GCST002321		biomarker	total cholesterol
GCST002321		biomarker	triglyceride
GCST002322		phenotype	asthma and hay fever
GCST002325		phenotype	memory performance
GCST002328		phenotype	lung function
GCST002329		phenotype	severe
GCST002332		phenotype	early onset
GCST002333		phenotype	heel (velocity of sound)
GCST002334		phenotype	heel bmd
GCST002335		phenotype	bone ultrasound measurement (heel)
GCST002337	C531617	phenotype	sporadic
GCST002339		phenotype	younng onset, obesity
GCST002342		response	corticosteroid
GCST002343		response	gemcitabine
GCST002345		response	cytosine arabinoside
GCST002346		background	early-onset
GCST002346		stratified	early-onset
GCST002347		response, biomarker	protease inhibitor (bilirubin toxicity)
GCST002348		interaction	environmental tobacco smoke
GCST002349		response, biomarker	protease inhibitor (peak serum total bilirubin levels)
GCST002350		phenotype	severe
GCST002351		phenotype	moderate to severe
GCST002355		biomarker	uric acid
GCST002357		phenotype	acpa-negative
GCST002358		phenotype	pit and fissure surface dental caries
GCST002359		biomarker	beta-amyloid 1-42 in plasma
GCST002360		biomarker	beta-amyloid 1-40 in plasma
GCST002361		phenotype	smooth surface dental caries
GCST002362		phenotype	preschool internalizing problems
GCST002363		response	anti-retroviral therapy (ddi/d4t) in hiv-1 infection (grade 3 peripheral neuropathy)
GCST002364		biomarker	urinary metabolite
GCST002365		response	anti-retroviral therapy (ddi/d4t) in hiv-1 infection (grade 2 peripheral neuropathy)
GCST002366		response	anti-retroviral therapy (ddi/d4t) in hiv-1 infection (grade 1 peripheral neuropathy)
GCST002368		phenotype	maternal genotype effects in families
GCST002369		background	parent of origin effect on language impairment (maternal)
GCST002371		background	parent of origin effect on language impairment (paternal)
GCST002372		phenotype	political ideology
GCST002373		phenotype	autoantibody against thyroid peroxidase
GCST002374		biomarker	plat
GCST002375		response	methotrexate
GCST002376		biomarker	urinary uromodulin
GCST002377	C563990	biomarker	white matter hyperintensity volume
GCST002378		phenotype	autoantibody against thyroid peroxidase
GCST002379		background	inflammatory bowel disease
GCST002380		background	inflammatory bowel disease
GCST002381		biomarker	resistin
GCST002382		background, phenotype	type 1 diabetes, urinary albumin excretion rate
GCST002383		phenotype	anterior chamber depth
GCST002384		biomarker	nhdl cholesterol
GCST002387		phenotype	musical aptitude
GCST002388		biomarker	serum metabolite
GCST002390		biomarker	glycated hemoglobin levels
GCST002391		biomarker	homocysteine
GCST002392		interaction or exposure	smoke
GCST002392		interaction	smoking
GCST002393		phenotype	quantity
GCST002394		phenotype	age of smoking initiation
GCST002396		phenotype	age of initiation
GCST002397		interaction or exposure	smoking
GCST002397		interaction	smoking
GCST002398		phenotype	resting heart rate
GCST002400		biomarker	trimethylamine n-oxide in plasma
GCST002402		biomarker	iga
GCST002403		phenotype	85 years and older
GCST002404		phenotype	90 years and older
GCST002405		background	hpv-associated
GCST002405		stratified	HPV-associated
GCST002406		background, biomarker	plasma cystastin c levels in acute coronary syndrome
GCST002408		response	methotrexate
GCST002409		phenotype	white matter microstructure (global fractional anisotropy)
GCST002410		phenotype	hand, severe
GCST002412		survival	
GCST002413		phenotype	early-onset
GCST002413		stratified	early-onset
GCST002414		biomarker	vitamin d-binding protein
GCST002415		interaction	diet
GCST002415		interaction or exposure	diet
GCST002416		phenotype	autoantibody against thyroid peroxidase
GCST002417		biomarker	tshb
GCST002418		biomarker	thyroxine
GCST002420		background	bipolar disorder
GCST002421		stratified	PSA-detected
GCST002423		phenotype	type-1
GCST002424		biomarker	c-reactive protein
GCST002426		phenotype	genital enlargement
GCST002427		phenotype	breast development
GCST002428		interaction, background	statin, elderly
GCST002430		phenotype	hippocampal sclerosis of aging
GCST002431		response	radiotherapy (late toxicity)
GCST002431		side effect, phenotype	radiotherapy for cancer, late toxicity
GCST002431		treatment side effect	cancer - radiotherapy (late toxicity)
GCST002432		response, phenotype	inhaled corticosteroid, change in fev1
GCST002438	C535464	phenotype	conotruncal heart defects
GCST002439		phenotype	mathematical ability
GCST002441		response	measles-mumps-rubella vaccine
GCST002442		biomarker	metabolite levels
GCST002443		biomarker	metabolite levels
GCST002444		biomarker	omega-6 pufa (dihomo-gamma-linolenic acid)
GCST002445		interaction	sex
GCST002446		biomarker	omega-6 pufa (linoleic acid)
GCST002447		biomarker	resting oxygen saturation
GCST002448		biomarker	omega-6 pufa (adrenic acid)
GCST002449		biomarker	omega-6 pufa (arachidonic acid)
GCST002450		biomarker	omega-6 pufa (gamma-linolenic acid)
GCST002456		phenotype	pr segment
GCST002457		phenotype	p wave duration
GCST002458		biomarker	tshb
GCST002459		phenotype	lean body mass
GCST002462		interaction	snp x snp
GCST002464		background, phenotype	type 1 diabetes, end-stage renal disease or diabetic nephropathy
GCST002465		response	haloperidol
GCST002466		phenotype	squamous
GCST002467		biomarker	total cholesterol
GCST002468		biomarker	triglyceride
GCST002469		biomarker	hdl
GCST002470		background	young-onset, pulse pressure
GCST002471		interaction	anthropometric measures
GCST002472		background	tonsillectomy and adenoidectomy surgery
GCST002473		response	rate control therapy
GCST002474		background	high-grade
GCST002474		stratified	high-grade
GCST002476		biomarker	
GCST002477		phenotype	age at onset
GCST002478		background	familial hypercholesterolemia
GCST002479		background	systemic lupus erythematosus
GCST002481		phenotype	severe
GCST002482		interaction	smoking
GCST002483		phenotype	fvc
GCST002484		phenotype	skin fluorescence
GCST002485		biomarker	
GCST002485		biomarker	carcinoembryonic antigen
GCST002487		interaction	snp x snp
GCST002488		response	autoantibody against cyclic citrullinated peptide
GCST002489		biomarker	rheumatoid factor
GCST002491		phenotype	age-related hearing impairment
GCST002492		phenotype	pediatric, lower limb
GCST002493		phenotype	pediatric, skull
GCST002494		phenotype	pediatric, total body less head
GCST002495		interaction	age
GCST002495		interaction, phenotype	age, mean arterial pressure
GCST002495		interaction, phenotype	age, pulse pressure
GCST002496		phenotype	pediatric, upper limb
GCST002497		phenotype	mean arterial pressure
GCST002497		phenotype	pulse pressure
GCST002498	C563333	phenotype	age-related nuclear cataracts
GCST002500		phenotype	qt interval
GCST002502		phenotype	corneal curvature
GCST002503		background	depression or bipolar disorder
GCST002505		background	depression or bipolar disorder
GCST002507		background	type 2 diabetes
GCST002510		phenotype	amyotrophic lateral sclerosis or frontotemporal dementia
GCST002511		side effect	radiotherapy for prostate cancer
GCST002511		treatment side effect	prostate cancer - radiotherapy (toxicity)
GCST002513		interaction	snp x snp
GCST002515		background	silica exposure
GCST002517		interaction	time
GCST002518		background, biomarker	igg levels, anti-food antigen
GCST002519		background	asthma
GCST002521		phenotype	fev1
GCST002522		phenotype	reading or mathematical ability
GCST002526		biomarker	cortisol levels (plasma)
GCST002530		biomarker	serum lipase
GCST002531		biomarker	cerebrospinal ab1-42 levels
GCST002532		biomarker	serum lipase, high
GCST002533		phenotype	qrs duration
GCST002534		background	chronic hepatitis c infection
GCST002535		phenotype	pr interval
GCST002536		biomarker	hemoglobin a2 levels
GCST002538		background	height adjusted
GCST002540		biomarker	oa biomarkers
GCST002541		phenotype	age at onset
GCST002542		phenotype	pr interval
GCST002542		phenotype	qrs duration
GCST002542		phenotype	qt interval
GCST002546		biomarker	osteoprotegerin
GCST002549		response	serotonin reuptake inhibitors (plasma drug and metabolite levels)
GCST002551		background	non-asthmatics
GCST002552		background	asthma
GCST002554		interaction, biomarker	left inferior lateral ventricle volume, t-tau (csf)
GCST002554		interaction	cerebrospinal fluid ab1-42 levels
GCST002555		phenotype	monocyte count
GCST002557		phenotype	neutrophil count
GCST002558		side effect, phenotype	phenytoin, severe cutaneous adverse reaction
GCST002559		background, biomarker	ischemic stroke, folic acid
GCST002559		background, biomarker	ischemic stroke, vitamin b12
GCST002559		background, biomarker	ischemic stroke, vitamin b6
GCST002564		phenotype	early onset
GCST002565		phenotype	sleep duration
GCST002566		side effect	bevacizumab for breast cancer (cumulative dose)
GCST002566		treatment side effect	breast cancer - bevacizumab (hypertension)
GCST002567		side effect	bevacizumab for breast cancer
GCST002567		treatment side effect	breast cancer - bevacizumab (hypertension)
GCST002569		phenotype	underweight body mass index
GCST002570		phenotype	overweight
GCST002572		phenotype	left-sided heart lesions
GCST002574		phenotype	left-sided heart lesions (maternal effect)
GCST002577		phenotype	survival time
GCST002577		survival stratified	early stage
GCST002578		biomarker	ferritin
GCST002579		phenotype	heschl's gyrus morphology
GCST002581		phenotype	high intraocular pressure
GCST002583		response	losartan
GCST002584		biomarker	exhaled carbon monoxide
GCST002585		phenotype	autoantibody against nuclear target(s)
GCST002587		interaction	smoking
GCST002589		phenotype	hippocampal sclerosis of aging
GCST002590		phenotype	vascular brain injury
GCST002594		biomarker	neurofibrillary tangles
GCST002595		side effect	clozapine
GCST002596		interaction	calcium intake
GCST002597		phenotype	laryngeal
GCST002597		stratified	laryngeal
GCST002599		phenotype	90 years and older
GCST002600		side effect	thiazide diuretic
GCST002601		biomarker	plasminogen in plasma
GCST002602		biomarker	vitamin d
GCST002603		side effect, biomarker	statin users, creatine kinase
GCST002604		phenotype	treatment refractory
GCST002605		side effect	high-dose melphalan for multiple myeloma
GCST002607		side effect	azathioprine and mercaptopurine for inflammatory bowel disease
GCST002608		phenotype	fev change
GCST002608		phenotype	pulmonary function
GCST002609		phenotype	iron binding capacity
GCST002610		phenotype	childhood
GCST002611		background	infants
GCST002612		phenotype	chronic mucus hypersecretion
GCST002616		phenotype	mitochondrial dna levels
GCST002618		phenotype	age at onset
GCST002619		phenotype	age-related cataracts
GCST002620		biomarker	asymmetrical dimethylarginine
GCST002621		background	chronic obstructive pulmonary disease
GCST002622		biomarker	symmetrical dimethylarginine
GCST002623		biomarker	l-arginine
GCST002626		phenotype	vertical cup-disc ratio
GCST002628		background	extreme obesity
GCST002632		background	extreme obesity
GCST002635		interaction	sex
GCST002636		phenotype	diffuse
GCST002637		response	medication adherence
GCST002639		phenotype	related traits
GCST002640		biomarker	inflammatory
GCST002641		interaction, phenotype	psychosocial stress, hip circumference
GCST002642		response, biomarker	simvastatin, pcsk9
GCST002644		background	birth
GCST002646		background	infants
GCST002648		phenotype	persistent
GCST002649		phenotype	nicotine glucuronidation
GCST002650		phenotype	coffee consumption (cups per day)
GCST002651		phenotype	coffee consumption
GCST002652		biomarker	cotinine glucuronidation
GCST002653		biomarker	vitamin k
GCST002654		phenotype	shingles
GCST002656		background	bipolar disorder
GCST002657		background	childhood
GCST002657		stratified	childhood
GCST002659		phenotype	disease-related phenotypes
GCST002661		interaction, biomarker	snp x snp, hdl
GCST002663		phenotype	superior frontal gyrus grey matter volume
GCST002664		phenotype	maximal oxygen uptake response
GCST002665		biomarker	angiotensin-converting enzyme
GCST002665		biomarker	ccl2
GCST002665		biomarker	ccl4
GCST002665		biomarker	interleukin-6
GCST002665		biomarker	matrix metalloproteinase
GCST002666		biomarker	interferon alpha levels
GCST002667		phenotype	dense area
GCST002667		stratified	dense area
GCST002668		phenotype	non-dense area
GCST002668		stratified	non-dense area
GCST002670		biomarker	selenium, blood and toenail
GCST002671		biomarker	selenium, toenail
GCST002672		phenotype	mmr vaccine related
GCST002673		phenotype	mmr vaccine unrelated
GCST002674		side effect	mmr vaccine-related
GCST002675		response, biomarker	statin, ldl
GCST002677		biomarker	ferritin
GCST002678		biomarker	transferrin
GCST002679		biomarker	iron
GCST002680		biomarker	transferrin saturation
GCST002682		phenotype	tourette's syndrome
GCST002683		phenotype	pulmonary function
GCST002684		background	type 2 diabetes
GCST002685		phenotype	refractive
GCST002686		biomarker	protein c
GCST002687		biomarker	fetal hemoglobin levels
GCST002688		biomarker	very long-chain saturated fatty acid levels (fatty acid 22:0)
GCST002689		biomarker	very long-chain saturated fatty acid levels (fatty acid 24:0)
GCST002690		biomarker	very long-chain saturated fatty acid levels (fatty acid 20:0)
GCST002691		side effect	red blood cell transfusion for sickle cell anemia
GCST002694		phenotype	general cognitive ability
GCST002698		biomarker	vegfr2
GCST002699		background	bipolar disorder
GCST002701		phenotype	verbal declarative memory
GCST002703		biomarker	
GCST002704		phenotype	nitric oxide exhalation
GCST002705		phenotype	hashimoto thyroiditis versus graves' disease
GCST002707		biomarker	tshb
GCST002708		phenotype	acoustic startle blink response
GCST002709		phenotype	alpha peak frequency measurement, alpha wave measurement, electroencephalogram measurement
GCST002709		phenotype	alpha wave measurement, electroencephalogram measurement
GCST002709		phenotype	beta wave
GCST002709		phenotype	delta wave
GCST002709		phenotype	theta wave
GCST002710		phenotype	anti-saccade response
GCST002711		phenotype	sleep duration
GCST002712		background, biomarker	linoleic acid in rbc
GCST002712		background, biomarker	linolenic acid in rbc
GCST002712		background, biomarker	oleic acid in rbc
GCST002712		background, biomarker	red blood cell fatty acid levels
GCST002712		biomarker	arachidonic acid, fatty acid
GCST002712		biomarker	docosapentaenoic acid in rbc
GCST002713		background	adolescents and young adults
GCST002713		stratified	adolescents
GCST002714		biomarker	renin activity in plasma
GCST002715		phenotype	duration
GCST002716		background	type 1 diabetes
GCST002717		biomarker	ige
GCST002720		phenotype	gfr change
GCST002720		phenotype	glomerular filtration rate
GCST002720		phenotype	rapid decline
GCST002721		biomarker	cis/trans-18:2 fatty acid
GCST002721		biomarker	trans fatty acid (trans-16:1n-7)
GCST002721		biomarker	trans fatty acid (trans-18:1)
GCST002721		biomarker	trans fatty acid (trans-18:1, cis/trans-18:2)
GCST002721		biomarker	trans fatty acid (trans-18:1, trans-16:1n-7 )
GCST002721		biomarker	trans fatty acid (trans-18:1, trans/cis-18:2)
GCST002721		biomarker	trans fatty acid (trans/cis-18:2)
GCST002721		biomarker	trans fatty acid (trans/trans-18:2)
GCST002722		side effect	heparin
GCST002723		phenotype	urgency
GCST002724		background	chronic obstructive pulmonary disease
GCST002725		background, phenotype	pneumonia, survival time
GCST002726		phenotype	glucose effectiveness
GCST002726		phenotype	insulin response
GCST002726		phenotype	insulin sensitivity
GCST002727		phenotype	survival time
GCST002727		survival	
GCST002729		background	crohn's disease
GCST002729		phenotype	perianal
GCST002729		phenotype	stricture
GCST002731		phenotype	endothelial growth factor, angiopoietin-2 receptor
GCST002731		phenotype	endothelial growth factor, hepatocyte growth factor
GCST002734		interaction, biomarker	smoking status, alcohol consumption or body mass index, fibrinogen
GCST002736		biomarker	b-type natriuretic peptide
GCST002739		interaction	household air pollution
GCST002743		background	hiv-infection
GCST002744		background, biomarker	hiv-infection, hdl
GCST002745		background	hiv-1 infection (continuous)
GCST002746		biomarker	lipoprotein a
GCST002747		response	dalcetrapib
GCST002749		response	homoharringtonine
GCST002751		phenotype	spontaneous preterm birth
GCST002753		background	familial
GCST002754		response, phenotype	inhaled glucocorticoid, change in fev1
GCST002755		interaction	ssri exposure
GCST002756		phenotype	subcortical brain region volumes
GCST002757		biomarker	immunoglobulin g index levels
GCST002758		phenotype	oligoclonal band status
GCST002760		phenotype	hippocampal atrophy
GCST002761		phenotype	hippocampal volume
GCST002762		phenotype	optic cup area
GCST002763		phenotype	optic disc area
GCST002764		phenotype	optic cup area
GCST002765		phenotype	optic disc area
GCST002766		phenotype	exudative
GCST002768		phenotype	behavioral disinhibition
GCST002769		response	abacavir-containing treatment in hiv-1 infection (virologic failure)
GCST002771		response	efavirenz-containing treatment in hiv 1 infection (virologic failure)
GCST002774		phenotype	cognitive function
GCST002775		phenotype	survival time
GCST002777		side effect	clozapine
GCST002778		phenotype	lewy body
GCST002779		side effect	cold medicine, severe mucosal involvement
GCST002780		side effect	cisplatin for brain tumor
GCST002782			bmi adjusted
GCST002784		response	hydrochlorothiazide
GCST002786		background	lung tissue
GCST002792		side effect	vincristine for acute lymphoblastic leukemia
GCST002793		response	vein graft stenosis in coronary artery bypass grafting
GCST002796		response	bronchodilator
GCST002797		background	chronic obstructive pulmonary disease
GCST002798		phenotype	chronic obstructive pulmonary disease
GCST002799		phenotype	number of pregnancies
GCST002800		phenotype	number of children (6+ vs. 0 or 1)
GCST002801		phenotype	number of children
GCST002802		phenotype	white wine liking
GCST002803		phenotype	red wine liking
GCST002804		phenotype	seropositive for chlamydia pneumoniae
GCST002804		phenotype	seropositive for cytomegalovirus
GCST002804		phenotype	seropositive for herpes virus
GCST002804		phenotype	seropositive for human herpesvirus 8
GCST002804		phenotype	seropositive for influenza a
GCST002811		phenotype	nonsyndromic cleft lip with or without cleft palate
GCST002812		interaction	seropositive for cytomegalovirus
GCST002812		interaction	seropositive for herpes simplex virus 1
GCST002812		interaction	seropositive for toxoplasma gondii
GCST002813		background	apoe e4+ carriers
GCST002814		interaction	apoe carrier
GCST002815		interaction	seropositive for cytomegalovirus
GCST002815		interaction	seropositive for herpes simplex virus 1
GCST002816		interaction	aspirin and/or nsaid use
GCST002816		interaction or exposure	aspirin/NSAID
GCST002817		background	apoe e4- carriers
GCST002818		phenotype	susceptibility
GCST002820		phenotype	microsatellite instability low/stable
GCST002820		survival	
GCST002821		phenotype	survival
GCST002821		survival	
GCST002822		phenotype	survival
GCST002822		survival	
GCST002826		interaction, biomarker	bmi, urate
GCST002827		interaction, biomarker	bmi, urate
GCST002828		background, phenotype	obese individuals, urate levels
GCST002829		background	overweight individuals, urate
GCST002830		background	lean individuals, urate
GCST002831		biomarker	lead levels
GCST002833		response	platinum-induced myelosuppression in non-small cell lung cancer
GCST002833		treatment side effect	non-small-cell lung cancer patients - platinum-based chemotherapy (myelosuppression)
GCST002834		phenotype	corneal curvature
GCST002836		phenotype	axial length
GCST002837		side effect	steroid treatment (triamcinolone acetonide)
GCST002839		phenotype	polychlorinated biphenyl levels
GCST002843		phenotype	sitting height ratio
GCST002847		phenotype	survival
GCST002847		survival	
GCST002850		phenotype	information processing speed
GCST002851		phenotype	tae-yang
GCST002852		phenotype	so-yang
GCST002853		phenotype	tae-eum
GCST002854		phenotype	so-eum
GCST002855	C563236	background	testicular germ cell tumor
GCST002855	C563236	stratified	testicular germ cell tumor
GCST002856		interaction, phenotype	sex, intima media thickness
GCST002857		biomarker	calcium level
GCST002858		response, biomarker	interleukin-6, response to corticosteroid, response to cytokine
GCST002859		response, biomarker	interleukin-6, response to cytokine
GCST002860		biomarker	magnesium
GCST002861		background	er-negative
GCST002861		phenotype	er-positive, survival time
GCST002861		phenotype	survival time
GCST002861		survival	
GCST002862		phenotype	prion disease
GCST002863		background	prion disease
GCST002864		background	prion disease
GCST002865		response, biomarker	statin, ldl
GCST002866		background	prion disease
GCST002867		background	prion disease
GCST002868		response	serotonin reuptake inhibitors
GCST002869		response	anti-tnf therapy (adalimumab, etanercept or infliximab)
GCST002870		biomarker	ldl subfractions
GCST002871		phenotype	prion disease
GCST002872		biomarker	mannose, blood metabolite
GCST002872		biomarker	metabolite levels
GCST002872		biomarker	urate
GCST002875		side effect	diisocyanate
GCST002876		phenotype	type 1 diabetes
GCST002878		phenotype	sporadic
GCST002881		biomarker	adamts13
GCST002882		drug metabolism	ticagrelor levels in acute coronary syndromes
GCST002883		drug metabolism	ticagrelor for acute coronary syndrome
GCST002885		drug metabolism	pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)
GCST002886		phenotype	aggressiveness
GCST002887		drug metabolism	pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)
GCST002888		drug metabolism	pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)
GCST002890		stratified	aggessiveness
GCST002891		drug metabolism	pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)
GCST002892		background	coronary artery bypass surgery
GCST002893		interaction	age
GCST002896		biomarker	total cholesterol
GCST002897		biomarker	triglyceride
GCST002898		biomarker	ldl
GCST002899		biomarker	hdl
GCST002900		side effect	adult survivors of childhood cancer exposed to cranial radiation
GCST002900		treatment side effect	childhood cancer - cranial radiation (obesity)
GCST002901		response, phenotype	endocrine treated, er-positive, survival time
GCST002901		treatment response	endocrine therapy
GCST002902		background	er-negative
GCST002903		phenotype	er-positive, survival time
GCST002904		associated disease	adult survivors of childhood cancer
GCST002904		background	adult survivors of childhood cancer not exposed to cranial radiation
GCST002905		background	healthy individuals
GCST002906		phenotype	skin colour saturation
GCST002907		phenotype	perceived skin darkness
GCST002908		phenotype	skin sensitivity to sun
GCST002910		response	interferon beta
GCST002911		biomarker	calcium level
GCST002912		phenotype	narcolepsy with cataplexy
GCST002913		background	type 1 autoimmune pancreatitis
GCST002915		side effect	peg-asparaginase for acute lymphoblastic leukemia
GCST002916		phenotype	initiation
GCST002917		phenotype	age at onset
GCST002918		side effect	lapatinib
GCST002922		associated disease	monoclonal gammopathy
GCST002922		phenotype	monoclonal gammopathy
GCST002923		side effect	paclitaxel
GCST002924		side effect	paclitaxel
GCST002924		treatment side effect	paclitaxel (sensory peripheral neuropathy)
GCST002925		biomarker	dehydroepiandrosterone sulphate
GCST002925		biomarker	estradiol
GCST002925		biomarker	follicle stimulating hormone
GCST002925		biomarker	free androgen index
GCST002925		biomarker	luteinizing hormone
GCST002925		biomarker	progesterone
GCST002925		biomarker	sex hormone-binding globulin
GCST002925		biomarker	testosterone
GCST002926		background	asthma (oral corticosteroid dose interaction)
GCST002927		biomarker	mercury levels
GCST002928		biomarker	nickel levels
GCST002929		biomarker	chromium levels
GCST002930		biomarker	cobalt levels
GCST002931		biomarker	aluminium levels
GCST002932		biomarker	manganese levels
GCST002933		biomarker	magnesium
GCST002934		biomarker	zinc levels
GCST002935		biomarker	lead levels
GCST002936		biomarker	cadmium levels
GCST002937		biomarker	molybdenum levels
GCST002938		biomarker	copper levels
GCST002939		phenotype	platelet aggregation
GCST002940		background	sporadic adenoma
GCST002940		stratified	sporadic adenoma
GCST002942		phenotype	gas trapping
GCST002946		response	vancomycin, trough
GCST002947		response	vancomycin
GCST002948		side effect, biomarker	vancomycin therapy, creatinine
GCST002949		side effect	lamotrignine for epilepsy
GCST002951		interaction, response	zileuton treatment
GCST002952		phenotype	pediatric bone mineral content (radius)
GCST002953		phenotype	radius, pediatric
GCST002954		phenotype	late onset
GCST002955		interaction, phenotype	occupational environmental exposures (biological dust), fev1
GCST002955		interaction, phenotype	occupational environmental exposures (gases and fumes), fev1
GCST002955		interaction, phenotype	occupational environmental exposures (mineral dust), fev1
GCST002956		biomarker	3-hydroxypropylmercapturic acid levels
GCST002957		biomarker	3-hydroxy-1-methylpropylmercapturic acid levels
GCST002958		background	allogeneic hematopoietic stem cell transplantation
GCST002959		biomarker	hexose levels
GCST002961		biomarker	acylcarnitine
GCST002962		phenotype	exacerbations
GCST002964		biomarker	sphingolipid
GCST002965		biomarker	glycerophospholipid
GCST002966		biomarker	amino acid levels
GCST002967		background	mucinous adenocarcinoma
GCST002967		stratified	mucinous adenocarcinoma
GCST002968		side effect	stavudine for hiv
GCST002969		phenotype	suicide behaviour
GCST002970		phenotype	corticobasal degeneration
GCST002971		phenotype	corticobasal degeneration
GCST002972		background	major depressive disorder
GCST002974		background	major depressive disorder
GCST002975		side effect	coronary artery bypass grafting surgery
GCST002976		phenotype	setpoint viral load
GCST002977		biomarker	srage measurement
GCST002978		associated disease	in osteosarcoma
GCST002978		background	osteosarcoma
GCST002979		response, phenotype	montelukast, change in fev1
GCST002980		phenotype	arterial stiffness (pulse-wave velocity)
GCST002982		side effect, biomarker	coronary artery bypass surgery, creatinine rise
GCST002983		phenotype	late onset
GCST002984		phenotype	early childhood
GCST002985		phenotype	middle childhood and early adolescence
GCST002986		phenotype	childhood and early adolescence
GCST002989		interaction	total fat intake
GCST002990		stratified	adenocarcinoma
GCST002993		side effect	platinum-based chemotherapy for nsclc
GCST002994		phenotype	ear protrusion
GCST002996		phenotype	folding of antihelix
GCST002997		phenotype	helix rolling
GCST002998		phenotype	lobe attachment
GCST002999		phenotype	lobe size
GCST003000		phenotype	darwin's tubercle
GCST003001		phenotype	ear morphology
GCST003002		phenotype	tragus size
GCST003003		phenotype	antitragus size
GCST003004		phenotype	crus helix
GCST003005		phenotype	superior crus of antihelix expression
GCST003007		background	non-cardia
GCST003007		stratified	non-cardia
GCST003008		side effect	triptolide
GCST003008		side effect	triptolide for aggression
GCST003009		background	cardia
GCST003009		stratified	cardia
GCST003013		phenotype	white matter hyperintensity burden
GCST003014		background, phenotype	high fat diet meal, postprandial triglyceride response to
GCST003016		background	bipolar disorder
GCST003018		side effect	thionamide for graves' disease
GCST003019		phenotype	black vs. non-black hair color
GCST003020		phenotype	red vs non-red hair color
GCST003021		phenotype	brown vs. non-brown hair color
GCST003022		phenotype	light vs. dark hair color
GCST003023		phenotype	blond vs non-blond hair color
GCST003024		phenotype	ultraviolet-induced skin pigmentation (minimal erythema dose)
GCST003025		biomarker	attention function
GCST003026		background	yu-zhi constitution type
GCST003027		side effect	angiotensin-converting enzyme inhibitor
GCST003028		biomarker	alpha-1-antitrypsin
GCST003030		biomarker	oppositional defiant disorder dimensions
GCST003031		background	smokers
GCST003032		phenotype	hearing function (2 khz)
GCST003033		phenotype	medium tone
GCST003034		phenotype	hearing function (8 khz)
GCST003035		phenotype	hearing function (4 khz)
GCST003036		phenotype	low tone
GCST003037		phenotype	hearing function (0.5 khz)
GCST003039		phenotype	hearing function (0.25 khz)
GCST003040		phenotype	high tone
GCST003041		phenotype	hearing function (1 khz)
GCST003042		background, phenotype	type 2 diabetes, sight-threatening
GCST003046		side effect	trichloroethylene
GCST003047		background	down syndrome
GCST003049		interaction	asbestos exposure
GCST003051		phenotype	survival
GCST003051		survival	
GCST003057		interaction, phenotype	chemotherapy, metastatic
GCST003057		treatment response stratified	metastatic - chemotherapy
GCST003058		response, phenotype	capox-b vs capox-b plus cetuximab, metastatic
GCST003058		treatment response stratified	metastatic - CAPOX-B vs CAPOX-B plus cetuximab
GCST003060		background, phenotype	gba carrier, age of onset
GCST003061		background	cutaneous
GCST003061		stratified	cutaneous
GCST003062		side effect	anthracycline for childhood cancer
GCST003062		treatment side effect	childhood cancer - anthracycline (cardiotoxicity)
GCST003063		background	type 2 diabetes
GCST003064		phenotype	exploratory eye movement dysfunction (cognitive search score)
GCST003065		phenotype	exploratory eye movement dysfunction (responsive search score)
GCST003066		phenotype	exploratory eye movement dysfunction (total eye scanning length)
GCST003067		phenotype	exploratory eye movement dysfunction (mean eye scanning length)
GCST003068		phenotype	exploratory eye movement dysfunction (number of eye fixations)
GCST003069		interaction, phenotype	schizophrenia, left superior temporal gyrus thickness
GCST003070		biomarker	t-tau (csf)
GCST003071		biomarker	cerebrospinal p-tau181p levels
GCST003072		biomarker	cerebrospinal fluid ab1-42 levels
GCST003074		background	apoe e4 non-carriers
GCST003076		background, phenotype	apoee4 carriers, cerebral amyloid deposition
GCST003078		biomarker	cerebrospinal fluid p-tau181p:ab1-42 ratio
GCST003079		biomarker	t-tau:beta-amyloid 1-42 ratio (csf)
GCST003080		side effect	glucocorticoid for acute lymphoblastic leukemia
GCST003081		side effect, background	glucocorticoid for acute lymphoblastic leukemia, age 10 and older
GCST003082		phenotype	longitudinal change
GCST003083		side effect	glucocorticoid for acute lymphoblastic leukemia
GCST003084		side effect	glucocorticoid for acute lymphoblastic leukemia
GCST003085		response	warfarin maintenance dose
GCST003088		biomarker	il2ra, soluble
GCST003089		biomarker	manic episodes
GCST003090		background	bipolar disorder
GCST003091		background	bipolar disorder
GCST003093		phenotype	nicotine dependence
GCST003095		background, biomarker	adipoq, bmi-adjusted
GCST003096		biomarker	adipoq
GCST003097		phenotype	autoimmune thyroid disease, type i diabetes mellitus, common variable immunodeficiency, ankylosing spondylitis, psoriasis, celiac disease, ulcerative colitis, crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus
GCST003097		phenotype	autoimmune thyroid disease, type i diabetes mellitus, common variable immunodeficiency, psoriasis, ankylosing spondylitis, celiac disease, ulcerative colitis, crohn's disease, autoimmune disease, juvenile idiopathic arthritis, systemic lupus erythematosus
GCST003100		phenotype	survival time
GCST003100		survival	
GCST003101		phenotype	age at menarche, spine bmd
GCST003102		phenotype	hip bmd, age at menarche
GCST003105		phenotype	hip bmd
GCST003106		phenotype	spine bmd
GCST003107		response, phenotype	post-bronchodilator, fev1/fvc
GCST003108		side effect, interaction	antipsychotic drug, time
GCST003109		side effect	antipsychotic drug
GCST003110		response, phenotype	post-bronchodilator, fev1
GCST003111		phenotype	sleep duration
GCST003112		phenotype	sleep duration
GCST003113		phenotype	cingulate cortical amyloid beta load
GCST003114		phenotype	intima media thickness
GCST003118		response	serotonin reuptake inhibitors
GCST003119		biomarker	urinary metabolite
GCST003122		biomarker	fetal hemoglobin
GCST003122		biomarker	hemoglobin a1
GCST003122		biomarker	hemoglobin a2
GCST003123		phenotype	h1n1
GCST003124		phenotype	h1n1
GCST003125		phenotype	h1n1
GCST003126		phenotype	h1n1 severity
GCST003127		biomarker	lipoprotein a
GCST003131		background, phenotype	apoee4 carriers, cerebrospinal fluid clusterin
GCST003132		background	bipolar disorder
GCST003133		biomarker	clusterin in plasma
GCST003134		biomarker	clusterin (csf)
GCST003135		background	bipolar disorder
GCST003137		biomarker	cerebrospinal fluid clusterin levels
GCST003138		phenotype	juvenile
GCST003139		biomarker	glomerular filtration rate
GCST003141		biomarker	proteinuria
GCST003142		biomarker	proteinuria
GCST003143		background	cystic fibrosis
GCST003145		phenotype	severe
GCST003146		phenotype	postburn hypertrophic scarring severity
GCST003147		biomarker	lactate
GCST003149		phenotype	skin and soft tissue
GCST003151		phenotype	white matter lesion progression
GCST003152		phenotype	white matter lesion progression, white matter lesion burden at baseline adjusted
GCST003153		phenotype	alcohol related
GCST003157		biomarker	homocysteine
GCST003158		response	lithium treatment
GCST003159		response	lithium treatment
GCST003160		response	lithium treatment
GCST003161		response	lithium treatment
GCST003162		phenotype	visceral:subcutaneous adipose tissue ratio
GCST003163		phenotype	visceral:subcutaneous adipose tissue ratio, bmi adjusted
GCST003164		phenotype	subcutaneous adipose tissue
GCST003165		phenotype	subcutaneous adipose tissue, bmi adjusted
GCST003166		phenotype	visceral adipose tissue
GCST003167		phenotype	visceral adipose tissue, bmi adjusted
GCST003168		phenotype	total adipose tissue
GCST003169		phenotype	total adipose tissue, bmi adjusted
GCST003170		phenotype	subcutaneous adipose tissue
GCST003171		phenotype	visceral adipose tissue
GCST003172		phenotype	visceral adipose tissue, bmi adjusted
GCST003173		phenotype	visceral:subcutaneous adipose tissue ratio
GCST003177		background	childhood
GCST003178		response	immunochemotherapy for diffuse large b-cell lymphoma
GCST003180		phenotype	childhood onset asthma, atopic eczema, atopic march
GCST003181		phenotype	nasal carriage (intermittent)
GCST003182		phenotype	staphylococcus aureus nasal carriage
GCST003183		phenotype	setpoint viral load
GCST003185		phenotype	nicotine dependence
GCST003186		interaction, background	ace inhibitor, hypertension
GCST003187		interaction, background	ace inhibitor, hypertension
GCST003189		associated disease	hepatitis B
GCST003189		background	hepatitis b infection
GCST003191		biomarker	vitamin d
GCST003192		background	kawasaki disease
GCST003193		response	interferon beta
GCST003194		biomarker	fibrinogen
GCST003195		biomarker	magnesium
GCST003196		phenotype	calcaneal bone quantitative ultrasound measurement
GCST003197		phenotype	thoracic-to-hip circumference ratio
GCST003200		background	laparoscopic-assisted colectomy (first 24 hours)
GCST003201		interaction, background	beta blocker, hypertension
GCST003202		interaction, background	diuretic, hypertension
GCST003203		interaction, background	beta blocker, hypertension
GCST003204		interaction, background	diuretic, hypertension
GCST003205		interaction, background	calcium channel blocker, hypertension
GCST003206		interaction, background	calcium channel blocker, hypertension
GCST003207		interaction, response	exercise, triglyceride
GCST003208		multiple disease	or endometrial cancer
GCST003208		pleiotropy	endometrial cancer
GCST003209		multiple disease	or endometrial cancer
GCST003209		pleiotropy	endometrial cancer
GCST003210		biomarker	vwf
GCST003211		background	ischemic stroke
GCST003212		biomarker	fibrinogen
GCST003213		background	ischemic stroke
GCST003214		biomarker	total cholesterol
GCST003215		biomarker	hdl
GCST003216		biomarker	ldl
GCST003217		biomarker	triglyceride
GCST003218		background	non-cardia
GCST003218		stratified	non-cardia
GCST003221		background	summer
GCST003222		background	summer and winter
GCST003223		background	winter
GCST003224		response	anthracycline-based chemotherapy
GCST003225		phenotype	moderate/severe
GCST003227		background	non-glioblastoma
GCST003227		stratified	non-glioblastoma
GCST003229		phenotype	survival
GCST003229		survival	
GCST003230		phenotype	distant metastatic
GCST003230		survival stratified	distant metastatic
GCST003231		phenotype	non-distant metastatic
GCST003231		survival stratified	non-distant metastatic
GCST003232		side effect	pazopanib for cancer
GCST003232		treatment side effect	cancer - pazopanib (liver injury)
GCST003233		biomarker	thrombin-antithrombin complex levels
GCST003234		biomarker	thrombomodulin levels
GCST003235		biomarker	prothrombin fragments f1+2 levels
GCST003236		biomarker	omega-6 pufa (arachidonic acid)
GCST003237		biomarker	omega-6 pufa (dihomo-gamma-linolenic acid)
GCST003238		biomarker	omega-6 pufa (gamma-linolenic acid)
GCST003239		biomarker	omega-6 pufa (linoleic acid)
GCST003240		biomarker	omega-3 pufa (docosahexaenoic acid)
GCST003241		biomarker	omega-3 pufa (eicosapentaenoic acid)
GCST003242		biomarker	omega-3 pufa (alphalinolenic acid)
GCST003243		biomarker	delta-5 desaturase activity
GCST003244		biomarker	delta-6 desaturase activity
GCST003245		biomarker	white matter hyperintensities
GCST003246	C563236	background	testicular germ cell tumor
GCST003246	C563236	stratified	testicular germ cell tumor
GCST003247	C563236	background	testicular germ cell tumor
GCST003247	C563236	stratified	testicular germ cell tumor
GCST003250		biomarker	urinary albumin-to-creatinine ratio
GCST003251		phenotype	late onset
GCST003253		phenotype	microalbuminuria
GCST003254		background, biomarker	non-diabetics, urinary albumin to creatinine ratio
GCST003255		biomarker	urinary albumin to creatinine ratio
GCST003256		background, phenotype	joint damage progression in acpa-negative rheumatoid arthritis
GCST003257		phenotype	cardioembolic ischemic stroke
GCST003259		phenotype	large artery atherosclerosis
GCST003260		phenotype	small artery occlusion
GCST003262		response	post-bronchodilator fev1
GCST003263		response	post-bronchodilator fev1
GCST003264		response	bronchodilator, fev1/fvc ratio
GCST003265		response	bronchodilator, fev1/fvc ratio
GCST003266		background, phenotype	pre-bronchodilator, fev1
GCST003267		phenotype	fev1/fec ratio
GCST003269		phenotype	cutaneous
GCST003271		phenotype	cutaneous psoriasis
GCST003274		phenotype	pulse pressure
GCST003275		phenotype	mean arterial pressure
GCST003298		background, biomarker	nt-probnp in acute coronary syndrome
GCST003299		background	childhood cancer survivors
GCST003300		side effect, interaction	anthracycline for childhood cancer
GCST003301		biomarker	triglyceride
GCST003302		biomarker	total cholesterol
GCST003303		biomarker	ldl
GCST003304		biomarker	hdl
GCST003318		phenotype	sporadic
GCST003319		interaction	stressful life events
GCST003321		phenotype	small vessel stroke
GCST003322		phenotype	large artery atherosclerosis
GCST003323		phenotype	cardioembolic ischemic stroke
GCST003327		stratified	cutaneous
GCST003328		response, phenotype	carboplatin and paclitaxel, serous epithelial ovarian cancer
GCST003329		response	anti-tnf therapy
GCST003330		phenotype	seropositive for rheumatoid factor
GCST003332	C531617	phenotype	rapid functional decline
GCST003333	C531617	phenotype	moderate functional decline
GCST003334		phenotype	length of menstrual cycle
GCST003336			bmi adjusted
GCST003338			bmi adjusted
GCST003339		response	igg levels, anti-epstein barr virus nuclear antigen 1
GCST003340		pleiotropy	igg levels, anti-epstein barr virus nuclear antigen 1
GCST003341		response, phenotype	antipsychotic drug dosage, schizophrenia or schizoaffective disorder
GCST003343		phenotype	low intraocular pressure
GCST003344		phenotype	high intraocular pressure
GCST003358		background, biomarker	betaine in cardiac evaluation
GCST003359		biomarker	uric acid
GCST003361		biomarker	ldl
GCST003362		biomarker	phospholipid
GCST003363		biomarker	hdl
GCST003364		biomarker	triglyceride
GCST003365		interaction	cigarette smoking
GCST003366		interaction	cigarette smoking
GCST003367		biomarker	leptin
GCST003368		background, biomarker	bmi adjusted, leptin levels
GCST003369		phenotype	factor score
GCST003371		biomarker	glomerular filtration rate (creatinine)
GCST003372		biomarker	glomerular filtration rate (creatinine)
GCST003373		background, biomarker	glomerular filtration rate in diabetics (creatinine)
GCST003375		biomarker	glomerular filtration rate (cystatin c)
GCST003376		phenotype	nicotine metabolite ratio
GCST003378		response	lithium treatment
GCST003379		phenotype	hip bmd
GCST003380		phenotype	spine bmd
GCST003381		background	femoral neck
GCST003385		interaction	menopausal hormone therapy
GCST003386		interaction	oestrogen-progestogen hormone therapy
GCST003386		interaction or exposure	estrogen plus progestogen therapy
GCST003387		interaction	oestrogen hormone therapy
GCST003388		phenotype	spine bmd
GCST003389		phenotype	hip bmd
GCST003391		biomarker	hdl
GCST003392		phenotype	parental longevity
GCST003393		phenotype	parental longevity
GCST003394		phenotype	parental longevity
GCST003395		phenotype	parental longevity
GCST003397		phenotype	linguistic errors
GCST003398		phenotype	syntactic complexity
GCST003399		interaction	brain beta-amyloid deposition
GCST003401		background, biomarker	glomerular filtration rate in non diabetics (creatinine)
GCST003403		biomarker	vegfa
GCST003418		biomarker	skin fluorescence in type 1 diabetes
GCST003419		phenotype	left-sided heart lesions
GCST003421		phenotype	mosaic loss of chromosome y
GCST003422		stratified	cutaneous
GCST003423		phenotype	small vessel stroke
GCST003426		side effect	flupertine
GCST003427		phenotype	age of onset
GCST003429		phenotype	morning vs. evening chronotype
GCST003432		response	risperidone
GCST003433		biomarker	lycopene
GCST003435		phenotype	body fat percentage
GCST003437		background	monozygotic twins
GCST003438		side effect	bortezomib for multiple myeloma
GCST003439		response	paclitaxel
GCST003439		treatment response	paclitaxel
GCST003440		response	carboplatin
GCST003440		treatment response	carboplatin
GCST003441		response	paclitaxel
GCST003441		treatment response	paclitaxel
GCST003442		response	carboplatin
GCST003443		response	carboplatin and paclitaxel
GCST003443		treatment response	carboplatin and paclitaxel
GCST003444		response	carboplatin and paclitaxel
GCST003444		treatment response	carboplatin and paclitaxel
GCST003445		response	cyclophosphamide
GCST003448		background	never smokers
GCST003450		side effect	clozapine for treatment-resistant schizophrenia
GCST003451		phenotype	age of onset
GCST003452		phenotype	posterior cortical atrophy
GCST003454		phenotype	morning vs. evening chronotype
GCST003455		interaction, phenotype	joint analysis main effects and education, spherical equivalent
GCST003456		side effect	dabrafenib-trametinib for melanoma
GCST003457		biomarker	advanced glycation end-product
GCST003460		response	igg1 response to plasmodium falciparum antigen (glurp)
GCST003461		response	igg response to plasmodium falciparum antigens (glurp, msp2 fc27, msp2 3d7)
GCST003462		response	igg1 response to plasmodium falciparum antigen (msp1)
GCST003463		response	igg3 response to plasmodium falciparum antigen (msp2 3d7)
GCST003464		response	igg3 response to plasmodium falciparum antigen (msp2 fc27)
GCST003466		background, biomarker	cotinine
GCST003469		response	cognitive-behavioural therapy
GCST003472		biomarker	oppositional defiant disorder dimensions
GCST003473		background	attention deficit hyperactivity disorder
GCST003474		phenotype	scalp hair shape
GCST003475		phenotype	beard thickness
GCST003476		phenotype	eyebrow thickness
GCST003477		phenotype	monobrow thickness
GCST003478		phenotype	hair greying
GCST003479		phenotype	hair color
GCST003481		phenotype	sleep latency
GCST003482		phenotype	childhood onset
GCST003483		biomarker	s-phenylmercapturic acid levels
GCST003484		phenotype	related phenotypes
GCST003485		response, biomarker	fenofibrate, hdl
GCST003486		response, biomarker	fenofibrate, ldl
GCST003487		response, biomarker	fenofibrate, total cholesterol
GCST003488		response, biomarker	fenofibrate, triglyceride
GCST003489		phenotype	food addiction
GCST003490		phenotype	cardioembolic ischemic stroke
GCST003493		phenotype	non-cardioembolic
GCST003497		phenotype	memory performance
GCST003498		phenotype	reasoning
GCST003500		side effect	peg-asparaginase for acute lymphoblastic leukemia
GCST003501		side effect	peg-asparaginase for acute lymphoblastic leukemia
GCST003518		phenotype	daytime rest
GCST003523		biomarker	coenzyme q10
GCST003526		side effect	non-chemotherapy drug
GCST003527		side effect	anti-thyroid drug
GCST003538		phenotype	symptom count
GCST003539		phenotype	mortality
GCST003540		biomarker	alkaline phosphatase
GCST003540		biomarker	bilirubin
GCST003540		biomarker	calcium level
GCST003540		biomarker	erythrocyte
GCST003540		biomarker	glucose
GCST003540		biomarker	hemoglobin
GCST003540		biomarker	mean corpuscular hemoglobin
GCST003541		phenotype	survival
GCST003541		survival	
GCST003542		phenotype	night sleep phenotypes
GCST003542		phenotype	nighttime rest
GCST003542		phenotype	sleep latency
GCST003542		phenotype	sleep quality
GCST003559		phenotype	hip bmd
GCST003560		background	kawasaki disease
GCST003563		phenotype	autoantibody against phospholipid
GCST003564			bmi adjusted
GCST003567		response, phenotype	inhaled corticosteroid, change in fev1
GCST003579		side effect	antipsychotic for schizophrenia
GCST003580		side effect	anti-thyroid drug
GCST003581		side effect, phenotype	radiotherapy for prostate cancer, decreased urine stream
GCST003581		treatment side effect	prostate cancer - radiotherapy (toxicity, decreased urine stream)
GCST003582		side effect, phenotype	radiotherapy for prostate cancer, urinary frequency
GCST003582		treatment side effect	prostate cancer - radiotherapy (toxicity, urinary frequency)
GCST003583		side effect	radiotherapy for prostate cancer
GCST003583		treatment side effect	prostate cancer - radiotherapy (overall toxicity)
GCST003584		side effect, phenotype	radiotherapy for prostate cancer, rectal bleeding
GCST003584		treatment side effect	prostate cancer - radiotherapy (toxicity, rectal bleeding)
GCST003585		phenotype	aggressiveness
GCST003587		phenotype	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma
GCST003588		phenotype	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma
GCST003588		phenotype	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, squamous cell lung carcinoma, lung adenocarcinoma
GCST003589		background	asthma
GCST003590		biomarker	apolipoprotein a4 levels
GCST003591		phenotype	severity of facial solar lentigines
GCST003598		phenotype	qrs duration
GCST003600		interaction	pesticide exposure
GCST003603		side effect	thiopurine for inflammatory bowel disease
GCST003605		background	egfr mutation-positive
GCST003605		stratified	EGFR mutation
GCST003606		background	hiv/hepatitis c co-infection
GCST003607		phenotype	knee peak torque response
GCST003608		phenotype	maximal oxygen uptake response
GCST003609		response, biomarker	thiopurine methyltransferase activity in all patients treated with mercaptopurines
GCST003610		phenotype	spine bmd
GCST003611		phenotype	hip bmd
GCST003612		background	femoral neck
GCST003614		phenotype	opioid dependence
GCST003615		phenotype	susceptibility
GCST003616		background	alagille syndrome
GCST003617		response, biomarker	statins, hdl
GCST003618		phenotype	spontaneous
GCST003620		phenotype	systemic lupus erythematosus
GCST003621		phenotype	coffee consumption
GCST003623		phenotype	age 2
GCST003624		phenotype	age 2 with doctor diagnosis
GCST003625		phenotype	age 1 with doctor diagnosis
GCST003626		phenotype	age 1
GCST003627		side effect	taxane for breast cancer
GCST003628		side effect	clozapine for treatment-resistant schizophrenia
GCST003629		biomarker	nicotine metabolite ratio
GCST003630		phenotype	qrs amplitude, r wave amplitude
GCST003632	C531617	phenotype	sporadic, survivial time
GCST003633		phenotype	middle facial morphology
GCST003634		phenotype	lower facial morphology traits (ordinal measurement)
GCST003635		phenotype	middle facial morphology
GCST003636		phenotype	lower facial morphology traits (quantitative measurement)
GCST003637		phenotype	facial morphology
GCST003638		phenotype	upper facial morphology traits
GCST003639		phenotype	breslow thickness
GCST003641		phenotype	facial width
GCST003642		phenotype	eye morphology
GCST003643		phenotype	nose morphology
GCST003644		phenotype	lip morphology
GCST003645		phenotype	facial height
GCST003646		phenotype	facial depth
GCST003648		phenotype	pathological
GCST003651		phenotype	non-familial, age of onset
GCST003652		phenotype	familial, age of onset
GCST003653		phenotype	age of onset
GCST003654		background	femoral neck (ward's triangle)
GCST003655		background	cutaneous
GCST003655		stratified	cutaneous
GCST003656		background	critical illness
GCST003657		phenotype	symptom score
GCST003658		phenotype	insulin sensitivity, bmi adjusted
GCST003659		interaction, phenotype	bmi, insulin sensitivity
GCST003660		biomarker	hdl
GCST003661		biomarker	triglyceride
GCST003662		biomarker	ldl
GCST003663		biomarker	total cholesterol
GCST003664		biomarker	lipid metabolites
GCST003665		biomarker	lipoprotein
GCST003666		biomarker	metabolite levels
GCST003667		phenotype	somatic complaints domain
GCST003668		phenotype	lack of positive affect domain
GCST003669		phenotype	lack of negative affect domain
GCST003672		side effect	docetaxel for metastatic castrate-resistant prostate cancer
GCST003672		treatment side effect	prostate cancer, metastatic castrate-resistant - docetaxel (peripheral neuropathy)
GCST003673		phenotype	average oxygen saturation during sleep
GCST003674		phenotype	apnea hypopnea index
GCST003675		phenotype	average respiratory event duration
GCST003676		phenotype	years of education
GCST003677		phenotype	college completion
GCST003678		pleiotropy, biomarker	c-reactive protein, total cholesterol
GCST003679		pleiotropy, biomarker	c-reactive protein, ldl
GCST003680		pleiotropy, phenotype	c-reactive protein, hdl
GCST003681		biomarker	c-reactive protein, triglyceride
GCST003682		interaction	snp x snp
GCST003683		pleiotropy	intracranial or abdominal aortic aneurysm
GCST003684		background	labor-initiated deliveries (maternal effect)
GCST003685		background	premature rupture of membrane-initiated deliveries (maternal effect)
GCST003687		background	labor-initiated deliveries (child effect)
GCST003689		background	premature rupture of membrane-initiated deliveries (child effect)
GCST003698		phenotype	brain activation in response to working memory task
GCST003718		phenotype	viral clearance
GCST003719		phenotype	attention function
GCST003723		biomarker	sulfate
GCST003727		phenotype	joint damage, height growth
GCST003739	C562730		
GCST003739		stratified	adenocarcinoma
GCST003740		pleiotropy	esophageal adenocarcinoma
GCST003741		phenotype	sleep duration
GCST003742		phenotype	early onset
GCST003743		biomarker	triglyceride
GCST003744		phenotype	mean interproximal clinical attachment
GCST003759		biomarker	resistin
GCST003760		background	head and neck squamous cell carcinoma
GCST003761		background	smoking
GCST003763		phenotype	age-related hearing impairment
GCST003766		phenotype	subjective well-being
GCST003767		phenotype	life satisfaction
GCST003768		phenotype	positive affect
GCST003774		biomarker	urinary albumin to creatinine ratio
GCST003777		phenotype	squamous
GCST003778		phenotype	current vs former
GCST003779		phenotype	cigarettes smoked per day
GCST003780		background	er-negative
GCST003780		stratified	ER-negative
GCST003781		background	er-positive
GCST003781		stratified	ER-positive?
GCST003782		background	er-negative
GCST003782		stratified	ER-negative
GCST003786		background	small intestine
GCST003786		stratified	small intestine
GCST003787		background	bronchial
GCST003787		stratified	bronchial
GCST003788		phenotype	neuroendocrine tumor
GCST003790		biomarker	glomerular filtration rate
GCST003791		response	metformin
GCST003792		side effect	anti-tuberculosis drug treatment
GCST003793		biomarker	l-arginine
GCST003794		response, background	gefitinib or erlotinib, egfr positive never smokers
GCST003795		phenotype	age at first birth
GCST003796		phenotype	number of children ever born
GCST003797		interaction, response	antihypertensive drug treatment (treatment strategy interaction)
GCST003798		background	childhood
GCST003800		response	bupropion
GCST003801		response	selective serotonin reuptake inhibitors
GCST003802		response	citalopram or escitalopram
GCST003803		response	antidepressants
GCST003804		response	non-response to bupropion
GCST003805		response	hydrochlorothiazide
GCST003806		response	bupropion
GCST003807		response	hydrochlorothiazide
GCST003808		response	non-response to selective serotonin reuptake inhibitors
GCST003809		response	selective serotonin reuptake inhibitors
GCST003810		response	non-response to citalopram or escitalopram
GCST003811		response	citalopram or escitalopram
GCST003812		response	non-response to antidepressants
GCST003813		response	antidepressants
GCST003815		phenotype	late onset
GCST003816		response	aromatase inhibitor
GCST003816		treatment response	aromatase inhibitor
GCST003818		phenotype	resting heart rate
GCST003821		biomarker	er status
GCST003821		stratified	ER-negative
GCST003822		phenotype	er status in her2 positive breast cancer
GCST003823		phenotype	er status in her2 negative breast cancer
GCST003823		stratified	ER-negative
GCST003824		side effect	interferon-based therapy in chronic hepatitis c
GCST003826		background, phenotype	never-smokers, pre bronchodilator fev1/fvc ratio
GCST003828		phenotype	chronic
GCST003829		phenotype	recurrent
GCST003830		response, phenotype	bronchodilator, change in fev1
GCST003832		phenotype	childhood onset
GCST003833		phenotype	adult
GCST003834		phenotype	intracranial volume
GCST003835		interaction	stressful life events
GCST003838		phenotype	morning vs. evening chronotype
GCST003839		phenotype	sleep duration
GCST003840		phenotype	sleep duration (oversleepers vs undersleepers)
GCST003841		phenotype	thiopurine methyltransferase activity
GCST003842		background	er-negative
GCST003842		stratified	ER-negative
GCST003843		phenotype	petaloid toenail
GCST003844		phenotype	qrs complex, qrs duration
GCST003845		background	er-negative
GCST003845		stratified	ER-negative
GCST003846		biomarker	caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level)
GCST003847		biomarker	caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) level)
GCST003848		biomarker	caffeine metabolism (plasma 1,3-dimethylxanthine (theophylline) level)
GCST003849		biomarker	caffeine metabolism (plasma 3,7-dimethylxanthine (theobromine) level)
GCST003850		biomarker	caffeine metabolism (plasma 1,3,7-trimethyluric acid level)
GCST003851		biomarker	caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)
GCST003852		response	dendritic cell-based immunotherapy
GCST003853		phenotype	hip cartilage thickness
GCST003854		phenotype	gut microbiota (functional units)
GCST003855		phenotype	gut microbiota (bacterial taxa)
GCST003856		phenotype	central corneal thickness
GCST003857		phenotype	oral cavity and pharyngeal cancer
GCST003860		interaction	alcohol dependence
GCST003861		background	type 1 diabetes
GCST003862		background	type 1 diabetes
GCST003863		background	type 1 diabetes
GCST003864		background	type 1 diabetes
GCST003865		background	type 1 diabetes
GCST003866		background	type 1 diabetes
GCST003867		background	type 1 diabetes
GCST003868		phenotype	job-related exhaustion in shift workers
GCST003870		phenotype	qrs amplitude, qrs complex
GCST003871		phenotype	qrs amplitude, qrs complex
GCST003872		phenotype	qrs amplitude, qrs complex
GCST003873		interaction	alcohol consumption
GCST003873		interaction or exposure	alcohol and smoking
GCST003874		interaction	smoking status
GCST003875		phenotype	gut microbiota (bacterial taxa)
GCST003876		phenotype	gut microbiota (beta diversity)
GCST003879		biomarker	parathyroid hormone
GCST003882		phenotype	parental longevity
GCST003898		side effect	cisplatin
GCST003899		response, background, phenotype	clopidogrel therapy in healthy amish, platelet reactivity
GCST003900		background	smoking status
GCST003902		phenotype	fast beta electroencephalogram
GCST003918		phenotype	idiopathic osteonecrosis
GCST003919		interaction, phenotype	alcohol consumption, spine bmd
GCST003920		phenotype	hip bmd, alcohol drinking
GCST003921		interaction	alcohol consumption
GCST003923		biomarker	ddt metabolite
GCST003924		phenotype	renal overload
GCST003926		phenotype	renal underexcretion
GCST003927		phenotype	dysmenorrheic pain
GCST003929		biomarker	magnesium/calcium ratio in urine
GCST003931		biomarker	beta-carotene
GCST003932		biomarker	lutein
GCST003933		biomarker	zeaxanthin
GCST003934		biomarker	cryptoxanthin
GCST003935		biomarker	alpha-tocopherol
GCST003936		biomarker	gamma-tocopherol
GCST003937		biomarker	retinol levels
GCST003938		biomarker	alpha-carotene
GCST003939		side effect	chemotherapy
GCST003940		phenotype	skin barrier function (trans-epidermal water loss)
GCST003941		background	bone marrow transplantation (recipient effect)
GCST003942		background	bone marrow transplantation (recipient effect)
GCST003943		biomarker	hepicidin
GCST003944		phenotype	hepcidin/ferritin ratio
GCST003945		phenotype	hepcidin/transferrin saturation ratio
GCST003961		phenotype	hippocampal volume
GCST003963		response	post total joint replacement surgery for osteoarthritis
GCST003964		side effect	bortezomib for multiple myeloma
GCST003965		phenotype	subcutaneous adipose tissue
GCST003966		phenotype	visceral adipose tissue
GCST003967		phenotype	visceral adipose tissue, bmi adjusted
GCST003968		phenotype	pericardial adipose tissue, height and weight adjusted
GCST003969		phenotype	visceral adipose tissue attenuation
GCST003970		phenotype	subcutaneous adipose tissue attenuation
GCST003971		phenotype	pericardial adipose tissue
GCST003972		phenotype	visceral:subcutaneous adipose tissue ratio
GCST003973		phenotype	visceral adipose tissue/subcutaneous adipose tissue ratio, bmi adjusted
GCST003974		phenotype	tonsillectomy risk
GCST003975		interaction	traffic air pollution exposure
GCST003979		phenotype	excessive daytime sleepiness
GCST003980		phenotype	sleep duration
GCST003982		phenotype	sleep traits
GCST003985		phenotype	breast size
GCST003989		phenotype	chin dimples
GCST003991		phenotype	susceptibility, childhood
GCST003992	C535300	phenotype	photic sneeze reflex
GCST003993		phenotype	age at onset
GCST003994		phenotype	age at voice drop
GCST003995		phenotype	tonsillectomy risk
GCST003996		phenotype	synophrys
GCST003998		phenotype	beighton score
GCST003999		phenotype	nose size
GCST004001		phenotype	bipolar disorder or attention deficit hyperactivity disorder
GCST004002		phenotype	bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder
GCST004004		phenotype	mean corpuscular volume
GCST004005		biomarker	hemoglobin
GCST004006		phenotype	mean corpuscular hemoglobin
GCST004007		phenotype	mean corpuscular hemoglobin concentration
GCST004010		interaction, phenotype	tricyclic/tetracyclic antidepressant, qt interval
GCST004011		interaction, phenotype	tricyclic/tetracyclic antidepressant, rr interval
GCST004013		phenotype	agreeableness
GCST004014		phenotype	conscientiousness
GCST004016		phenotype	openness
GCST004018		interaction	snp x snp
GCST004020		phenotype	small vessel stroke
GCST004021		phenotype	cardioembolic stroke
GCST004022		phenotype	large artery
GCST004025		phenotype	systemic
GCST004027		phenotype	heavy vs. light/non-drinkers
GCST004029	C563514	response	angiotensin-converting enzyme inhibitor intolerance
GCST004031		interaction, phenotype	sulfonylurea, qt interval
GCST004032		interaction, phenotype	sulfonylurea treatment, jt interval
GCST004033		interaction, phenotype	sulfonylurea, qrs interval
GCST004035		biomarker	nhdl cholesterol to hdl cholesterol ratio
GCST004036		biomarker	ldl cholesterol to hdl cholesterol ratio
GCST004037		biomarker	triglyceride to hdl ratio
GCST004038		biomarker	chga cleavage product
GCST004038		biomarker	chgb cleavage product
GCST004039		response, biomarker	paliperidone (cgi-s score)
GCST004040		response, biomarker	paliperidone (positive marder score)
GCST004041		response, biomarker	paliperidone (negative marder score)
GCST004042		response, biomarker	paliperidone (panss score)
GCST004043		response, biomarker	paliperidone (multivariate)
GCST004044		multiple diseases	cancer, heart failure, diabetes mellitus, stroke, coronary heart disease, atrial fibrillation
GCST004044		phenotype	cancer, heart failure, diabetes mellitus, stroke, coronary heart disease, atrial fibrillation, mortality
GCST004045		phenotype	multiple
GCST004046		phenotype	multiple
GCST004047		phenotype	cup-to-disc ratio
GCST004048		phenotype	fast beta
GCST004049		side effect	angiotensin-converting enzyme inhibitor
GCST004050		phenotype	cleft lip with or without cleft palate
GCST004051		phenotype	orofacial cleft
GCST004053		background	poor prognosis
GCST004054		biomarker	uric acid
GCST004055		biomarker	uric acid
GCST004056		biomarker	urinary uric acid to urinary creatinine ratio
GCST004057		biomarker	creatinine clearance
GCST004058		biomarker	uric acid
GCST004059		phenotype	nitric oxide exhalation
GCST004060		phenotype	nitric oxide exhalation
GCST004063			bmi adjusted
GCST004066		phenotype	hip circumference
GCST004067		phenotype	hip circumference, bmi adjusted
GCST004068		background	sickle cell variant rs77121243-t adjusted
GCST004069		biomarker	cerebrospinal fluid ab1-42 levels
GCST004070		biomarker	cerebrospinal p-tau181p levels
GCST004071		biomarker	t-tau (csf)
GCST004072		side effect	cold medicine, severe mucosal involvement
GCST004075		phenotype	cup-to-disc ratio
GCST004076		phenotype	optic disc area
GCST004077		phenotype	cognitive function
GCST004078		side effect	terbinafine
GCST004079		side effect	drug
GCST004080		side effect	statins
GCST004081		side effect	drug
GCST004082		side effect	nitrofurantoin
GCST004083		side effect	diclofenac
GCST004084		side effect	anti-tuberculosis drugs
GCST004085		side effect	fluoroquinolones
GCST004086		side effect	drug
GCST004087		side effect	nsaid
GCST004088		phenotype	nonsyndromic cleft lip with or without cleft palate
GCST004090		background	hepatitis c infection
GCST004091		phenotype	palmar length-width ratio
GCST004092		biomarker	t-tau
GCST004096		phenotype	age at onset
GCST004097		response	platinum-based neoadjuvant chemotherapy
GCST004097		treatment response	platinum-based neoadjuvant chemotherapy
GCST004098		background	lumbar disc herniation
GCST004099		multiple disease	CLL, Hodgkin lymphoma or multiple myeloma
GCST004099		pleiotropy	chronic lymphocytic leukemia, hodgkin lymphoma or multiple myeloma
GCST004100		associated disease	in gastrointestinal cancer and COPD
GCST004100		background	gastrointestinal cancer or chronic obstructive pulmonary disease
GCST004101		associated disease	in gastrointestinal cancer
GCST004101		background	gastrointestinal cancer
GCST004102		associated disease	in lung cancer or COPD
GCST004102		background	lung cancer or chronic obstructive pulmonary disease
GCST004103		associated disease	in cancer or COPD
GCST004103		background	cancer or chronic obstructive pulmonary disease
GCST004104		associated disease	in lung cancer
GCST004104		background	lung cancer
GCST004105		background	chronic obstructive pulmonary disease
GCST004106		associated disease	in cancer
GCST004106		background	cancer
GCST004107		interaction, phenotype	dust mite allergen exposure, fev1
GCST004108		interaction, phenotype	fev1/fvc, dust mite allergen exposure
GCST004110		background	old age
GCST004111		phenotype	phlegm
GCST004114		side effect	nevirapine for hiv
GCST004115		side effect	nevirapine for hiv (stevens-johnson syndrome or toxic epidermal necrosis)
GCST004116		side effect	nevirapine for hiv
GCST004117		side effect, phenotype	nevirapine for hiv, rash
GCST004118		side effect	nevirapine for hiv
GCST004121		biomarker	fibrinogen
GCST004122		biomarker	fibrinogen
GCST004123		phenotype	mathematical ability
GCST004124		biomarker	factor xi
GCST004125		phenotype	age of onset
GCST004128		phenotype	neutrophil count
GCST004129		phenotype	monocyte count
GCST004134		phenotype	squamous, keratinocyte carcinoma, basal cell carcinoma
GCST004135		phenotype	eosinophil count
GCST004136		response	methadone dose
GCST004137		phenotype	optic cup area
GCST004138		phenotype	early onset
GCST004159		biomarker	iga1 galactose-deficient
GCST004160		response, background	post hepatitis c eradication by interferon therapy
GCST004161		biomarker	vitamin b12
GCST004163		response	resistance
GCST004164		phenotype	monocyte count
GCST004165		background	hepatitis b
GCST004166		background, phenotype	nonsyndromic cleft lip with cleft palate
GCST004170		phenotype	monocyte-lymphocyte ratio
GCST004173		phenotype	rheumatoid factor and anti-cyclic citrullinated peptide seronegative
GCST004174		phenotype	rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive
GCST004175		phenotype	pediatric bone mineral content (radius)
GCST004176		phenotype	radius, pediatric
GCST004177		background	femoral neck (pediatric)
GCST004178		phenotype	hip bmd
GCST004179		phenotype	pediatric bone mineral content (femoral neck)
GCST004180		phenotype	pediatric bone mineral content (hip)
GCST004181		phenotype	spine bmd
GCST004182		phenotype	pediatric bone mineral content (spine)
GCST004183		phenotype	fev1
GCST004184		phenotype	fvc
GCST004185		phenotype	fev1/fec ratio
GCST004198		phenotype	severe gingival inflammation
GCST004199		phenotype	with total hip replacement
GCST004200	C535833	phenotype	high altitude pulmonary edema
GCST004205		phenotype	pulse pressure
GCST004207		biomarker	hdl
GCST004209		biomarker	total cholesterol
GCST004210		phenotype	body fat percentage
GCST004211		biomarker	urate
GCST004213		phenotype	resting heart rate
GCST004214		biomarker	creatinine
GCST004215		biomarker	urea levels
GCST004216			bmi adjusted
GCST004218		phenotype	lean body mass
GCST004220		interaction	smoking
GCST004221		background, phenotype	non-smokers, adult onset
GCST004222		background	ever-smokers
GCST004223		phenotype	attention deficit hyperactivity disorder
GCST004224		interaction	traffic exposure
GCST004225		interaction	trauma
GCST004228		background	tp53 positive
GCST004229		interaction	tp53 expression
GCST004231		biomarker	total cholesterol
GCST004232		biomarker	hdl
GCST004233		biomarker	ldl
GCST004234		biomarker	hdl
GCST004235		biomarker	total cholesterol
GCST004236		biomarker	ldl
GCST004237		biomarker	triglyceride
GCST004238		biomarker	triglyceride
GCST004241		biomarker	triglyceride
GCST004242		biomarker	hdl
GCST004243		biomarker	ldl
GCST004247		interaction	apoe e4 interaction
GCST004248		background	apoe e4+ carriers
GCST004249		background	apoe e4- carriers
GCST004250		side effect, biomarker	emission induction therapy for actute lymphoblastic leukemia, alanine aminotransferase
GCST004251		phenotype	paneth cell defects
GCST004252		pleiotropy	amyotrophic lateral sclerosis
GCST004253		interaction	alzhiemer's diagnosis trajectory
GCST004254		biomarker	urinary 1,3-butadiene
GCST004259		phenotype	mean arterial pressure (long-term average)
GCST004260		phenotype	pulse pressure (long-term average)
GCST004261		side effect	anti-retroviral drug for hiv
GCST004262		side effect	combined anti-retroviral and anti-tuberculosis drug-treated hiv with tuberculosis
GCST004263		phenotype	achilles
GCST004264		drug metabolism	clopidogrel metabolite
GCST004265		phenotype	anterior cruciate ligament rupture
GCST004266		response, background, phenotype	clopidogrel therapy in coronary heart disease, platelet reactivity
GCST004267		phenotype	blood osmolality (transformed sodium)
GCST004268		response, biomarker	measles vaccine, ifn gamma
GCST004269		response, biomarker	measles vaccine, neutralising antibody
GCST004270		response, biomarker	venlafaxine (responders vs non-responders after 12 weeks)
GCST004271		response, biomarker	venlafaxine (hama-a score reduction after 24 weeks)
GCST004272		response, biomarker	venlafaxine (hama-a score reduction after 12 weeks)
GCST004273		response, biomarker	venlafaxine (remitters vs non-remitters after 24 weeks)
GCST004274		response, biomarker	venlafaxine (remitters vs non-remitters after 12 weeks)
GCST004275		response, biomarker	venlafaxine (responders vs non-responders after 24 weeks)
GCST004276		biomarker	tshb
GCST004277		biomarker	thyroxine
GCST004278		phenotype	pulse pressure
GCST004281		phenotype	midgestational circulating levels of organochlorine pesticides
GCST004282		phenotype	midgestational circulating levels of organochlorine pesticides (fetal genetic effect)
GCST004283		phenotype	midgestational circulating levels of pcbs
GCST004284		phenotype	midgestational circulating levels of pcbs (fetal genetic effect)
GCST004285		phenotype	midgestational circulating levels of pbdes
GCST004286		phenotype	midgestational circulating levels of pbdes (fetal genetic effect)
GCST004289		background, biomarker	adipoq, pregnancy
GCST004292		biomarker	glomerular filtration rate (creatinine)
GCST004293		biomarker	glomerular filtration rate (cystatin c)
GCST004294		phenotype	nicotine dependence
GCST004300		phenotype	incident
GCST004301		phenotype	prevalent
GCST004306		phenotype	facial morphology (factor 2, vertical position of orbits relative to midface)
GCST004307		phenotype	facial morphology (length of philtrum)
GCST004308		phenotype	facial height
GCST004309		phenotype	facial morphology (width of mouth relative to central midface)
GCST004310		phenotype	facial morphology (height of vermillion lower lip)
GCST004311		phenotype	facial morphology (width of cartilaginous portion of nose)
GCST004312		phenotype	facial morphology (factor 8, orbital inclination due to vertical and horizontal position of exocanthion)
GCST004313		phenotype	facial height
GCST004314		phenotype	facial morphology (width of nasal floor)
GCST004315		phenotype	facial morphology (projection of the nose)
GCST004316		phenotype	facial morphology (vertical position of sublabial sulcus relative to central midface)
GCST004317		phenotype	facial morphology (vertical position of alar curvature relative to upper lip)
GCST004318		phenotype	facial morphology (factor 14, intercanthal width)
GCST004319		phenotype	facial morphology (philtrum width)
GCST004320		phenotype	facial morphology
GCST004321		phenotype	facial morphology (height of vermillion upper lip)
GCST004322		phenotype	facial morphology
GCST004323		phenotype	facial morphology
GCST004324		phenotype	facial morphology
GCST004325		phenotype	facial morphology (depth of nasal alae)
GCST004326		phenotype	facial morphology
GCST004327		phenotype	facial morphology
GCST004328		phenotype	facial width
GCST004329		phenotype	mean corpuscular hemoglobin concentration
GCST004331		biomarker	hemoglobin
GCST004333		phenotype	red blood cell distribution width
GCST004334		phenotype	mean corpuscular hemoglobin
GCST004335		phenotype	mean corpuscular volume
GCST004336		biomarker	executive inhibition (stroop wit and cit)
GCST004337		biomarker	gondoic acid
GCST004338		biomarker	oleic acid
GCST004339		biomarker	palmitoleic acid
GCST004340		biomarker	erucic acid
GCST004341		biomarker	nervonic acid (24:1n-9) levels
GCST004342		biomarker	vaccenic acid (18:1n-7)
GCST004344		biomarker	tfpi
GCST004345		background	healthy men
GCST004348		stratified	non-glioblastoma
GCST004350		phenotype	bone ultrasound measurement (velocity of sound)
GCST004351		phenotype	bone ultrasound measurement (broadband ultrasound attenuation)
GCST004352		phenotype	early onsei
GCST004353		side effect	anthracycline treatment
GCST004358		side effect	methotrexate for rheumatoid arthritis
GCST004359		background, biomarker	resected early stage er-positive breast cancer, plasma estrone conjugates
GCST004359		stratified	ER positive resected early stage
GCST004360		background, biomarker	resected early stage er-positive breast cancer, estrone conjugates/estrone ratio
GCST004360		stratified	ER positive resected early stage
GCST004361		biomarker	estrone/androstenedione ratio in resected early stage-receptor positive breast cancer
GCST004361		stratified	ER positive resected early stage
GCST004362		background, biomarker	er-positive breast cancer, estrone
GCST004362		stratified	ER positive resected early stage
GCST004363		biomarker	plasma androstenedione levels in resected early stage-receptor positive breast cancer
GCST004363		stratified	ER positive resected early stage
GCST004365		biomarker	abl2
GCST004365		biomarker	adamts13
GCST004365		biomarker	adamts5
GCST004365		biomarker	adipoq
GCST004365		biomarker	afm
GCST004365		biomarker	agrp (agouti-related protein)
GCST004365		biomarker	alcohol dehydrogenase
GCST004365		biomarker	alkaline phosphatase
GCST004365		biomarker	alpha-1-antichymotrypsin
GCST004365		biomarker	alpha-1-antichymotrypsin complex
GCST004365		biomarker	alpha-1-antitrypsin
GCST004365		biomarker	alpha-2-hs-glycoprotein
GCST004365		biomarker	alpha-2-macroglobulin receptor-associated protein
GCST004365		biomarker	amyloid a-1 protein
GCST004365		biomarker	amyloid p-component
GCST004365		biomarker	angiogenin
GCST004365		biomarker	angiopoietin-1 receptor, soluble
GCST004365		biomarker	angiostatin
GCST004365		biomarker	angiotensinogen
GCST004365		biomarker	annexin a1
GCST004365		biomarker	annexin a2
GCST004365		biomarker	apolipoprotein b levels
GCST004365		biomarker	apolipoprotein e2 levels
GCST004365		biomarker	apolipoprotein e levels
GCST004365		biomarker	arylsulfatase b
GCST004365		biomarker	aspartate aminotransferase
GCST004365		biomarker	basal cell adhesion molecule
GCST004365		biomarker	beta-ala-his dipeptidase
GCST004365		biomarker	beta-endorphin
GCST004365		biomarker	breast cancer anti-estrogen resistance protein 3
GCST004365		biomarker	bst1
GCST004365		biomarker	cadherin-5
GCST004365		biomarker	calcineurin
GCST004365		biomarker	calcium/calmodulin-dependent protein kinase type 1d measurement
GCST004365		biomarker	calcium/calmodulin-dependent protein kinase type 1 measurement
GCST004365		biomarker	calpain i
GCST004365		biomarker	calpastatin
GCST004365		biomarker	carbohydrate sulfotransferase 15
GCST004365		biomarker	carbonic anhydrase 13
GCST004365		biomarker	carbonic anhydrase 6
GCST004365		biomarker	carboxypeptidase b2
GCST004365		biomarker	caspase-3
GCST004365		biomarker	catalase
GCST004365		biomarker	cathepsin b
GCST004365		biomarker	cathepsin s
GCST004365		biomarker	cathepsin z
GCST004365		biomarker	cation-independent mannose-6-phosphate receptor
GCST004365		biomarker	ccl1
GCST004365		biomarker	ccl14
GCST004365		biomarker	ccl15
GCST004365		biomarker	ccl16
GCST004365		biomarker	ccl17
GCST004365		biomarker	ccl18
GCST004365		biomarker	ccl19
GCST004365		biomarker	ccl21
GCST004365		biomarker	ccl23
GCST004365		biomarker	ccl25
GCST004365		biomarker	ccl3
GCST004365		biomarker	ccl3-like 1
GCST004365		biomarker	ccl4
GCST004365		biomarker	ccl5
GCST004365		biomarker	ccl7
GCST004365		biomarker	ccl8
GCST004365		biomarker	cd109 antigen
GCST004365		biomarker	cd209 antigen
GCST004365		biomarker	cd27 antigen
GCST004365		biomarker	cd36 (platelet glycoprotein 4)
GCST004365		biomarker	cdon
GCST004365		biomarker	cgmp-specific 3',5'-cyclic phosphodiesterase
GCST004365		biomarker	chitotriosidase-1
GCST004365		biomarker	chorionic gonadotropin
GCST004365		biomarker	ck-beta-8-1
GCST004365		biomarker	cmrf35-like molecule 6
GCST004365		biomarker	coagulation factor v
GCST004365		biomarker	collectin-11
GCST004365		biomarker	complement c1q
GCST004365		biomarker	complement c1r
GCST004365		biomarker	complement c1s
GCST004365		biomarker	complement c4
GCST004365		biomarker	complement c4b
GCST004365		biomarker	complement c7
GCST004365		biomarker	complement c8
GCST004365		biomarker	complement decay-accelerating factor
GCST004365		biomarker	complement factor b
GCST004365		biomarker	complement factor h
GCST004365		biomarker	complement factor h-related protein 5
GCST004365		biomarker	complement factor i
GCST004365		biomarker	contactin-2
GCST004365		biomarker	contactin-5
GCST004365		biomarker	copine-1
GCST004365		biomarker	cxcl10
GCST004365		biomarker	cxcl11
GCST004365		biomarker	cxcl1 (growth-regulated alpha protein)
GCST004365		biomarker	cxcl5
GCST004365		biomarker	cxcl6
GCST004365		biomarker	cystatin c
GCST004365		biomarker	cystatin d
GCST004365		biomarker	cystatin f
GCST004365		biomarker	cystatin sa
GCST004365		biomarker	cystatin sn
GCST004365		biomarker	death-associated protein kinase 2
GCST004365		biomarker	dermatopontin
GCST004365		biomarker	dickkopf-related protein 3
GCST004365		biomarker	dickkopf-related protein 4
GCST004365		biomarker	dual specificity mitogen-activated protein kinase kinase 2
GCST004365		biomarker	dual specificity mitogen-activated protein kinase kinase 4
GCST004365		biomarker	dynein light chain roadblock-type 1
GCST004365		biomarker	ectonucleoside triphosphate diphosphohydrolase 5
GCST004365		biomarker	edar
GCST004365		biomarker	egf-like module-containing mucin-like hormone receptor-like 2
GCST004365		biomarker	elafin
GCST004365		biomarker	endoglin
GCST004365		biomarker	ephrin type-a receptor 1
GCST004365		biomarker	ephrin type-b receptor 2
GCST004365		biomarker	e-selectin
GCST004365		biomarker	estrogen receptor
GCST004365		biomarker	extracellular matrix protein 1
GCST004365		biomarker	factor vii
GCST004365		biomarker	factor xi
GCST004365		biomarker	fc receptor-like protein 3 measurement
GCST004365		biomarker	ferritin
GCST004365		biomarker	fetuin-b
GCST004365		biomarker	fgf2
GCST004365		biomarker	fibronectin
GCST004365		biomarker	fibronectin fragment 3
GCST004365		biomarker	fibronectin fragment 4
GCST004365		biomarker	ficolin-1
GCST004365		biomarker	ficolin-2
GCST004365		biomarker	flt4
GCST004365		biomarker	galactoside 34-l-fucosyltransferase
GCST004365		biomarker	galectin-3
GCST004365		biomarker	gcsf
GCST004365		biomarker	gdnf family receptor alpha-2
GCST004365		biomarker	glypican-5
GCST004365		biomarker	gp6 (platelet glycoprotein vi)
GCST004365		biomarker	gpnmb
GCST004365		biomarker	granulins
GCST004365		biomarker	granulysin
GCST004365		biomarker	granzyme a
GCST004365		biomarker	haptoglobin
GCST004365		biomarker	havcr2 (hepatitis a virus cellular receptor 2)
GCST004365		biomarker	hemoglobin
GCST004365		biomarker	hemojuvelin
GCST004365		biomarker	hemopexin
GCST004365		biomarker	heparin cofactor 2
GCST004365		biomarker	hepatocyte growth factor activator
GCST004365		biomarker	hepatocyte growth factor-like protein
GCST004365		biomarker	hepatocyte growth factor receptor
GCST004365		biomarker	histidine-rich glycoprotein
GCST004365		biomarker	hiv level (gp41 c34)
GCST004365		biomarker	icam-1
GCST004365		biomarker	icam2
GCST004365		biomarker	icam5
GCST004365		biomarker	igf-1
GCST004365		biomarker	igfbp-3
GCST004365		biomarker	igfbp7
GCST004365		biomarker	inorganic pyrophosphatase
GCST004365		biomarker	inosine-5'-monophosphate dehydrogenase 1
GCST004365		biomarker	inosine-5'-monophosphate dehydrogenase 2
GCST004365		biomarker	insulin receptor
GCST004365		biomarker	integrin alpha1beta1
GCST004365		biomarker	interleukin 12 receptor subunit beta-1
GCST004365		biomarker	interleukin 15 receptor subunit alpha
GCST004365		biomarker	interleukin 16
GCST004365		biomarker	interleukin 17 receptor a
GCST004365		biomarker	interleukin 17 receptor b
GCST004365		biomarker	interleukin 17 receptor d
GCST004365		biomarker	interleukin 18 receptor 1
GCST004365		biomarker	interleukin 18 receptor accessory protein
GCST004365		biomarker	interleukin 19
GCST004365		biomarker	interleukin-1 beta
GCST004365		biomarker	interleukin 1 receptor accessory protein
GCST004365		biomarker	interleukin 1 receptor-like 1
GCST004365		biomarker	interleukin 1 receptor-like 2
GCST004365		biomarker	interleukin 23 receptor
GCST004365		biomarker	interleukin 25
GCST004365		biomarker	interleukin 27 receptor subunit alpha
GCST004365		biomarker	interleukin 5
GCST004365		biomarker	interleukin 5 receptor subunit alpha
GCST004365		biomarker	interleukin 6 receptor subunit alpha
GCST004365		biomarker	interleukin 6 receptor subunit beta
GCST004365		biomarker	interleukin 7 receptor subunit alpha
GCST004365		biomarker	interstitial collagenase
GCST004365		biomarker	jagged-1
GCST004365		biomarker	kallikrein-12
GCST004365		biomarker	kallikrein-7
GCST004365		biomarker	kallikrein in plasma
GCST004365		biomarker	kallistatin
GCST004365		biomarker	kdr
GCST004365		biomarker	killer cell immunoglobulin-like receptor 2dl4
GCST004365		biomarker	kininogen-1
GCST004365		biomarker	kunitz-type protease inhibitor 1
GCST004365		biomarker	kunitz-type protease inhibitor 2
GCST004365		biomarker	kynureninase
GCST004365		biomarker	lactadherin
GCST004365		biomarker	leptin receptor
GCST004365		biomarker	leucine carboxyl methyltransferase 1
GCST004365		biomarker	leukocyte immunoglobulin-like receptor subfamily b member 1
GCST004365		biomarker	leukocyte immunoglobulin-like receptor subfamily b member 2
GCST004365		biomarker	low affinity immunoglobulin epsilon fc receptor
GCST004365		biomarker	low affinity immunoglobulin gamma fc region receptor ii-a/b
GCST004365		biomarker	low affinity immunoglobulin gamma fc region receptor iii-b
GCST004365		biomarker	low molecular weight phosphotyrosine protein phosphatase
GCST004365		biomarker	l-selectin
GCST004365		biomarker	ly9
GCST004365		biomarker	lymphotactin
GCST004365		biomarker	lysosomal protective protein
GCST004365		biomarker	lysozyme c
GCST004365		biomarker	macrophage metalloelastase
GCST004365		biomarker	macrophage migration inhibitory factor
GCST004365		biomarker	macrophage scavenger receptor types i and ii
GCST004365		biomarker	mannan-binding lectin serine protease 1
GCST004365		biomarker	mannose-binding protein c
GCST004365		biomarker	map kinase-activated protein kinase 2
GCST004365		biomarker	map kinase-activated protein kinase 3
GCST004365		biomarker	matrilysin
GCST004365		biomarker	mediator of rna polymerase ii transcription subunit 1
GCST004365		biomarker	metalloproteinase inhibitor 3
GCST004365		biomarker	methionine aminopeptidase 2
GCST004365		biomarker	mia (melanoma-derived growth regulatory protein)
GCST004365		biomarker	mica (mhc class i polypeptide-related sequence a)
GCST004365		biomarker	micb (mhc class i polypeptide-related sequence b)
GCST004365		biomarker	mmp8
GCST004365		biomarker	myeloid cell surface antigen cd33
GCST004365		biomarker	n-acetyl-d-glucosamine kinase
GCST004365		biomarker	n-acylethanolamine-hydrolyzing acid amidase
GCST004365		biomarker	nad-dependent protein deacetylase sirtuin-2
GCST004365		biomarker	nadph--cytochrome p450 reductase
GCST004365		biomarker	natural cytotoxicity triggering receptor 3
GCST004365		biomarker	neurexophilin-1
GCST004365		biomarker	neurogenic locus notch homolog protein 1
GCST004365		biomarker	neutral ceramidase
GCST004365		biomarker	nidogen-1
GCST004365		biomarker	nkg2-d type ii integral membrane protein
GCST004365		biomarker	non-receptor tyrosine-protein kinase tyk2
GCST004365		biomarker	ocia domain-containing protein 1
GCST004365		biomarker	ox-2 membrane glycoprotein
GCST004365		biomarker	pcsk7
GCST004365		biomarker	pdk1
GCST004365		biomarker	peptidyl-prolyl cis-trans isomerase d
GCST004365		biomarker	peptidyl-prolyl cis-trans isomerase e
GCST004365		biomarker	persulfide dioxygenase ethe1, mitochondrial
GCST004365		biomarker	phospholipase a2, membrane associated
GCST004365		biomarker	plasminogen in plasma
GCST004365		biomarker	platelet-derived growth factor receptor beta
GCST004365		biomarker	plexin-c1
GCST004365		biomarker	polymeric immunoglobulin receptor
GCST004365		biomarker	proc
GCST004365		biomarker	programmed cell death 1 ligand 2
GCST004365		biomarker	properdin
GCST004365		biomarker	protease c1 inhibitor in plasma
GCST004365		biomarker	proto-oncogene tyrosine-protein kinase receptor ret
GCST004365		biomarker	prss2
GCST004365		biomarker	p-selectin
GCST004365		biomarker	relt (tumor necrosis factor receptor superfamily member 19l)
GCST004365		biomarker	repulsive guidance molecule a
GCST004365		biomarker	retinoic acid receptor responder protein 2
GCST004365		biomarker	scavenger receptor class f member 1
GCST004365		biomarker	secreted frizzled-related protein 3
GCST004365		biomarker	semaphorin-3a
GCST004365		biomarker	semaphorin-3e
GCST004365		biomarker	serine protease 27
GCST004365		biomarker	serine/threonine-protein kinase 17b
GCST004365		biomarker	s-formylglutathione hydrolase
GCST004365		biomarker	siglec14
GCST004365		biomarker	siglec6
GCST004365		biomarker	siglec9
GCST004365		biomarker	slamf7
GCST004365		biomarker	smpdl3a
GCST004365		biomarker	snrpf
GCST004365		biomarker	sod2
GCST004365		biomarker	sparcl1
GCST004365		biomarker	spon1 (spondin-1)
GCST004365		biomarker	tdgf1
GCST004365		biomarker	tenascin
GCST004365		biomarker	tff3
GCST004365		biomarker	tgfbi
GCST004365		biomarker	thbs2
GCST004365		biomarker	tie1, soluble
GCST004365		biomarker	tlr4:ly96 complex
GCST004365		biomarker	tnfaip6
GCST004365		biomarker	tpsb2
GCST004365		biomarker	txndc12
GCST004365		biomarker	ump-cmp kinase
GCST004365		biomarker	vwf
GCST004365		biomarker	wfikkn2
GCST004365		biomarker	wnt1-inducible-signaling pathway protein 1
GCST004365		phenotype	endoplasmic reticulum aminopeptidase 1
GCST004365		phenotype	endothelial cell-selective adhesion molecule
GCST004365		phenotype	endothelin-converting enzyme 1
GCST004370		phenotype	deep ovarian and/or rectovaginal disease with dense adhesions
GCST004371		interaction	time
GCST004372		background	older adults, episodic memory adjusted
GCST004374		interaction	antipsychotic resistance, childhood trauma
GCST004375		response	antipsychotic resistance
GCST004377		phenotype	restricted and repetitive behaviours
GCST004378		phenotype	mean corpuscular hemoglobin
GCST004379		phenotype	red blood cell density
GCST004380		phenotype	autoantibody against glutamate decarboxylase
GCST004381		phenotype	autoantibody against insulinoma-associated antigen 2
GCST004382		phenotype	autoantibody against gastric parietal cells
GCST004383		phenotype	autoantibody against thyroid peroxidase
GCST004387		phenotype	pulse pressure
GCST004388		phenotype	blood pressure traits
GCST004389		biomarker	chemerin
GCST004398		biomarker	lipoprotein a
GCST004399		biomarker	lipoprotein a, apolipoprotein(a) isoform adjusted
GCST004400		phenotype	bone erosion
GCST004401		pleiotropy	reading disability
GCST004402		background, phenotype	intelligence quotient
GCST004403		background	osteoporosis
GCST004404		phenotype	drinkers vs non-drinkers
GCST004405		phenotype	drinks per week
GCST004406		background	hiv-1 infection (continuous)
GCST004407		background	hiv-1 infection (dichotomous)
GCST004408		phenotype	mild neurocognitive disorder
GCST004410		phenotype	asymptomatic neurocogntive impairment
GCST004411		phenotype	mild neurocognitive disorder or asymptomatic neurocognitive impairment
GCST004414		background	brca1 mutation carriers
GCST004414		stratified	BRCA1 positive
GCST004415		phenotype	invasive
GCST004416		background	brca2 mutation carriers
GCST004416		stratified	BRCA2 positive
GCST004417		phenotype	clear cell
GCST004418		phenotype	endometriod
GCST004419		background	mucinous adenocarcinoma
GCST004419		stratified	mucinous adenocarcinoma
GCST004420		biomarker	ccl27
GCST004421		biomarker	beta-nerve growth factor
GCST004422		biomarker	vegfa
GCST004423		biomarker	macrophage migration inhibitory factor
GCST004424		biomarker	tnfsf10 (tnf-related apoptosis-inducing ligand)
GCST004425		biomarker	tumor necrosis factor beta levels
GCST004426		biomarker	
GCST004426		biomarker	tnf
GCST004427		biomarker	cxcl12
GCST004428		biomarker	clec11a
GCST004429		biomarker	kitlg
GCST004430		biomarker	interleukin 16
GCST004431		biomarker	ccl5
GCST004432		biomarker	platelet-derived growth factor bb measurement
GCST004433		biomarker	macrophage inflammatory protein 1b
GCST004434		biomarker	macrophage inflammatory protein 1a
GCST004435		biomarker	monokine induced by gamma interferon
GCST004436		biomarker	macrophage colony stimulating factor
GCST004437		biomarker	ccl7
GCST004438		biomarker	ccl2
GCST004439		biomarker	interleukin 12
GCST004440		biomarker	cxcl10
GCST004441		biomarker	interleukin 18
GCST004442		biomarker	interleukin 17
GCST004443		biomarker	interleukin 13
GCST004444		biomarker	interleukin 10
GCST004445		biomarker	interleukin-8
GCST004446		biomarker	interleukin-6
GCST004447		biomarker	interleukin 1 receptor antagonist
GCST004448		biomarker	interleukin-1 beta
GCST004449		biomarker	hepatocyte growth factor
GCST004450		biomarker	interleukin 9
GCST004451		biomarker	interleukin 7
GCST004452		biomarker	interleukin 5
GCST004453		biomarker	interleukin 4
GCST004454		biomarker	interleukin 2 receptor antagonist
GCST004455		biomarker	interleukin 2
GCST004456		biomarker	interferon gamma
GCST004457		biomarker	cxcl1 (growth-regulated alpha protein)
GCST004458		biomarker	gcsf
GCST004459		biomarker	fgf basic
GCST004460		biomarker	eotaxin
GCST004461		phenotype	low-grade serous
GCST004478		phenotype	serous invasive
GCST004479		phenotype	serous borderline
GCST004480		phenotype	high-grade serous
GCST004481		phenotype	low-grade serous and serous borderline
GCST004482		interaction	traffic-related air pollution
GCST004484		biomarker	trimethylamine n-oxide in plasma
GCST004485		phenotype	survival
GCST004485		survival	
GCST004487		phenotype	peak insulin response
GCST004488		phenotype	insulin secretion rate
GCST004490		biomarker	t-tau:beta-amyloid 1-42 ratio (csf)
GCST004491		biomarker	t-tau (csf)
GCST004492		biomarker	cerebrospinal fluid ab1-42 levels
GCST004495		background	smoking behavior adjusted
GCST004496		interaction	smoking
GCST004497		interaction	smoking
GCST004498		background	smokers
GCST004499		background	non-smokers
GCST004500		background	bmi and smoking behavior adjusted
GCST004501		interaction, background	smoking, bmi adjusted
GCST004502		interaction, background	smoking, bmi adjusted
GCST004503		background	smokers, bmi adjusted
GCST004504		background	non smokers, bmi adjusted
GCST004505		background	bmi and smoking behavior adjusted
GCST004506		interaction, background	smoking, bmi adjusted
GCST004507		interaction, background	smoking, bmi adjusted
GCST004508		background	non smokers
GCST004509		background	smokers, bmi adjusted
GCST004510		phenotype	sporadic
GCST004510		stratified	sporadic
GCST004511		phenotype	daily vs non-daily
GCST004512		phenotype	heavy vs light
GCST004513		phenotype	current vs former
GCST004514		phenotype	ever vs never
GCST004518			bmi adjusted
GCST004519		background	adult
GCST004521		phenotype	autism spectrum disorder or schizophrenia
GCST004522		response, biomarker	metformin, glycated hemoglobin levels
GCST004523		phenotype	resting metabolic rate
GCST004525		phenotype	basilar peel-core ratio of high attentuation areas on ct scan
GCST004526		phenotype	basilar percentage of high attenuation areas on ct scan
GCST004527		phenotype	percentage of high attenuation areas on ct scan
GCST004528		phenotype	her2 status
GCST004528		stratified	ER-positive
GCST004530		biomarker	c-reactive protein
GCST004533		biomarker	fasting blood insulin
GCST004536		biomarker	hemoglobin
GCST004537		biomarker	hdl
GCST004538		phenotype	bone size (hip)
GCST004539		phenotype	homeostasis model assessment of insulin resistance
GCST004540		phenotype	homeostasis model assessment of insulin resistance, bmi adjusted
GCST004541		biomarker	ldl
GCST004542		phenotype	mean corpuscular hemoglobin
GCST004543		phenotype	mean corpuscular hemoglobin concentration
GCST004544		phenotype	mean corpuscular volume
GCST004548		biomarker	total cholesterol
GCST004550		biomarker	triglyceride
GCST004552			bmi adjusted
GCST004556			bmi adjusted
GCST004558		interaction	physical activity
GCST004559		background	physically active individuals
GCST004560		background	physically inactive individuals
GCST004561		interaction, background	bmi adjusted, physical activity
GCST004562			bmi adjusted
GCST004563		interaction, background	bmi adjusted, joint analysis main effects and physical activity
GCST004564		background	bmi adjusted, active individuals
GCST004565		background	bmi adjusted, inactive individuals
GCST004566		interaction, background	bmi adjusted, physical activity
GCST004567		interaction, background	bmi adjusted, joint analysis main effects and physical activity
GCST004568		interaction	physical activity
GCST004570		biomarker	iron
GCST004571		phenotype	iron binding capacity
GCST004572		phenotype	transferrin saturation
GCST004573		biomarker	ferritin
GCST004575		response	acute insulin response
GCST004576			bmi adjusted
GCST004577		background	bmi adjusted, inactive individuals
GCST004578		background	bmi adjusted, active individuals
GCST004579		interaction	alcohol consumption
GCST004580		interaction	recreational physical activity
GCST004581		interaction	smoking years
GCST004582		interaction	dietary factor
GCST004583		interaction	recreational physical activity
GCST004584		interaction	smoking years
GCST004585		background	excluding migration to or from binge-eating disorder or bulimia nervosa
GCST004586		interaction	smoking (ever vs never)
GCST004587		interaction	dietary energy
GCST004598		phenotype, biomarker	ischaemic stroke and hyperhomocysteinaemia, vwf levels
GCST004599		phenotype	mean platelet volume
GCST004600		phenotype	eosinophil percentage of leukocytes
GCST004602		phenotype	mean corpuscular volume
GCST004605		phenotype	mean corpuscular hemoglobin concentration
GCST004606		phenotype	eosinophil count
GCST004607		phenotype	platelet crit
GCST004608		phenotype	granulocyte count
GCST004609		phenotype	monocyte percentage of leukocytes
GCST004613		phenotype	sum neutrophil eosinophil counts
GCST004614		phenotype	granulocyte count
GCST004615		biomarker	hemoglobin
GCST004616		phenotype	platelet component distribution width
GCST004617		phenotype	eosinophil percentage of granulocytes
GCST004620		phenotype	sum basophil neutrophil counts
GCST004621		phenotype	red blood cell distribution width
GCST004623		phenotype	neutrophil percentage of granulocytes
GCST004624		phenotype	basophil count, eosinophil count
GCST004625		phenotype	monocyte count
GCST004626		phenotype	myeloid white cell count
GCST004629		phenotype	neutrophil count
GCST004630		phenotype	mean corpuscular hemoglobin
GCST004631		phenotype	basophil percentage of white cells
GCST004632		phenotype	lymphocyte percentage of leukocytes
GCST004633		phenotype	neutrophil percentage of leukocytes
GCST004634		phenotype	basophil percentage of granulocytes
GCST004635	C563236	background	testicular germ cell tumor
GCST004635	C563236	stratified	testicular germ cell tumor
GCST004638		phenotype	lower urinary tract symptoms
GCST004639		phenotype	prudent dietary pattern
GCST004640		phenotype	western dietary pattern
GCST004642		interaction, phenotype	ambient particulate matter, qt interval
GCST004643		biomarker	1,5-anhydroglucitol levels
GCST004644		phenotype	vaso-occlusive pain
GCST004645		phenotype	left ventricular fractional shortening
GCST004646		phenotype	left ventricle wall thickness
GCST004647		phenotype	left atrial antero-posterior diameter
GCST004648		phenotype	left  ventricle systolic dysfunction
GCST004649		phenotype	isovolumetric relaxation time
GCST004650		phenotype	diastolic dysfunction with preserved ejection pressure
GCST004651		phenotype	aortic root size
GCST004652		phenotype	peak velocity of the mitral a-wave
GCST004653		phenotype	peak velocity of the mitral e-wave
GCST004654		phenotype	deceleration time of the mitral e-wave
GCST004655		phenotype	left ventricle diastolic internal dimension
GCST004656		phenotype	ratio of the peak velocity of the mitral e-wave divided by the peak velocity of the mitral a-wave.
GCST004657		phenotype	ratio of the peak velocity of the excursion of the lateral mitral annulus in the early diastolic phase and the peak velocity of the mitral e-wave
GCST004658		phenotype	peak velocity of excursion of lateral mitral annulus in early diastolic phase
GCST004659		phenotype	left ventricular mass
GCST004660		phenotype	heart failure with preserved ejection fraction
GCST004661	C536494	phenotype	uveal melanoma
GCST004661	C536494	stratified	melanoma
GCST004678		phenotype	psychosis predisposition
GCST004679		phenotype	psychosis predisposition
GCST004680		phenotype	psychosis predisposition
GCST004681		phenotype	psychosis predisposition
GCST004682		phenotype	psychosis predisposition
GCST004683		phenotype	psychosis predisposition
GCST004684		phenotype	psychosis predisposition
GCST004685		phenotype	psychosis predisposition
GCST004686		phenotype	psychosis predisposition
GCST004687		phenotype	psychosis predisposition
GCST004688		phenotype	psychosis predisposition
GCST004689		background, phenotype	hiv-positive, resistance measured by tuberculin skin test
GCST004690		background, phenotype	hiv-positive, resistance measured by tuberculin skin test
GCST004691		phenotype	progression
GCST004693		phenotype	daytime rest
GCST004694		phenotype	sleep duration
GCST004697		phenotype	morning person
GCST004699		phenotype	excessive daytime sleepiness
GCST004700		interaction	sex
GCST004701		phenotype	continuous
GCST004702		phenotype	dichotomous
GCST004703		phenotype	autism specrtrum
GCST004704		biomarker	hdl
GCST004704		biomarker	ldl
GCST004706		phenotype	fear of pain
GCST004707		phenotype	fear of pain
GCST004708		phenotype	fear of pain
GCST004709		phenotype	fear of pain
GCST004713	C563236	background	testicular germ cell tumor
GCST004713	C563236	stratified	testicular germ cell tumor
GCST004714		phenotype	heart rate variability
GCST004715		phenotype	heart rate
GCST004716		phenotype	heart rate variability
GCST004717		pleiotropy	lumbar spine bone mineral density
GCST004718		phenotype	inherited effect
GCST004719		phenotype	left ventricular obstructive tract defect (inherited effect)
GCST004720	C535464	phenotype	conotruncal heart defects (inherited effects)
GCST004721		phenotype	maternal effect
GCST004722		phenotype	left ventricular obstructive tract defect (maternal effect)
GCST004723	C535464	phenotype	conotruncal heart defects (maternal effects)
GCST004724		background	type 1 diabetes
GCST004725		background	type 1 diabetes
GCST004726		biomarker	vitamin d
GCST004728		phenotype	angry faces
GCST004729		phenotype	happy faces
GCST004730		phenotype	sad faces
GCST004731		phenotype	fearful faces
GCST004732		phenotype	heart rate variability
GCST004733		phenotype	heart rate variability
GCST004734		phenotype	heart rate variability
GCST004735		response	ebv copy number
GCST004736		associated disease	hepatitis B
GCST004736		background	hepatitis b infection
GCST004737		phenotype	neovascular
GCST004738		response	duloxetine (% change in symptom score)
GCST004739		response	placebo (% change in symptom score)
GCST004740		response	duloxetine (remitter/non-remitter status)
GCST004741		response	duloxetine (responder/non-responder status)
GCST004742		response	placebo (remitter/non-remitter status)
GCST004743		response	placebo (responder/non-responder status)
GCST004747		background	never smokers
GCST004747		stratified	never smokers
GCST004749		background	ever smokers
GCST004749		interaction or exposure	ever smokers
GCST004750		phenotype	squamous
GCST004750		stratified	squamous
GCST004751		response, biomarker	allopurinol, uric acid
GCST004752		response	relapse
GCST004755		phenotype	chronic alcoholic pancreatitis or alcohol-related cirrhosis
GCST004757		phenotype	alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis
GCST004759		biomarker	very low density lipoprotein cholesterol levels
GCST004760		phenotype	bone size (hip), bmi adjusted
GCST004761			bmi adjusted
GCST004762			bmi adjusted
GCST004763		response, background, biomarker	response to fenofibrate in statin-treated type 2 diabetes, hdl
GCST004764		response, background, biomarker	fenofibrate, statin-treated type 2 diabetes, ldl
GCST004765		response, background, biomarker	fenofibrate in statin-treated type 2 diabetes, totoal cholesterol
GCST004766		interaction, background, biomarker	fenofibrate, type 2 diabetes, triglyceride
GCST004767		phenotype	age at onset
GCST004768		interaction	prenatal lead exposure
GCST004769		interaction	prenatal lead exposure
GCST004770		phenotype	lean body mass
GCST004771		pleiotropy	lean body mass
GCST004772		phenotype	pediatric, lower limb
GCST004775		phenotype	pulse pressure
GCST004779		phenotype	uterine fibroid
GCST004780		biomarker	cortisol levels (saliva)
GCST004781		side effect	sulfasalazine
GCST004783		background	preterm infants
GCST004786		side effect	thiazide
GCST004787		phenotype	myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease
GCST004788		side effect, phenotype	paclitaxel and trastuzumab for her+ breast cancer, lvef
GCST004789		side effect	paclitaxel for her2+ breast cancer
GCST004790		side effect, phenotype	paclitaxel and trastuzumab for her+ breast cancer, lvef
GCST004790		treatment side effect	ER positive bresat cancer - paclitaxel and trastuzumab (cardiotoxicity)
GCST004791		interaction	c9orf72 mutation
GCST004792		background	c9orf72 mutation positive individuals
GCST004793		background	c9orf72 mutation negative individuals
GCST004794		background, phenotype	infant intracranial volume
GCST004795		background, phenotype	infant white matter volume
GCST004796		background, phenotype	infant cerebrospinal fluid volume
GCST004797		background, phenotype	infant grey matter volume
GCST004798		phenotype	differentiated
GCST004799		phenotype	family history of upper gastrointestinal cancer
GCST004800		interaction, phenotype	environmental tobacco smoke, fev1
GCST004801		response	ranibizumab
GCST004802		response	ranibizumab
GCST004803		response	ranibizumab, additional treatment requirement
GCST004804		phenotype	serum ig light chain only lambda based profile
GCST004805		phenotype	heart involvement
GCST004806		phenotype	heart and kidney involvement
GCST004807		phenotype	liver involvement
GCST004808		phenotype	serum igg profile
GCST004809		phenotype	serum ig lambda profile
GCST004810		phenotype	serum ig kappa profile
GCST004811		phenotype	serum ig light chain only lambda/kappa based profile
GCST004812		phenotype	kidney involvement
GCST004813		biomarker	laterality
GCST004814		interaction, biomarker	red blood cell fatty acid level, il-6
GCST004815		interaction, biomarker	eicosadienoic acid in rbc, c-reactive protein
GCST004815		interaction, biomarker	red blood cell fatty acid level, c-reactive protein
GCST004816		interaction, biomarker	red blood cell fatty acid level, lppla2
GCST004817		interaction, biomarker	red blood cell fatty acid level, tnfr ii
GCST004818		interaction, biomarker	docosapentaenoic acid in rbc, icam-1
GCST004819		interaction, biomarker	red blood cell fatty acid level, osteoprotegerin
GCST004820		interaction, biomarker	oleic acid in rbc, cellular adhesion molecule
GCST004821		interaction, biomarker	red blood cell fatty acid level, mcp-1
GCST004822		interaction, biomarker	red blood cell fatty acid level, p-selectin
GCST004824		phenotype	p wave terminal force
GCST004825		biomarker	uric acid
GCST004826		phenotype	p wave duration
GCST004827		phenotype	verbal memory performance (immediate recall change)
GCST004828		phenotype	verbal memory performance (immediate recall level)
GCST004829		phenotype	verbal memory performance (residualized delayed recall level)
GCST004830		phenotype	verbal memory performance (residualized delayed recall change)
GCST004831		phenotype	verbal memory performance (delayed recall level)
GCST004832		phenotype	verbal memory performance (delayed recall change)
GCST004834		phenotype	spine bmd
GCST004835		background	femoral neck
GCST004836		pleiotropy	femoral neck bone mineral density
GCST004837		pleiotropy	lumbar spine bone mineral density
GCST004838		pleiotropy	body mass index
GCST004841		phenotype	maternal effect
GCST004842		interaction	maternal pre-pregnancy bmi
GCST004843		interaction	maternal pre-pregnancy bmi
GCST004845		phenotype	spontaneous (maternal effect)
GCST004861		phenotype	itch intensity from mosquito bite
GCST004862		phenotype	itch intensity from mosquito bite adjusted by bite size
GCST004863		phenotype	mosquito bite size
GCST004864		phenotype	perceived unattractiveness to mosquitos
GCST004865		phenotype	itch intensity from mosquito bite adjusted by bite size
GCST004869		interaction	snp x mitochondrial t5004c interaction
GCST004870		interaction	snp x mitochondrial a4917g interaction
GCST004871		interaction	snp x mitochondrial g12771a interaction
GCST004872		interaction	snp x mitochondrial c16069t interaction
GCST004880		pleiotropy	type 2 diabetes
GCST004882		phenotype	11q deletion vs 11q undeleted and mycn amplification
GCST004883		phenotype	11q deletion
GCST004883		stratified	11q deletion
GCST004884		phenotype	1p deletion
GCST004884		stratified	1p deletion
GCST004885		phenotype	mycn amplification
GCST004885		stratified	MYCN amplification
GCST004887		background	current drinkers
GCST004891		phenotype	mean arterial pressure
GCST004892		phenotype	pulse pressure
GCST004896		response, phenotype	carboplatin and paclitaxel for serous epithelial ovarian cancer
GCST004896		treatment response	paclitaxel and cisplatin
GCST004897		response, phenotype	carboplatin and paclitaxel, serous epithelial ovarian cancer
GCST004897		treatment response	carboplatin and paclitaxel
GCST004898		phenotype	maternal effect
GCST004901	C531617	phenotype	sporadic
GCST004903		biomarker	glycated hemoglobin levels
GCST004919		biomarker	hdl
GCST004920		biomarker	ldl
GCST004921		biomarker	apolipoprotein a1 levels
GCST004924		biomarker	igg monogalactosylation
GCST004925		biomarker	igg glycosylation
GCST004926		biomarker	igg digalactosylation
GCST004927		biomarker	igg galactosylation
GCST004928		biomarker	igg bisecting n-acetyl glucosamine
GCST004929		biomarker	igg fucosylation
GCST004930		biomarker	igg sialylation
GCST004931		biomarker	igg disialylation
GCST004932		biomarker	igg monosialylation
GCST004938		background	pediatric non-alcoholic fatty acid liver disease
GCST004939		biomarker	glycated hemoglobin levels
GCST004940		biomarker	gpt
GCST004941		biomarker	dehydroepiandrosterone sulphate
GCST004942		background	pediatric, disease activity score
GCST004943		background	pediatric nonalcoholic steatohepatitis
GCST004944		pleiotropy	coornary artery disease
GCST004945		phenotype	lumbar
GCST004953		phenotype	disturbances of the gamma-frequency band of electroencephalography measures
GCST004955		background	alcohol dependence
GCST004956		interaction	alcohol dependence
GCST004957		response	darapladib
GCST004958		interaction	darapladib
GCST004959		interaction, background	darapladib, cardiovascular disease
GCST004960		side effect	darapladib for cardiovascular disease
GCST004961		phenotype	time to event
GCST004962		side effect	darapladib for cardiovascular disease
GCST004963		biomarker	lppla2
GCST004964		response, background	darapladib, cardiovascular disease
GCST004965		phenotype	time to event
GCST004966		response, biomarker	darapladib, lp-pla2 activity change
GCST004967		side effect, phenotype	darapladib for cardiovascular disease, moderate to severe
GCST004968		response, biomarker	darapladib, lp-pla2 activity change (adjusted for baseline)
GCST004969		phenotype	caudate activity during disappointment
GCST004970		phenotype	caudate activity during reward
GCST004971		phenotype	putamen activity during reward
GCST004972		background, phenotype	disappointment, putamen activity
GCST004973		pleiotropy	verbal-numerical reasoning
GCST004974		pleiotropy	schizophrenia
GCST004975		pleiotropy	schizophrenia
GCST004976		biomarker	nicotine metabolite ratio
GCST004981		phenotype	progression
GCST004983		phenotype	parental longevity
GCST004984		phenotype	clinic systolic blood pressure minus home systolic blood pressure
GCST004987		side effect, phenotype	antipsychotic for schizophrenia, qt prolongation
GCST004989		phenotype	early childhood
GCST004990		phenotype	ove the past year
GCST004991		phenotype	white matter microstructure in first episode schizophrenia (left inferior parietal cortex)
GCST004992		background, phenotype	first episode schizophrenia, right posterior cingulate cortex
GCST004993		background, phenotype	first episode schizophrenia, right anterior cingulate cortex
GCST004994		background, phenotype	first episode schizophrenia, left anterior cingulate cortex
GCST004995		background, phenotype	first episode schizophrenia, left posterior cingulate cortex
GCST004996		phenotype	first episode schizophrenia (total mean fractional anisotropy measurement)
GCST004997		background	microstructural abnormality of first episode
GCST004998		background	rheumatoid arthritis
GCST004999		phenotype	susceptibility
GCST005000		phenotype	cold sores
GCST005001		phenotype	susceptibility, shingles
GCST005002		phenotype	susceptibility
GCST005003		phenotype	susceptibility
GCST005004		phenotype	susceptibility
GCST005005		phenotype	susceptibility, plantar warts
GCST005006		phenotype	susceptibility
GCST005007		phenotype	susceptibility, strep throat
GCST005008		phenotype	susceptibility
GCST005009		phenotype	susceptibility
GCST005010		phenotype	susceptibility
GCST005011		phenotype	susceptibility
GCST005012		phenotype	susceptibility
GCST005013		phenotype	susceptibility, childhood
GCST005014		phenotype	tonsillectomy risk
GCST005015		phenotype	myringotomy, childhood
GCST005016		phenotype	susceptibility
GCST005017		phenotype	susceptibility
GCST005018		phenotype	susceptibility
GCST005019		phenotype	susceptibility
GCST005020		phenotype	susceptibility
GCST005021		phenotype	susceptibility, chronic
GCST005022		background	alcohol dependence
GCST005023		phenotype	eye movements (initial pursuit acceleration)
GCST005024		phenotype	eye movements (pursuit maintenance gain)
GCST005025		phenotype	anti-saccade response
GCST005026		phenotype	eye movements (initial pursuit acceleration)
GCST005027		background	psychotic disorders
GCST005028		phenotype	eye movements (pursuit maintenance gain)
GCST005029		phenotype	early gain, maternal effect
GCST005030		phenotype	late gain, fetal effect
GCST005031		phenotype	fetal effect
GCST005032		phenotype	early gain, fetal effect
GCST005033		phenotype	maternal effect
GCST005034		phenotype	late gain, maternal effect
GCST005035		biomarker	growth hormone
GCST005036		phenotype	lean body mass
GCST005037		phenotype	appendicular lean mass
GCST005038		phenotype	asthma, hay fever or eczema
GCST005039		response, phenotype	uncontrolled by combination therapy (beta blocker and thiazide diuretic)
GCST005040		response	combination therapy (beta blocker and thiazide diuretic)
GCST005041		response	combination therapy (beta blocker and thiazide diuretic)
GCST005046		biomarker	n-glycan
GCST005048		phenotype	idiopathic osteonecrosis
GCST005049		phenotype	apnea hypopnea index, non-rem sleep
GCST005050		phenotype	apnea hypopnea index, rem sleep
GCST005051		phenotype	apnea hypopnea index
GCST005052		phenotype	platelet-to-lymphocyte ratio
GCST005053		phenotype	neutrophil-to-lymphocyte ratio
GCST005056		phenotype	neutrophil count
GCST005057		phenotype	small vessel stroke
GCST005058		biomarker	hdl
GCST005059		biomarker	alb
GCST005060		biomarker	hemoglobin
GCST005061		biomarker	alkaline phosphatase
GCST005062		biomarker	fibrinogen
GCST005063		biomarker	glomerular filtration rate
GCST005064		biomarker	aspartate aminotransferase
GCST005065		biomarker	total cholesterol
GCST005066		biomarker	creatinine
GCST005067		biomarker	c-reactive protein
GCST005068		biomarker	ldl
GCST005069		biomarker	gamma-glutamyl transferase
GCST005070		biomarker	urea levels
GCST005071		biomarker	insulin like growth factor
GCST005072		biomarker	ferritin
GCST005073		biomarker	triglyceride
GCST005074		biomarker	testosterone
GCST005075		background	brca1 mutation carriers
GCST005075		stratified	BRCA1 positive, ER negative
GCST005076		background	er-negative
GCST005076		stratified	ER-negative
GCST005077		background	er-negative
GCST005077		stratified	ER-negative
GCST005079		phenotype	orofacial clefts (cleft lip vs. cleft lip and palate)
GCST005080		phenotype	pr interval
GCST005081		response, phenotype	lithium, bipolar disorder or schizophrenia
GCST005082		response, phenotype	lithium, bipolar disorder or schizophrenia
GCST005083		phenotype	putamen volume
GCST005085		phenotype	visceral adipose tissue
GCST005086		interaction	sex
GCST005087		phenotype	visceral adipose tissue, bmi adjusted
GCST005088		interaction, background	sex, bmi adjusted
GCST005089		phenotype	visceral:subcutaneous adipose tissue ratio
GCST005090		interaction, phenotype	sex,  visceral:subcutaneous adipose tissue ratio
GCST005091		phenotype	subcutaneous adipose tissue
GCST005092		interaction, phenotype	sex, subcutaneous adipose tissue
GCST005093		phenotype	a* coordinate
GCST005094		phenotype	l* coordinate
GCST005095		phenotype	heterochromicity
GCST005096		phenotype	b* coordinate
GCST005106		phenotype	survival time
GCST005109		biomarker	progranulin
GCST005110		background	childhood cancer survivors treated with less than 10 gray radiotherapy
GCST005110		treatment side effect	childhood cancer - radiation (breast cancer)
GCST005111		background	childhood cancer survivors
GCST005111		treatment side effect	childhood cancer - radiation (breast cancer)
GCST005112		background	childhood cancer survivors treated with more than 10 gray radiotherapy
GCST005112		treatment side effect	childhood cancer - radiotherapy (breast cancer)
GCST005114		pleiotropy	osteoporosis
GCST005115		response	mepolizumab
GCST005117		phenotype	activities of daily living score
GCST005118		phenotype	mid-arm muscle circumference
GCST005119		phenotype	calf circumference
GCST005120		phenotype	four meter walk test score
GCST005121		phenotype	short physical performance battery score
GCST005124		biomarker	magnesium/creatinine ratio in urine
GCST005125		biomarker	magnesium
GCST005126		phenotype	fractional excretion of magnesium
GCST005127		phenotype	maximal voluntary ventilation
GCST005129		phenotype	maximal midexpiratory flow rate
GCST005130		phenotype	fev1/fec ratio
GCST005131		phenotype	fvc
GCST005132		phenotype	fev1
GCST005134		response, phenotype	sotalol, t wave peak and end interval change
GCST005135		response, phenotype	solatol, t wave maximal amplitude change
GCST005136		response, phenotype	sotalol, ventricular repolarization changes pc2
GCST005137		response, phenotype	sotalol, t wave morphology notching
GCST005138		response, phenotype	sotalol, ventricular repolarization changes pc13
GCST005139		response, phenotype	sotalol, ventricular repolarization changes pc1
GCST005140		response, phenotype	solatol, ventricular repolarization duration change
GCST005141		phenotype	cognitive ability
GCST005142		phenotype	cognitive ability
GCST005144		background, biomarker	kidney transplantation, tacrolimus trough concentration
GCST005145		biomarker	glycated hemoglobin levels
GCST005147		phenotype	colonoscopy-negative controls vs population controls
GCST005148		stratified	advanced colorectal adenomas
GCST005149		stratified	advanced colorectal adenomas
GCST005150		stratified	advanced colorectal adenomas
GCST005151		phenotype	advanced colorectal adenoma
GCST005151		stratified	advanced
GCST005152		stratified	advanced colorectal adenomas
GCST005153		phenotype	advanced colorectal adenoma
GCST005153		stratified	advanced
GCST005154		phenotype	pregnancy induced alloimmunization (hla class i and ii)
GCST005155		phenotype	pregnancy induced alloimmunization
GCST005156		phenotype	pregnancy induced alloimmunization (hla class )
GCST005157		phenotype	pregnancy induced alloimmunization (hla class ii)
GCST005158		phenotype	osteosarcoma
GCST005158		survival	
GCST005159		phenotype	insulin
GCST005160		phenotype	insulin
GCST005161		phenotype	insulin
GCST005162		biomarker	glucagon
GCST005163		biomarker	glucagon
GCST005164		biomarker	glp-1
GCST005165		biomarker	glp-1
GCST005166		biomarker	gip
GCST005167		biomarker	gip
GCST005171		phenotype	qt interval
GCST005173		background, phenotype	coronary artery calcified atherosclerotic plaque (130 hu threshold) in type 2 diabetes
GCST005174		background, phenotype	coronary artery calcified atherosclerotic plaque score in type 2 diabetes
GCST005175		background, phenotype	coronary artery calcified atherosclerotic plaque (90 or 130 hu threshold) in type 2 diabetes
GCST005176		response, biomarker	rubella vaccine, interleukin-6
GCST005177		response, biomarker	rubella vaccine, interferon gamma
GCST005178		phenotype	insulin sensitivity
GCST005179		phenotype	homeostasis model assessment of insulin resistance
GCST005180		phenotype	homeostasis model assessment of beta-cell function
GCST005182		phenotype	intima media thickness
GCST005183		phenotype	intima media thickness
GCST005184		background, phenotype	hiv infection, intimal medial thickness
GCST005185		biomarker	fasting blood insulin
GCST005187		biomarker	mmp8 (matrix metalloproteinase 8)
GCST005191		phenotype	hair shape
GCST005192		phenotype	lobe attachment (rater-scored or self-reported)
GCST005193		phenotype	lobe attachment (rater scored)
GCST005197		biomarker	antiepileptic drug
GCST005198		biomarker	carbamazepine
GCST005199		side effect	lamotrignine
GCST005200		biomarker	phenytoin
GCST005201		interaction, phenotype	potassium, pulse pressure
GCST005202		interaction	dietary potassium intake
GCST005203		interaction, phenotype	dietary potassium intake, mean arterial pressure
GCST005204		interaction	dietary potassium intake
GCST005205		biomarker	nt-probnp
GCST005206		biomarker	b-type natriuretic peptide
GCST005207		biomarker	midregional pro atrial natriuretic peptide
GCST005208		biomarker	b-type natriuretic peptide to n-terminal pro b-type natriuretic peptide ratio
GCST005210		phenotype	mixed cellularity
GCST005211		background	nodular sclerosis
GCST005211		stratified	nodular sclerosis
GCST005213		phenotype	childhood onset
GCST005214		side effect, phenotype	combined chemotherapy for acute lymphoblastic leukemia, spine bone mineral density
GCST005215		phenotype	insulin response
GCST005216		phenotype	insulin response, insulin sensitivity adjusted
GCST005217		phenotype	insulin response, bmi adjusted
GCST005218		phenotype	insulin response
GCST005219		biomarker	insulin
GCST005220		biomarker	insulin
GCST005221		phenotype	insulin sensitivity
GCST005223		phenotype	insulin response
GCST005224		phenotype	femoral neck bone mineral density
GCST005225		phenotype	lumbar spine bone mineral density
GCST005226		phenotype	lumbar spine bone mineral density
GCST005227		phenotype	lumbar spine bone mineral density
GCST005228		phenotype	femoral neck bone mineral density
GCST005229		phenotype	femoral neck bone mineral density
GCST005230		phenotype	recurrent
GCST005234		phenotype	lean body mass
GCST005236		background	trauma-exposed individuals
GCST005237		phenotype	mood instability
GCST005238		phenotype	mood instability
GCST005239		background	trauma-exposed individuals, amygdala volume
GCST005240		background	trauma-exposed individuals, caudate volume
GCST005241		background	trauma-exposed individuals, nucleus accumbens volume
GCST005242		phenotype	trauma, pallidum volume
GCST005243		background	trauma-exposed individuals, hippocampal volume
GCST005244		background	trauma-exposed individuals, putamen volume
GCST005245		background	trauma-exposed individuals, thalamus volume
GCST005248		phenotype	delayed reward discounting
GCST005266		pleiotropy, phenotype	schizophrenia
GCST005267		pleiotropy	schizophrenia
GCST005268		phenotype	nasal polyps
GCST005269		biomarker	luteinizing hormone
GCST005270		biomarker	follicle stimulating hormone
GCST005270		biomarker	in polycystic ovary syndrome
GCST005271		biomarker	in polycystic ovary syndrome
GCST005271		biomarker	sex hormone-binding globulin
GCST005272		biomarker	in polycystic ovary syndrome
GCST005272		biomarker	testosterone
GCST005274		biomarker	dehydroepiandrosterone sulphate
GCST005277		phenotype	lumbar spondylosis (kellgren-lawrence grade)
GCST005278		phenotype	lumbar spondylosis (presence and severity of osteophytes)
GCST005279		phenotype	lumbar spondylosis (disc space narrowing)
GCST005286		background, phenotype	trauma-exposed individuals, lateral ventricle volume
GCST005287		phenotype	extrinsic epigenetic age acceleration
GCST005288		phenotype	extrinsic epigenetic age acceleration
GCST005307		phenotype	brunt stage
GCST005309		associated disease	Nonalcoholic steatohepatitis
GCST005309		background	nonalcoholic steatohepatitis
GCST005310		phenotype	brunt grade
GCST005311		phenotype	hepatocyte fat droplet content
GCST005312		phenotype	age at onset
GCST005313		phenotype	spontaneous
GCST005314		phenotype	offspring birth weight
GCST005315		background	childhood
GCST005315		stratified	childhood
GCST005317		pleiotropy	lipids
GCST005318		response	methylphenidate
GCST005319		pleiotropy	immune-mediated diseases
GCST005320		pleiotropy	immune-mediated diseases
GCST005321		pleiotropy	immune-mediated diseases
GCST005322		pleiotropy, phenotype	corticobasal degeneration and immune-mediated diseases (pleiotropy)
GCST005325		phenotype	subjective well-being (mtag)
GCST005328		phenotype	subjective well-being
GCST005329		phenotype	cups of coffee per day
GCST005330		phenotype	cups of coffee per day
GCST005331		biomarker	tryptophan (csf)
GCST005332		phenotype	autoantibody against topoisomerase
GCST005333		response	autoantibody against centromere
GCST005334		phenotype	cutaneous
GCST005335		pleiotropy	cutaneous
GCST005342		drug metabolism	plasma kynurenine levels in major depressive disorder
GCST005343		drug metabolism	plasma kynurenine to tryptophan ratio in major depressive disorder
GCST005344		background	age 15-30
GCST005345		background	age 0-15
GCST005346		background	age 30-45
GCST005347		phenotype	pseudoexfoliation syndrome
GCST005349		background	age over 60
GCST005350		background	age 45-60
GCST005351		drug metabolism	carboplatin disposition in epthelial ovarian cancer
GCST005351		drug metabolism	carboplatin levels in epithelial ovarian cancer
GCST005352		drug metabolism	paclitaxel disposition in epithelial ovarian cancer
GCST005352		drug metabolism	paclitaxel levels in epithelial ovarian cancer
GCST005353		response, biomarker	glp-1-stimulated insulin response, glp-1 stimulated
GCST005356		phenotype	severe
GCST005357		background	sickle cell variant rs334 adjusted
GCST005358		phenotype	progression
GCST005359		phenotype	disease progression
GCST005360		phenotype	progression
GCST005361		interaction	sex
GCST005363		phenotype	sex
GCST005364		response, background	opioid requirements, laparoscopic-assisted colectomy
GCST005365		biomarker	c3d:c3 ratio (systemic complement activation)
GCST005366		interaction	vitamin d, vitamin d dietary intake
GCST005367		biomarker	vitamin d
GCST005368		phenotype	opioid dependence
GCST005369		biomarker	uric acid
GCST005387		background	bipolar disorder
GCST005389		phenotype	tooth agenesis
GCST005390		phenotype	tooth agenesis (mandibular second premolars)
GCST005391		phenotype	tooth agenesis (maxillary lateral incisors)
GCST005392		phenotype	tooth agenesis (maxillary second premolars)
GCST005406		phenotype	optic cup area
GCST005408		phenotype	intra-ocular pressure
GCST005409		phenotype	cup-to-disc ratio
GCST005410		phenotype	optic disc area
GCST005411		biomarker	thrombin activatable fibrinolysis inhibitor activation peptide
GCST005412		biomarker	carboxypeptidase b2
GCST005415		phenotype	self-reported risk-taking behaviour
GCST005416		phenotype	airflow obstruction
GCST005418		phenotype	fev1
GCST005419		phenotype	fev1/fec ratio
GCST005426		background	renal transplantation
GCST005427		background	kidney transplantation (recipient effect)
GCST005428		background	kidney transplantation (recipient effect)
GCST005429		background	kidney transplantation (donor effect)
GCST005430		interaction, background, phenotype	donor-recipient, kidney transplantation, graft survival time
GCST005431		background, phenotype	kidney transplantation, acute draft rejection (recipient effect)
GCST005432		background, phenotype	kidney transplantation, acute draft rejection (donor effect)
GCST005433		interaction, background, phenotype	donor-recipient, kidney transplantation, acute draft rejection
GCST005435		background, biomarker	stimulated c-peptide levels in type i diabetes
GCST005436		background, biomarker	c-peptide levels in type i diabetes
GCST005437		background, biomarker	random c-peptide levels in type i diabetes
GCST005438		background, biomarker	fasting c-peptide levels in type i diabetes
GCST005439		response	alcohol consumption
GCST005440		phenotype	symptom count
GCST005441		phenotype	max-drinks
GCST005442		biomarker	apolipoprotein b levels
GCST005443		biomarker	apolipoprotein a1, apolipoprotein b levels
GCST005444		biomarker	esterified cholesterol
GCST005445		biomarker	free cholesterol levels
GCST005446		biomarker	total cholesterol levels in hdl
GCST005447		biomarker	total cholesterol levels in ldl
GCST005448		biomarker	total cholesterol
GCST005449		biomarker	triglyceride
GCST005450		biomarker	very low density lipoprotein cholesterol levels
GCST005451		biomarker	phospholipid levels in very large vldl
GCST005452		background, biomarker	triglyceride levels in very large vldl
GCST005453		biomarker	cholesterol ester levels in large vldl
GCST005454		biomarker	phospholipid levels in large vldl
GCST005455		biomarker	mean diameter of hdl particles
GCST005456		biomarker	mean diameter of ldl particles
GCST005457		phenotype	vldl mean diameter
GCST005458		biomarker	total cholesterol levels in large vldl
GCST005459		biomarker	free cholesterol levels in large vldl
GCST005460		background, biomarker	triglyceride levels in large vldl
GCST005461		biomarker	cholesterol ester levels in large vldl
GCST005462		biomarker	vldl medium
GCST005463		biomarker	phospholipid levels in medium vldl
GCST005464		biomarker	total cholesterol levels in medium vldl
GCST005465		biomarker	cholesterol ester levels in medium vldl
GCST005466		biomarker	free cholesterol levels in medium vldl
GCST005467		background, biomarker	triglyceride levels in medium vldl
GCST005468		biomarker	vldl small
GCST005469		biomarker	phospholipid levels in small vldl
GCST005470		biomarker	total cholesterol levels in small vldl
GCST005471		biomarker	free cholesterol levels in small vldl
GCST005472		background, biomarker	triglyceride levels in small vldl
GCST005473		biomarker	vldl very small
GCST005474		biomarker	phospholipid levels in very small vldl
GCST005475		background, biomarker	triglyceride levels in very small vldl
GCST005476		biomarker	idl
GCST005477		biomarker	phospholipid levels in idl
GCST005478		biomarker	idl
GCST005479		biomarker	free cholesterol levels in idl
GCST005480		background, biomarker	triglyceride levels in idl
GCST005481		biomarker	large ldl particle concentration
GCST005482		biomarker	phospholipid levels in large ldl
GCST005483		biomarker	total cholesterol levels in large ldl
GCST005484		biomarker	esterified cholesterol in large ldl
GCST005485		biomarker	free cholesterol levels in large ldl
GCST005486		biomarker	medium ldl particle concentration
GCST005487		biomarker	phospholipid levels in medium ldl
GCST005488		biomarker	total cholesterol levels in medium ldl
GCST005489		biomarker	esterified cholesterol in medium ldl
GCST005490		biomarker	medium ldl particle concentration
GCST005491		biomarker	total cholesterol levels in small ldl
GCST005492		biomarker	very large hdl particle concentration
GCST005493		biomarker	phospholipid levels in very large hdl
GCST005494		biomarker	total cholesterol levels in very large hdl
GCST005495		biomarker	esterified cholesterol in very large hdl
GCST005496		biomarker	free cholesterol levels in very large hdl
GCST005497		biomarker	large hdl particle concentration
GCST005498		background, biomarker	triglyceride levels in very large hdl
GCST005499		biomarker	phospholipid levels in large hdl
GCST005500		biomarker	total cholesterol levels in large hdl
GCST005501		biomarker	esterified cholesterol in very large hdl
GCST005502		biomarker	free cholesterol levels in large hdl
GCST005503		biomarker	medium hdl particle concentration
GCST005504		biomarker	phospholipid levels in medium hdl
GCST005505		biomarker	total cholesterol levels in medium hdl
GCST005506		biomarker	esterified cholesterol in medium hdl
GCST005507		biomarker	free cholesterol levels in medium hdl
GCST005508		biomarker	small hdl particle concentration
GCST005509		background, biomarker	triglyceride levels in small hdl
GCST005510		phenotype	chylomicron and largest vldl particle concentration
GCST005511		biomarker	phospholipid levels in chylomicrons and largest vldl
GCST005512		phenotype, biomarker	chylomicrons and largest vldl, triglyceride
GCST005513		biomarker	apolipoprotein a1 levels
GCST005514		pleiotropy	neurofibrillary tangles or cerebral amyloid angiopathy
GCST005515		pleiotropy	cerebral amyloid angiopathy
GCST005516		pleiotropy	neurofibrillary tangles (pleiotropy)
GCST005517		pleiotropy	neurofibrillary tangles
GCST005518		background	childhood cancer survivors
GCST005518		treatment side effect	childhood cancer - gonadotoxic therapy (premature menopause)
GCST005519		response, phenotype	beta blockers, heart rate
GCST005520		response, phenotype	beta blockers (atenolol add-on therapy), heart rate
GCST005521		response, phenotype	beta blockers (atenolol monotherapy), heart rate
GCST005522		phenotype	narcolepsy with cataplexy
GCST005524		phenotype	graves disease or hashimoto's thyroiditis
GCST005528		phenotype	oligoarticular or rheumatoid factor-negative polyarticular
GCST005530		interaction	snp x snp
GCST005533		phenotype	cutaneous
GCST005535		pleiotropy	cutaneous
GCST005537		phenotype	ankylosing spondylitis, crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis
GCST005540		phenotype	lofgren's syndrome
GCST005541		phenotype	lofgren's syndrome vs non-lofgren's syndrome
GCST005542		phenotype	non-lofgren's syndrome without extrapulmonary manifestations
GCST005543		phenotype	non-lofgren's syndrome
GCST005544		background	femoral neck
GCST005545		phenotype	spine bmd
GCST005546		phenotype	forearm
GCST005549		phenotype	late onset
GCST005550		background	trauma-exposed individuals
GCST005551		phenotype	autoantibody against topoisomerase
GCST005552		response	autoantibody against centromere
GCST005553		pleiotropy	cutaneous
GCST005555		phenotype	cutaneous
GCST005556		phenotype	pollinosis
GCST005557		biomarker	uric acid
GCST005558		phenotype	plantar fasciitis or fibromatosis
GCST005559		phenotype	virologic severity, hsv2
GCST005560		phenotype	age at onset
GCST005563		pleiotropy	immune-mediated diseases
GCST005567		phenotype	acpa-negative
GCST005568		phenotype	acpa-positive
GCST005570		associated disease	hepatitis B
GCST005570		background	hepatitis b infection
GCST005571		phenotype	hip or knee, with total joint replacement
GCST005572		phenotype	with total joint replacement
GCST005573		phenotype	hip or knee
GCST005574		phenotype	with total joint replacement
GCST005577		side effect, phenotype	thiazide diuretic for hypertension, glucose change
GCST005586		background, biomarker	breast milk (maternal genotype effect), fatty acid levels
GCST005587		background, biomarker	breast milk (infant genotype effect), fatty acid levels
GCST005589		side effect	proton beam irradiation treatment of choroidal melanoma
GCST005590		phenotype	non-typhoidal
GCST005606		response	hepatitis b vaccine
GCST005626		phenotype	extremely high intelligence
GCST005646		side effect, biomarker	hydrochlorothiazide in hypertension, serum uric acid levels
GCST005648		biomarker	serum metabolite concentrations
GCST005649		biomarker	urinary metabolite ratios
GCST005650		biomarker	serum metabolite ratios
GCST005651		biomarker	urinary metabolite concentrations
GCST005652		interaction	maternal periconceptional vitamin use
GCST005653		interaction, phenotype	cleft lip with or without cleft palate (maternal periconceptional alcohol intake interaction)
GCST005654		interaction	maternal periconceptional cigarette smoking
GCST005656		biomarker	igg glycosylation
GCST005666		biomarker	fractional excretion of metabolites
GCST005667		phenotype	central corneal thickness
GCST005668		response, biomarker	delta-5 desaturase activity, response to n3-polyunsaturated fat supplement
GCST005669		response, biomarker	delta-6 desaturase activity, response to n3-polyunsaturated fat supplement
GCST005670		biomarker	trimethyllysine
GCST005671		phenotype	cholesterol efflux capacity
GCST005672		biomarker	cholesteryl ester transfer protein levels
GCST005686		associated disease	in multiple myeloma
GCST005686		background	multiple myeloma
GCST005689		background	unexposed to adversity
GCST005690		background	exposed to adversity
GCST005706		response, biomarker	neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)
GCST005707		response, biomarker	neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)
GCST005708		response, biomarker	neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years)
GCST005709		response, biomarker	neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels)
GCST005710		response, biomarker	neutralising antibody response to interferon beta therapy in multiple sclerosis (time to production)
GCST005711		biomarker	gdf15
GCST005712		biomarker	gdf15
GCST005713		phenotype	plasma neurofilament light levels
GCST005714		biomarker	cerebrospinal fluid beta-site app cleaving enzyme levels
GCST005715		phenotype	myopic maculopathy
GCST005717		phenotype	paranoia and hallucinations
GCST005719		phenotype	cognitive disorganisation
GCST005720		phenotype	parent-rated negative symptoms
GCST005723		phenotype	maternal genetic effect
GCST005727		phenotype	parent-of-origin effect
GCST005729		biomarker	vitamin d (25-hydroxy form)
GCST005746		associated disease	hepatitis B
GCST005746		background	hepatitis b infection
GCST005747		background	heavy smokers
GCST005748		phenotype	digit length ratio (right hand)
GCST005749		phenotype	digit length ratio (left hand)
GCST005750		phenotype	digit length ratio
GCST005753		response, biomarker	metformin, glycated hemoglobin levels
GCST005759		phenotype	social domain
GCST005761		biomarker	igm against phosphorylcholine
GCST005763		biomarker	glucose
GCST005770		biomarker	c-reactive protein
GCST005771		biomarker	creatinine
GCST005773		phenotype	fvc
GCST005774		phenotype	heart rate
GCST005776		biomarker	hdl
GCST005780		biomarker	triglyceride
GCST005781		biomarker	total cholesterol
GCST005782		biomarker	vitamin d (25-hydroxy form)
GCST005783		background	inflammatory bowel disease
GCST005784		background	inflammatory bowel disease
GCST005785		phenotype	calcific aortic valve stenosis
GCST005787		response, phenotype	exercise, heart rate
GCST005788		response, phenotype	recovery post exercise, heart rate
GCST005789		phenotype	resting heart rate
GCST005790		phenotype	symptom severity
GCST005791		biomarker	creatinine
GCST005792		biomarker	glomerular filtration rate
GCST005793		biomarker	uric acid
GCST005794		biomarker	blood urea nitrogen levels
GCST005795		background	femoral neck
GCST005796		phenotype	spine bmd
GCST005800		background	extremely premature birth
GCST005801		phenotype	gout vs. hyperuricemia
GCST005803		phenotype	corneal
GCST005804		side effect	taxane for breast cancer
GCST005804		treatment side effect	breast cancer - taxane (peripheral neuropathy)
GCST005806		biomarker	blood protein levels
GCST005807		background, biomarker	type 2 diabetes, haptoglobin (urinary)
GCST005808		background, biomarker	type 2 diabetes, haptoglobin (plasma)
GCST005809	C535300	phenotype	photic sneeze reflex
GCST005810		phenotype	hospital-diagnosed
GCST005811		phenotype	self-reported
GCST005812		phenotype	hip or knee, hospital-diagnosed
GCST005813		phenotype	hospital-diagnosed
GCST005814		phenotype	hospital-diagnosed
GCST005826		phenotype	sero-negative rheumatoid arthritis
GCST005827		biomarker	estrone
GCST005828		biomarker	estradiol
GCST005832		background	childhood
GCST005833		response, phenotype	ssri for mdd or openness
GCST005834		response, phenotype	ssri for mdd or openness
GCST005835		response, phenotype	ssri for mdd or neuroticism
GCST005836		response, background	ssri, conscientiouness
GCST005837		phenotype	ulcerative colitis or crohn's disease
GCST005840		phenotype	large artery
GCST005841		phenotype	small vessel ischemic stroke
GCST005842		phenotype	cardioembolic stroke
GCST005845		response, phenotype	exercise, heart rate
GCST005846		response, phenotype	recovery post exercise (10 sec), heart rate
GCST005847		response, phenotype	recovery post exercise (20 sec), heart rate
GCST005848		response, phenotype	recovery post exercise (50 sec), heart rate
GCST005849		response, phenotype	recovery post exercise (40 sec), heart rate
GCST005850		response, phenotype	recovery post exercise (30 sec), heart rate
GCST005852		phenotype	colectomy
GCST005853		background	primary sclerosing cholangitis
GCST005854		phenotype	small duct vs large duct
GCST005855		associated disease	primary sclerosing cholangitis
GCST005855		background	primary sclerosing cholangitis
GCST005856		associated disease	in primary sclerosing cholangitis
GCST005856		background	primary sclerosing cholangitis
GCST005857		background	primary sclerosing cholangitis
GCST005858		background	primary sclerosing cholangitis
GCST005859		phenotype	liver transplant-free survival
GCST005860		associated disease	primary sclerosing cholangitis
GCST005860		background	primary sclerosing cholangitis (time to event)
GCST005861		biomarker	circulating odd-numbered chain saturated fatty acid levels (c23:0)
GCST005862		biomarker	circulating odd-numbered chain saturated fatty acid levels (c19:0)
GCST005863		phenotype	age at onset
GCST005864		phenotype	late age at menarche
GCST005865		phenotype	early age at menarche
GCST005866		biomarker	circulating odd-numbered chain saturated fatty acid levels (c15:0+c17:0)
GCST005867		phenotype	age at onset
GCST005868		biomarker	circulating odd-numbered chain saturated fatty acid levels (c17:0)
GCST005869		biomarker	circulating odd-numbered chain saturated fatty acid levels (c15:0)
GCST005873		biomarker	triglyceride
GCST005874		biomarker	hdl
GCST005880		background	diabetes
GCST005881		background	diabetes
GCST005882		background	type 2 diabetes
GCST005883		background	type 2 diabetes
GCST005884		background	diabetes
GCST005885		background	type 2 diabetes
GCST005886		background	diabetes
GCST005887		background, phenotype	type 2 diabetes, late
GCST005888		background, phenotype	diabetes, late
GCST005889		background, phenotype	type 2 diabetes, early
GCST005890		background, phenotype	diabetes, early
GCST005891		background, biomarker	glomerular filtration rate in diabetes
GCST005892		background, biomarker	glomerular filtration rate in type 2 diabetes
GCST005893		background	type 2 diabetes (esrd vs. no esrd)
GCST005894		background	diabetes (esrd vs. no esrd)
GCST005895		background	type 2 diabetes
GCST005896		phenotype	non-melanoma
GCST005897		phenotype	low tan response
GCST005900		response, phenotype	er-positive, endocrine treated
GCST005900		survival stratified	ER-positive, endocrine treated
GCST005901		phenotype	er-positive
GCST005901		survival stratified	ER-positive
GCST005902		phenotype	broad
GCST005904		phenotype	probable
GCST005906		multiple disease	endometriosis
GCST005906		pleiotropy	endometriosis
GCST005909		interaction	smoking
GCST005910		interaction	smoking
GCST005911		interaction, phenotype	smoking, squamous cell lung cancer
GCST005914		biomarker	glycated hemoglobin levels
GCST005915		biomarker	fasting blood insulin
GCST005916		background, biomarker	smoking status, cotinine
GCST005917		background	chronic obstructive pulmonary disease
GCST005918		background	chronic obstructive pulmonary disease
GCST005919		background, phenotype	smokers, exhaled carbon monoxide
GCST005920		background	paternal history
GCST005921		background	family history
GCST005922		background	family history
GCST005923		background	maternal history
GCST005924		phenotype	peak cortisol < 500 nmol/l
GCST005925		response, biomarker	baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma
GCST005926		response, biomarker	peak cortisol response to low dose short synacthen test in corticosteroid treated asthma
GCST005927		phenotype	peak cortisol < 350 nmol/l
GCST005928		phenotype	refractory
GCST005933		background	non-glioblastoma
GCST005933		stratified	non-glioblastoma
GCST005934		associated disease	in head and neck cancer
GCST005934		background	head and neck cancer
GCST005935		pleiotropy	supraventricular ectopy
GCST005936		phenotype	supraventricular ectopy
GCST005937		phenotype	ventricular ectopy
GCST005938		phenotype	maximum cranial length
GCST005939		phenotype	cephalic index
GCST005940		phenotype	maximum cranial width
GCST005941		phenotype	seropositive for epstein barr virus nuclear antigen 1
GCST005942		response	igg levels, anti-epstein-barr virus viral capsid antigen (vca)
GCST005943		response	immune response, epstein-barr virus (multivariate analysis)
GCST005944		phenotype	seropositive for viral capsid antigen
GCST005945		biomarker	adamts13
GCST005949		interaction	sex
GCST005950		interaction	sex, age
GCST005952		background	age>50
GCST005953		background	age<50
GCST005954		interaction	age
GCST005955		interaction	sex, age
GCST005956			bmi adjusted
GCST005957		background	bmi adjusted, age <50
GCST005958		background	bmi adjusted, age <50
GCST005959		interaction, background	bmi adjusted, sex
GCST005960		interaction, background	bmi adjusted, sex, age
GCST005961		interaction, background	bmi adjusted, age
GCST005962		interaction, background	bmi adjusted, sex, age
GCST005963		response	igg levels, anti-epstein-barr virus nuclear antigen (ebna)
GCST005965		phenotype	normal cytogenetics
GCST005965		stratified	normal cytogenetics
GCST005966		phenotype	hyperdiploid negative
GCST005966		stratified	hyperdiploid negative
GCST005967		phenotype	philadelphia chromosome negative
GCST005967		stratified	Philadelphia chromosome negative
GCST005968		phenotype	abnormal cytogenetics
GCST005968		stratified	abnormal cytogenetics
GCST005969		background	childhood
GCST005970		background	young adulthood
GCST005970		stratified	young adulthood
GCST005971		background	adulthood
GCST005971		stratified	adulthood
GCST005974		phenotype	neutrophil count
GCST005975		phenotype	eosinophil count
GCST005977		phenotype	monocyte count
GCST005980		biomarker	bilirubin
GCST005981		biomarker	phosphorus
GCST005982		biomarker	calcium level
GCST005983		biomarker	uric acid
GCST005984		biomarker	glomerular filtration rate
GCST005985		biomarker	creatinine
GCST005986		biomarker	blood urea nitrogen levels
GCST005987		biomarker	albumin-globulin ratio
GCST005988		biomarker	alb
GCST005989		biomarker	serum total protein level
GCST005990		biomarker	serum non-albumin protein
GCST005992		phenotype	mean corpuscular hemoglobin concentration
GCST005993		phenotype	mean corpuscular hemoglobin
GCST005995		biomarker	hemoglobin
GCST005998		biomarker	gpt
GCST005999		biomarker	aspartate aminotransferase
GCST006000		biomarker	igg
GCST006001		biomarker	glycated hemoglobin levels
GCST006002		biomarker	glucose
GCST006003		biomarker	triglyceride
GCST006004		biomarker	ldl
GCST006005		biomarker	hdl
GCST006006		phenotype	ejection fraction
GCST006007		phenotype	left ventricular internal dimension in systole
GCST006008		phenotype	left ventricular internal dimension in diastole
GCST006009		phenotype	pulse pressure
GCST006010		phenotype	mean arterial pressure
GCST006011		phenotype	mean corpuscular volume
GCST006012		biomarker	c-reactive protein
GCST006013		biomarker	l lactate dehydrogenase
GCST006014		biomarker	creatine kinase
GCST006015		biomarker	fibrinogen
GCST006016		biomarker	alkaline phosphatase
GCST006017		phenotype	prothrombin time
GCST006018		phenotype	partial thromboplastin time
GCST006019		biomarker	gamma-glutamyl transferase
GCST006022		phenotype	pulse pressure
GCST006024		phenotype	e/a ratio
GCST006025		phenotype	left ventricular mass index
GCST006026		phenotype	left ventricular mass
GCST006027		phenotype	posterior wall thickness
GCST006028		phenotype	interventricular septum thickness
GCST006029		phenotype	fractional shortening
GCST006030		biomarker	chloride
GCST006031		biomarker	potassum
GCST006032		biomarker	sodium
GCST006033		phenotype	relative wall thickness
GCST006034		biomarker	total cholesterol
GCST006035		multiple disease	breast cancer
GCST006035		pleiotropy	breast cancer
GCST006037		associated disease	hepatitis C
GCST006037		background	hepatitis c infection
GCST006042		background	chronic obstructive pulmonary disease
GCST006043		biomarker	renin activity in plasma
GCST006044		phenotype	age at first birth
GCST006045		phenotype	age at first birth
GCST006046		phenotype	number of children ever born
GCST006047		phenotype	number of children ever born
GCST006048		phenotype	acpa-positive
GCST006049		phenotype	central corneal thickness
GCST006050		phenotype	central corneal thickness
GCST006053		phenotype	juvenile
GCST006054		phenotype	high altitude adaptation
GCST006055		response, biomarker	long-chain n-3 polyunsaturated fatty acid, triglyceride
GCST006056		biomarker	fructosamine
GCST006057		biomarker	percent glycated albumin
GCST006058		biomarker	total glycated albumin
GCST006060		biomarker	hemoglobin a1c levels
GCST006062		phenotype	white matter hyperintensity volume
GCST006063		phenotype	white matter integrity (fractional anisotropy)
GCST006064		phenotype	white matter integrity (mean diffusivity)
GCST006068		phenotype	sub-foveal choroidal thickness
GCST006069		interaction, response, phenotype	time and treatment arm, tenofovir, creatinine clearance
GCST006070		interaction, response, phenotype	concomitant antiretroviral treatment, tenofovir,creatinine clearance
GCST006071		interaction, drug metabolism	concomitant antiretroviral treatment, tenofovir clearance in hiv infection
GCST006072		interaction, response, phenotype	treatment arm, tenofovir, creatinine clearance
GCST006073		drug metabolism	tenofovir clearance in hiv infection
GCST006074		side effect	tenofovir for hiv
GCST006075		phenotype	hair color
GCST006076		biomarker	leucine
GCST006077		biomarker	isoleucine
GCST006078		biomarker	valine
GCST006079		phenotype	accelerometer-based physical activity (fraction of time with accelerations >425 milli-gravities)
GCST006080		phenotype	aggressiveness (high vs low)
GCST006081		phenotype	advanced vs non-advanced
GCST006082		phenotype	aggressiveness (high vs low/intermediate)
GCST006083		phenotype	advanced
GCST006083		stratified	advanced
GCST006084		phenotype	gleason score
GCST006086		background	familial
GCST006086		stratified	familial
GCST006087		background	familial
GCST006088		background, phenotype	familial, squamous
GCST006088		stratified	squamous
GCST006089		phenotype	early-onset
GCST006089		stratified	early-onset
GCST006092		phenotype	double-edged eyelids
GCST006093		phenotype	thick vs thin eyebrows
GCST006094		phenotype	straight vs curly hair
GCST006097		phenotype	moderate to vigorous physical activity levels
GCST006098		phenotype	vigorous physical activity
GCST006099		phenotype	accelerometer-based physical activity (average acceleration)
GCST006100		phenotype	strenuous sports or other exercises
GCST006101		biomarker	hdl
GCST006101		biomarker	uric acid
GCST006101		phenotype	mean corpuscular hemoglobin
GCST006101		phenotype	mean corpuscular volume
GCST006102		biomarker	interleukin 10
GCST006103		biomarker	interleukin-6
GCST006104		biomarker	interleukin 1 receptor antagonist
GCST006105		phenotype	eye morphology
GCST006106		phenotype	forehead morphology
GCST006107		phenotype	upper eyelid morphology
GCST006108		phenotype	facial morphology
GCST006109		phenotype	lip morphology
GCST006110		phenotype	nose morphology
GCST006111		interaction	sodium
GCST006112		interaction	sodium
GCST006113		interaction	sodium
GCST006114		interaction	sodium
GCST006115		interaction	sodium
GCST006116		interaction	sodium
GCST006117		interaction, phenotype	sodium, pulse pressure
GCST006118		interaction, phenotype	sodium, pulse pressure
GCST006119		biomarker	protein c
GCST006120		phenotype	age of onset
GCST006126		background	juvenile idiopathic arthritis
GCST006127		background	juvenile idiopathic arthritis
GCST006129		phenotype	pediatric areal
GCST006130		phenotype	pediatric areal
GCST006132		interaction, background	current smokers (1df test)
GCST006133		interaction, background	current smokers (2df test)
GCST006134		phenotype	hippocampal volume
GCST006135		phenotype	cortical amyloid beta
GCST006136		phenotype	progression score
GCST006137		biomarker	folic acid
GCST006138		phenotype	resting-state
GCST006139		biomarker	hematoma volume
GCST006140		biomarker	hematoma volume
GCST006141		phenotype	high bmd
GCST006142		phenotype	spine bmd
GCST006143		phenotype	hip bmd
GCST006144		side effect	heparin
GCST006146		phenotype	behavioral changes
GCST006147		phenotype	age at onset
GCST006149		phenotype	grn mutation
GCST006151		background	frontotemporal lobe dementia
GCST006152		background	frontotemporal lobe dementia
GCST006153		background	frontotemporal lobe dementia
GCST006166		interaction	alcohol consumption
GCST006167		interaction, phenotype	alcohol consumption, mean arterial pressure
GCST006168		interaction, phenotype	alcohol consumption, pulse pressure
GCST006169		interaction	alcohol consumption
GCST006170		interaction	alcohol consumption (light vs heavy)
GCST006171		interaction, phenotype	alcohol consumption (light vs heavy), pulse pressure
GCST006172		interaction, phenotype	alcohol consumption (light vs heavy), mean arterial pressure
GCST006173		interaction	bmi
GCST006175		phenotype	aggression
GCST006186		interaction	smoking (current vs non-current)
GCST006187		interaction	cigarette smoking
GCST006188		interaction	cigarette smoking
GCST006189		interaction	smoking (ever vs never)
GCST006190		interaction	smoking (ever vs never)
GCST006191		interaction	smoking (ever vs never)
GCST006192		interaction	smoking (ever vs never)
GCST006193		interaction	smoking (current vs non-current)
GCST006194		interaction	smoking (current vs non-current)
GCST006195		interaction	smoking (current vs non-current)
GCST006196		background	high risk hla genotype individuals (time to event)
GCST006197		phenotype	type 1 diabetes autoantibodies
GCST006199		side effect	thiopurine for inflammatory bowel disease
GCST006200		side effect	thiopurine for inflammatory bowel disease
GCST006201		side effect	thiopurine for inflammatory bowel disease
GCST006202		side effect	thiopurine for inflammatory bowel disease
GCST006203		drug metabolism	atazanavir
GCST006204		side effect	thiopurine for inflammatory bowel disease
GCST006205		side effect	thiopurine for inflammatory bowel disease
GCST006206		side effect	thiopurine for inflammatory bowel disease
GCST006207		side effect	thiopurine for inflammatory bowel disease
GCST006208		side effect	thiopurine for inflammatory bowel disease
GCST006209		side effect	thiopurine for ibd
GCST006210		side effect	thiopurine for inflammatory bowel disease
GCST006211		side effect	thiopurine for ibd
GCST006212		side effect	thiopurine for ibd
GCST006213		side effect	thiopurine for ibd
GCST006214		side effect	thiopurine for inflammatory bowel disease
GCST006215		side effect	thiopurine for inflammatory bowel disease
GCST006216		pleiotropy	educational attainment (years of education)
GCST006217		response	statin
GCST006218		phenotype	severe vs non-severe
GCST006219		biomarker	executive function
GCST006220		phenotype	basal ganglia growth
GCST006221		phenotype	white matter growth
GCST006222		phenotype	cerebellum growth
GCST006223		phenotype	cerebral cortical growth
GCST006224		phenotype	right lateral prefrontal cortical growth
GCST006225		phenotype	seropositive for chlamydia trachomatis
GCST006226		phenotype	severe vs none or mild
GCST006230		phenotype	pulse pressure
GCST006231		phenotype	mean arterial pressure
GCST006246	C536404	phenotype	childhood steroid-sensitive nephrotic syndrome
GCST006247		phenotype	pediatric areal
GCST006248		response	lurasidone
GCST006249		biomarker	serum metabolite
GCST006251		biomarker	high fetal hemoglobin levels
GCST006252	C536404	phenotype	childhood steroid-sensitive nephrotic syndrome
GCST006253		phenotype	short-term memory (digit-span task)
GCST006254		phenotype	short-term memory (visuospatial task)
GCST006255		phenotype	short-term memory (shared component of digit-span and visuospatial tasks)
GCST006256		phenotype	long-term memory (delayed word recall task)
GCST006260		phenotype	childhood onset
GCST006266		response	selective serotonin reuptake inhibitors
GCST006267		response	selective serotonin reuptake inhibitors
GCST006269		phenotype	general cognitive ability
GCST006270		side effect	interferon-beta for multiple sclerosis
GCST006273		phenotype	diastolic blood pressure night-to-day ratio
GCST006274		biomarker	systolic blood pressure night-to-day ratio
GCST006276		phenotype	non-richardson's syndrome vs richardson's syndrome
GCST006277		response	ranibizumab
GCST006278		side effect	antithyroid drugs for graves disease
GCST006279		biomarker	alpha synuclein (csf)
GCST006281		background	type 1 diabetes
GCST006282		background	type 2 diabetes
GCST006283		background	type 2 diabetes
GCST006284		background, biomarker	stable coronary artery disease, pcsk9
GCST006285		response	aripiprazole
GCST006286		phenotype	age at loss of ambulation
GCST006288		phenotype	heel bmd
GCST006290		phenotype	age of diagnosis
GCST006291		phenotype	refractive error measurement
GCST006292		response	antipsychotic
GCST006293		response	olanzapine
GCST006294		response	risperidone
GCST006295		response	quetiapine
GCST006296		response	ziprazidone
GCST006297		response	perphenazine
GCST006298		response	haloperidol
GCST006299		phenotype	cigarettes smoked per day
GCST006300		phenotype	maximum cigarettes in a 24 hour period
GCST006301		phenotype	nicotine dependence
GCST006302		phenotype	nicotine dependence
GCST006303		phenotype	nicotine withdrawal
GCST006305		biomarker	total cholesterol
GCST006306		biomarker	hdl
GCST006307		biomarker	ldl
GCST006308		biomarker	triglyceride
GCST006309		response, background	post bronchodilator percent predicted fev1, smoking
GCST006310		response, background	post bronchodilator fev1/fvc ratio, smoking
GCST006311		background	permanent teeth
GCST006312		background	primary teeth
GCST006326		phenotype	conscientiousness
GCST006329		phenotype	agreeableness
GCST006330		phenotype	seropositive for epstein-barr virus early antigen (ea)
GCST006331		phenotype	seropositive for cytomegalovirus
GCST006332		phenotype	seropositive for epstein-barr virus nuclear antigen (ebna)
GCST006333		phenotype	seropositive for epstein-barr virus viral capsid antigen
GCST006334		phenotype	seropositive for herpes simplex virus 1
GCST006335		phenotype	seropositive for herpes simplex virus 2
GCST006336		phenotype	seropositive for varicella zoster virus
GCST006337		phenotype	seropositive for helicobacter pylori
GCST006338		phenotype	seropositive for toxoplasma gondii
GCST006339		phenotype	seropositive for influenza a virus
GCST006340		phenotype	seropositive for measles virus
GCST006341		phenotype	seropositive for mumps virus
GCST006342		phenotype	seropositive for rubella virus
GCST006343		phenotype	seropositive for hepatitis b virus core antigen (hbc)
GCST006344		response	igg status, anti-cytomegalovirus
GCST006345		response	igg levels, anti-epstein-barr virus early antigen
GCST006346		response	igg levels, anti-herpes simplex virus 1
GCST006347		response	igg levels, anti-herpes simplex virus 2
GCST006348		response	igg levels, anti-varicella zoster virus
GCST006349		response	igg levels, anti-toxoplasma gondii
GCST006350		response	igg levels, anti-influenza a virus
GCST006351		response	igg levels, anti-measles virus
GCST006352		response	igg levels, anti-mumps virus
GCST006353		response	igg levels, anti-rubella virus
GCST006354		response	igg levels, anti-hepatitis b virus surface antigen (hbs)
GCST006355		response	igg levels, anti-hepatitis b virus core antigen (hbc)
GCST006356		phenotype	seropositive for hepatitis b virus surface antigen (hbs)
GCST006357		biomarker	igg
GCST006358		biomarker	ige
GCST006359		biomarker	igm
GCST006360		biomarker	iga
GCST006361		response	igg levels, anti-epstein-barr virus nuclear antigen (ebna)
GCST006362		response	igg levels, anti-epstein-barr virus viral capsid antigen (vca)
GCST006363		response	igg levels, anti-helicobacter pylori
GCST006364		biomarker	hepatitis b surface antigen seroclearance
GCST006366		phenotype	central corneal thickness
GCST006367		phenotype	central corneal thickness
GCST006386		phenotype	age at onset
GCST006387		associated disease	thyroid cancer
GCST006388		phenotype	dietary macronutrient intake
GCST006392		biomarker	glomerular filtration rate
GCST006393		biomarker	creatinine
GCST006396		phenotype	disrupted circadian rhythm (low relative amplitude of rest-activity cycles)
GCST006397		phenotype	relative amplitude of rest-activity cycles
GCST006398		interaction	snp x snp
GCST006400		background	ever smokers
GCST006400		interaction or exposure	ever smokers
GCST006402		phenotype	energy intake
GCST006404		biomarker	glucose
GCST006405		background	diabetes
GCST006406		phenotype	cognitive flexibility
GCST006407		phenotype	philtrum width
GCST006410		interaction, phenotype	smoking, acpa-positive
GCST006411		background	colorectal cancer
GCST006411		stratified	mucinous
GCST006413		interaction or exposure	radon-induced
GCST006413		interaction	radon exposure
GCST006415		phenotype	nonsyndromic cleft lip with or without cleft palate
GCST006417		biomarker	factor vii activating protease
GCST006420		phenotype	affective disorder
GCST006424		background	type 2 diabetes
GCST006425		background	chronic kidney disease
GCST006426		interaction, biomarker	chronic kidney disease, urate
GCST006427		background	smokers
GCST006430		pleiotropy	body mass index
GCST006431		biomarker	parathyroid hormone
GCST006433		phenotype	heel bmd
GCST006434		interaction	alcohol consumption
GCST006435		side effect	coronary artery bypass surgery
GCST006436		biomarker	triglyceride
GCST006437		biomarker	ldl
GCST006438		biomarker	hdl
GCST006439		biomarker	total cholesterol
GCST006440		phenotype	motor composite
GCST006441		phenotype	mental composite score
GCST006442		phenotype	years of education
GCST006444		phenotype	hip bmd
GCST006445		background	femoral neck
GCST006446		phenotype	ulna and radius
GCST006447		phenotype	spine bmd
GCST006448		phenotype	eye movement (horizontal position gain)
GCST006449		phenotype	eye movement (integrated eye movement score)
GCST006450		phenotype	eye movement (integrated eye movement score)
GCST006451		phenotype	eye movement (integrated eye movement score)
GCST006452		phenotype	eye movement (duration of fixations)
GCST006453		phenotype	eye movement (duration of fixations)
GCST006454		phenotype	eye movement (duration of fixations)
GCST006455		phenotype	eye movement (scanpath length)
GCST006456		phenotype	eye movement (scanpath length)
GCST006457		phenotype	eye movement (horizontal position gain)
GCST006458		phenotype	eye movement (horizontal position gain)
GCST006459		phenotype	eye movement (scanpath length)
GCST006460		background	preterm infants
GCST006461		phenotype	self-reported risk-taking behaviour
GCST006462		phenotype	uterine fibroid
GCST006463		background	no hypertensive medication
GCST006465		background	endometrioid histology
GCST006465		stratified	endometrioid histology
GCST006466		background	non-endometrioid histology
GCST006466		stratified	non-endometrioid histology
GCST006468		phenotype	straight vs curly hair
GCST006469		biomarker	total cholesterol
GCST006470		biomarker	hdl
GCST006471		biomarker	ldl
GCST006472		biomarker	triglyceride
GCST006473		phenotype	diffusing capacity of the lung for carbon monoxide
GCST006474		phenotype	non-allergic rhinitis
GCST006480		phenotype	age-stratified
GCST006481		phenotype	fev1
GCST006482		phenotype	fev1/fec ratio
GCST006483		phenotype	fvc
GCST006491		biomarker	fgf23
GCST006494		interaction	snp x snp
GCST006495		interaction	snp x snp
GCST006496		background, phenotype	heart transplant, glomerular filtration rate change
GCST006497		phenotype	nose wing breadth
GCST006498		phenotype	brow ridge morphology
GCST006499		phenotype	nose length
GCST006500		phenotype	nosetip height
GCST006501		phenotype	nasal root breadth
GCST006502		phenotype	nasal root height
GCST006503		phenotype	eye length
GCST006504		phenotype	interorbital distance
GCST006505		phenotype	labial fissure length
GCST006506		phenotype	lip thickness
GCST006507		phenotype	facial morphology
GCST006508		phenotype	eye morphology (principal component model)
GCST006509		phenotype	facial morphology
GCST006510		phenotype	cheekbone morphology
GCST006511		phenotype	nose morphology
GCST006512		phenotype	mouth morphology
GCST006513		phenotype	brow ridge morphology
GCST006514		phenotype	eye morphology (partial least square model)
GCST006515		phenotype	facial morphology
GCST006516		phenotype	cheekbone morphology
GCST006517		phenotype	nose morphology
GCST006518		phenotype	mouth morphology
GCST006519		biomarker	gdf15
GCST006520		phenotype	pemphigus foliaceus
GCST006521		phenotype	pemphigus vulgaris
GCST006523		phenotype	general cognitive ability
GCST006524		interaction	snp-snp
GCST006524		stratified	SNP-SNP interactions
GCST006525	C562730	interaction	bmi
GCST006526		interaction	gastroesophageal reflux disease
GCST006527		interaction	smoking status
GCST006528		interaction	pack-years of smoking exposure
GCST006529		interaction	bmi
GCST006530	C562730	interaction	smoking interaction
GCST006531	C562730	interaction	gastroesophageal reflux disease
GCST006532	C562730	interaction	pack-years of smoking exposure
GCST006533		phenotype	visceral adipose tissue, bmi adjusted
GCST006534		phenotype	visceral adipose tissue, bmi adjusted
GCST006536		biomarker	erythropoetin
GCST006537		phenotype	subcutaneous adipose tissue
GCST006538		phenotype	subcutaneous adipose tissue
GCST006540		phenotype	visceral adipose tissue
GCST006541		phenotype	axial length
GCST006542		phenotype	visceral adipose tissue
GCST006543		phenotype	pericardial adipose tissue, height and weight adjusted
GCST006544		phenotype	pericardial adipose tissue, height and weight adjusted
GCST006545		phenotype	pericardial adipose tissue
GCST006546		phenotype	pericardial adipose tissue
GCST006547		phenotype	visceral adipose tissue attenuation
GCST006548		phenotype	visceral adipose tissue attenuation
GCST006549		phenotype	subcutaneous adipose tissue attenuation
GCST006550		phenotype	subcutaneous adipose tissue attenuation
GCST006551		phenotype	visceral:subcutaneous adipose tissue ratio
GCST006552		phenotype	visceral:subcutaneous adipose tissue ratio
GCST006553		phenotype	visceral adipose tissue/subcutaneous adipose tissue ratio, bmi adjusted
GCST006554		phenotype	visceral adipose tissue/subcutaneous adipose tissue ratio, bmi adjusted
GCST006567		response	ketogenic dietary therapies
GCST006568		phenotype	mathematical ability
GCST006569		phenotype	mathematical ability
GCST006573		phenotype	mathematical ability
GCST006574		phenotype	mathematical ability
GCST006576		phenotype	anorexia nervosa or obsessive-compulsive disorder
GCST006584		phenotype	pemphigus vulgaris
GCST006585		biomarker	blood protein levels
GCST006606		response, biomarker	tnf inhibitor (change in swollen 28-joint count)
GCST006607		response, biomarker	tnf inhibitor (erythrocyte sedimentation rate)
GCST006608		response, biomarker	tnf inhibitor (change in patient global heath assessment score)
GCST006609		response, biomarker	tnf inhibitor (change in tender 28-joint count)
GCST006610		response, biomarker	tnf inhibitor (change in disease activity score)
GCST006611		biomarker	hdl
GCST006612		biomarker	ldl
GCST006613		biomarker	triglyceride
GCST006614		biomarker	total cholesterol
GCST006615		response	tamoxifen in er-positive/her2 negative breast cancer
GCST006615		treatment response	ER positive HER negative - tamoxifen
GCST006616		phenotype	uterine fibroid (single vs multiple)
GCST006617		phenotype	uterine fibroid (maximum volume)
GCST006618		phenotype	uterine fibroid (maximum dimension)
GCST006621		biomarker	il2ra, soluble (maternal genetic effect)
GCST006621		biomarker	interleukin 1 alpha (maternal genetic effect)
GCST006621		interaction, biomarker	ccl11, maternal genetic
GCST006622		biomarker	ccl21, fetal genetic effect
GCST006622		biomarker	cx3cl1 (fetal genotype effect)
GCST006622		biomarker	cxcl11, fetal genetic effect
GCST006622		biomarker	cxcl12 (fetal genotype effect)
GCST006622		biomarker	cxcl13 (fetal genotype effect)
GCST006622		biomarker	cxcl6, fetal genetic effect
GCST006622		biomarker	interferon gamma
GCST006622		biomarker	interleukin 10 (fetal genotype effect)
GCST006622		biomarker	interleukin-1 beta (fetal genotype effect)
GCST006622		biomarker	interleukin 2 (fetal genotype effect)
GCST006622		biomarker	interleukin 4 (fetal genotype effect)
GCST006622		biomarker	interleukin-6 (fetal genotype effect)
GCST006622		biomarker	interleukin 8 (fetal genotype effect)
GCST006622		biomarker	monocyte chemotactic protein 3, fetal genetic effect
GCST006622		biomarker	monokine induced by gamma interferon, fetal genetic effect
GCST006622		interaction, biomarker	ccl15, fetal genetic
GCST006622		interaction, biomarker	ccl17, fetal genetic
GCST006622		interaction, biomarker	ccl19, fetal genetic
GCST006622		interaction, biomarker	ccl23, fetal genetic
GCST006622		interaction, biomarker	ccl24, fetal genetic
GCST006623		biomarker	il2ra, soluble (fetal genetic effect)
GCST006625		biomarker	cxcl5 (fetal genotype effect)
GCST006625		biomarker	interleukin 16 (maternal genotype effect)
GCST006625		interaction, biomarker	ccl24, maternal genetic
GCST006626		phenotype	pulse pressure
GCST006629		phenotype	pulse pressure
GCST006631		background	nicotine dependence
GCST006632		background	posterior cingulate cortex
GCST006633		phenotype	alcohol sensitivity (initial)
GCST006634		phenotype	hedonic well-being
GCST006635		phenotype	eudaimonic well-being
GCST006636		background	menstruation
GCST006637		phenotype	pain medicine use
GCST006638		background	menstruation
GCST006639		background	menstruation, heavy vaginal discharge
GCST006640		background	menstruation
GCST006641		background	menstruation
GCST006642		background, phenotype	menstruation, increased appetite
GCST006643		background, phenotype	menstruation, bowel movement
GCST006644		background	menstruation
GCST006645		background	menstruation
GCST006646		background	menstruation
GCST006647		background	menstruation
GCST006648		background, phenotype	menstruation, loss of concentration
GCST006649		background, phenotype	menstruation, nervousness
GCST006650		background, phenotype	menstruation, pressure in breast
GCST006651		background	menstruation
GCST006652		background, phenotype	menstruation, stiff neck
GCST006653		phenotype	vaginal discharge itching
GCST006654		phenotype	vaginal discharge smell
GCST006655		phenotype	breast size
GCST006656		phenotype	dysmenorrheic pain
GCST006657		phenotype	vaginal discharge
GCST006663		biomarker	hdl
GCST006664		biomarker	triglyceride
GCST006665		pleiotropy	social science traits
GCST006666		pleiotropy	lipid traits
GCST006667		pleiotropy	lipid traits
GCST006668		pleiotropy	attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder
GCST006669		pleiotropy, biomarker	hdl, triglyceride
GCST006672		biomarker	cerebrospinal fluid ab1-42 levels
GCST006673		biomarker	t-tau:beta-amyloid 1-42 ratio (csf)
GCST006674		biomarker	cerebrospinal fluid p-tau181p:ab1-42 ratio
GCST006675		phenotype	peak insulin response, insulin secretion adjusted
GCST006676		phenotype	peak insulin response, insulin secretion adjusted
GCST006677		response, background	acute insulin response, insulin secretion adjusted
GCST006678		response, background	acute insulin response, insulin secretion and bmi adjusted
GCST006679		phenotype	insulin secretion rate, bmi adjusted
GCST006680		interaction, phenotype	nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test)
GCST006681			bmi adjusted
GCST006682		biomarker	hdl, triglyceride
GCST006683		response	fenofibrate
GCST006685		phenotype	sleep duration (oversleepers)
GCST006686		phenotype	sleep duration (undersleepers)
GCST006696		phenotype	parental longevity
GCST006697		phenotype	parental longevity
GCST006698		phenotype	parental longevity
GCST006699		phenotype	parental longevity
GCST006700		phenotype	parental longevity
GCST006701		phenotype	parental longevity
GCST006702		phenotype	parental longevity
GCST006703		phenotype	bitter
GCST006704		phenotype	bitter
GCST006705		phenotype	infantile
GCST006706		phenotype	eyebrow thickness
GCST006716		phenotype	total score
GCST006717		phenotype	dependence and problematic use scores
GCST006718		phenotype	consumption score
GCST006719		background	brca1/2 negative
GCST006719		stratified	BRCA1/2 negative
GCST006720		biomarker	hemoglobin
GCST006721		phenotype	children died <5 years
GCST006722		phenotype	children died <5 years
GCST006723		phenotype	children died <5 years
GCST006724		phenotype	children died <5 years
GCST006725		phenotype	children died <15 years
GCST006726		phenotype	children died <15 years
GCST006727		phenotype	children died <15 years
GCST006728		phenotype	children died <1 year
GCST006729		phenotype	children died <1 year
GCST006730		phenotype	children died <15 years
GCST006731		phenotype	children died <1 year
GCST006733		phenotype	children surviving at 1 year
GCST006734		phenotype	children surviving at 1 year
GCST006735		phenotype	children surviving at 1 year
GCST006736		phenotype	children surviving at 1 year
GCST006737		phenotype	number of miscarriages
GCST006738		phenotype	number of miscarriages in continuous marriage
GCST006739		phenotype	proportion of miscarriages
GCST006740		phenotype	proportion of miscarriages in continuous marriage
GCST006741		phenotype	number of stillbirths
GCST006742		phenotype	number of stillbirths in continuous marriage
GCST006743		phenotype	proportion of stillbirths
GCST006744		phenotype	proportion of stillbirths in continuous marriage
GCST006745		phenotype	oxygen saturation of hemoglobin
GCST006746		phenotype	resting heart rate
GCST006747		biomarker	hemoglobin
GCST006748		biomarker	hemoglobin
GCST006749		phenotype	children surviving at 1 year but died <5 years
GCST006750		phenotype	children surviving at 1 year but died <5 years
GCST006751		phenotype	children surviving at 5 years
GCST006752		phenotype	children surviving at 5 years
GCST006753		phenotype	children surviving at 1 year but died <5 years
GCST006754		phenotype	children surviving at 1 year but died <5 years
GCST006755		phenotype	children surviving at 5 years
GCST006756		phenotype	children surviving at 5 years
GCST006757		phenotype	children surviving at 5 years but died <15 years
GCST006758		phenotype	children surviving at 5 years but died <15 years
GCST006759		phenotype	children surviving at 5 years but died <15 years
GCST006760		phenotype	children surviving at 5 years but died <15 years
GCST006761		phenotype	children surviving at 15 years
GCST006762		phenotype	children surviving at 15 years
GCST006763		phenotype	children surviving at 15 years
GCST006764		phenotype	children surviving at 15 years
GCST006765		phenotype	number of live births
GCST006766		phenotype	number of live births in continuous marriage
GCST006767		phenotype	proportion of live births
GCST006768		phenotype	proportion of live births in continuous marriage
GCST006769		phenotype	age at first birth
GCST006770		background	continuous marriage
GCST006771		phenotype	number of pregnancies
GCST006772		phenotype	number of pregnancies in continuous marriage
GCST006773		phenotype	number of twin births
GCST006774		phenotype	number of twin births in continuous marriage
GCST006775		phenotype	age at last pregnancy
GCST006776		background	continuous marriage
GCST006796		phenotype	excitement-seeking behaviour
GCST006797		biomarker	vitamin b6 (carboxyaldehyde form pyridoxal)
GCST006798		biomarker	vitamin b6 (catabolic product 4-pyridoxic acid)
GCST006799		biomarker	vitamin b6 (active form pyridoxal phosphate)
GCST006800		background	childhood
GCST006804		phenotype	red blood cell distribution width
GCST006805		background	staphylococcus aureus infection
GCST006806		phenotype	late onset
GCST006807		interaction, phenotype	smoking, acpa-negative
GCST006808		response	anti-vegf
GCST006810		phenotype	self-reported risk-taking behaviour
GCST006812		phenotype	ever vs never
GCST006813		interaction	apol1 genotype
GCST006815		background	apol1 risk genotype-negative individuals
GCST006816		background	apol1 risk genotype-positive individuals
GCST006817		response	antidepressants
GCST006818		response	antidepressant remission
GCST006819		phenotype	emotional support seeking
GCST006820		phenotype	positive reappraisal
GCST006822		phenotype	disengagement
GCST006823		phenotype	emotional coping (emotional expression/emotional support seeking)
GCST006824		phenotype	approach coping (positive reappraisal/problem solving)
GCST006826		phenotype	emotional expression
GCST006856		response	methadone dose
GCST006858		background	age
GCST006859		phenotype	children died <1 year
GCST006860		biomarker	hdl
GCST006861		pleiotropy	type 2 diabetes, femoral neck bone mineral density
GCST006864		phenotype	axial length or spherical error (univariate decomposition analysis)
GCST006866		interaction	snp x snp
GCST006869		phenotype	nicotine withdrawal
GCST006870		phenotype	hippocampal tail volume
GCST006871		phenotype	hippocampal volume
GCST006872		phenotype	presubiculum volume (corrected for total hippocampal volume)
GCST006873		background, phenotype	subiculum volume (corrected for total hippocampal volume)
GCST006874		phenotype	hippocampal ca1 volume (corrected for total hippocampal volume)
GCST006875		phenotype	hippocampal ca3 volume (corrected for total hippocampal volume)
GCST006876		phenotype	hippocampal ca4 volume (corrected for total hippocampal volume)
GCST006877		biomarker	granule cell layer dentate gyrus volume (corrected for total hippocampal volume)
GCST006878		phenotype	hippocampus molecular layer volume (corrected for total hippocampal volume)
GCST006879		biomarker	metabolite levels
GCST006880		phenotype	hippocampal fissure volume (corrected for total hippocampal volume)
GCST006881		phenotype	hippocampal tail volume (corrected for total hippocampal volume)
GCST006882		phenotype	hippocampus fimbria volume (corrected for total hippocampal volume)
GCST006883		phenotype	hippocampal amigdala transition area volume (corrected for total hippocampal volume)
GCST006884		phenotype	parasubiculum volume (corrected for total hippocampal volume)
GCST006885		phenotype	presubiculum volume
GCST006886		phenotype	subiculum volume
GCST006887		phenotype	hippocampal ca1 volume
GCST006888		phenotype	hippocampal ca3 volume
GCST006889		phenotype	hippocampal ca4 volume
GCST006890		biomarker	granule cell layer dentate gyrus volume
GCST006891		phenotype	hippocampus molecular layer volume
GCST006892		phenotype	hippocampal fissure volume
GCST006893		phenotype	hippocampus fimbria volume
GCST006894		phenotype	hippocampal amigdala transition area volume
GCST006895		phenotype	parasubiculum volume
GCST006896		biomarker	thyroxine
GCST006899		biomarker	tshb
GCST006903		phenotype	hip geometry
GCST006905		biomarker	uric acid
GCST006907		phenotype	large artery
GCST006909		phenotype	small vessel ischemic stroke
GCST006910		phenotype	cardioembolic stroke
GCST006911		phenotype	moderate or severe
GCST006912		phenotype	overall physical activity time
GCST006913		phenotype	sedentary behaviour duration
GCST006914		phenotype	sleep duration
GCST006915		phenotype	moderate intensity activity duration
GCST006918		phenotype	social isolation
GCST006919		phenotype	ability to confide in someone
GCST006920		phenotype	regular attendance at a gym or sports club
GCST006921		phenotype	regular attendance at a pub or social club
GCST006922		phenotype	regular attendance at a religious group
GCST006927		background	major depressive disorder
GCST006928		phenotype	visual memory
GCST006929		phenotype	attention function
GCST006931		phenotype	verbal memory
GCST006932		phenotype	reasoning
GCST006934		phenotype	information processing speed
GCST006935		phenotype	3-month functional outcome
GCST006936		phenotype	mitochondrial dna levels
GCST006937		phenotype	aqp4-igg-positive
GCST006938		phenotype	aqp4-igg-negative
GCST006939		phenotype	skin hydration
GCST006943		phenotype	feeling miserable
GCST006944		phenotype	experiencing mood swings
GCST006945		phenotype	feeling guilty
GCST006946		phenotype	worry too long after an embarrassing experience
GCST006947		phenotype	feeling fed-up
GCST006948		phenotype	feeling nervous
GCST006949		phenotype	nervousness
GCST006950		phenotype	feeling worry
GCST006951		phenotype	feeling hurt
GCST006952		phenotype	feeling tense
GCST006957		background	marfan syndrome
GCST006958		phenotype	length of menstrual cycle
GCST006976		phenotype	macular thickness
GCST006977		phenotype	predicted suicide risk
GCST006979		phenotype	heel bmd
GCST006983		phenotype	cannibis use
GCST006986		phenotype	red vs. brown/black hair color
GCST006987		side effect	clonzapine for treatment-resistant schizophrenia
GCST006988		phenotype	blond vs. brown/black hair color
GCST006989		phenotype	brown vs. black hair color
GCST006990		biomarker	cerebrospinal ab1-42 levels
GCST006991		biomarker	cerebrospinal fluid t-tau levels
GCST006992		biomarker	cerebrospinal fluid p-tau levels
GCST006993		phenotype	hippocampal volume
GCST006994		phenotype	logical memory (immediate recall)
GCST006995		phenotype	logical memory (delayed recall)
GCST006996		background, biomarker	cerebrospinal ab1-42 levels in mild cognitive impairment
GCST006997		background, biomarker	cerebrospinal fluid t-tau levels in mild cognitive impairment
GCST006998		background, biomarker	cerebrospinal fluid p-tau levels in mild cognitive impairment
GCST006999		background, phenotype	logical memory (immediate recall) in mild cognitive impairment
GCST007000		background, phenotype	logical memory (delayed recall) in mild cognitive impairment
GCST007001		biomarker	cerebrospinal fluid ab1-42 levels
GCST007002		background, biomarker	normal cognition, t-tau (csf)
GCST007003		background, phenotype	normal cognition, cerebrospinal fluid p-tau levels
GCST007004		background, phenotype	normal cognition, hippocampal volume
GCST007005		background, phenotype	normal cognition, ogical memory (immediate recall)
GCST007006		background, phenotype	normal cognition, logical memory (delayed recall)
GCST007007		biomarker	t-tau (csf)
GCST007008		phenotype	cerebrospinal fluid p-tau levels
GCST007009		phenotype	hippocampal volume
GCST007010		phenotype	logical memory (delayed recall)
GCST007011		phenotype	logical memory (immediate recall)
GCST007012		biomarker	cerebrospinal fluid ab1-42 levels
GCST007013		background	mild cognitive impairment
GCST007014		phenotype	spine bmd (lumbar trabecular)
GCST007015		phenotype	spine bmd (lumbar intergral)
GCST007016		interaction, background, biomarker	sex in metabolic syndrome, bilirubin
GCST007017		interaction, background, biomarker	mediterranean diet adherence, bilirubin in metabolic syndrome
GCST007018		biomarker	bilirubin, phenotype
GCST007019		phenotype	severity
GCST007021		background	type 2 diabetes
GCST007022		phenotype	microalbuminuria
GCST007037		phenotype	years of education
GCST007040		background, phenotype	rheumatoid arthritis, intimal medial thickness
GCST007041		background	rheumatoid arthritis
GCST007042		response	ssri
GCST007044		phenotype	extremely high intelligence
GCST007045		phenotype	pr interval
GCST007046		response	with or without bevacizumab
GCST007047		response	bevacizumab
GCST007048		response	chemotherapy with bevacizumab
GCST007049		response	chemotherapy with or without bevacizumab
GCST007051		phenotype	heart rate
GCST007052		biomarker	lipoprotein a
GCST007058		phenotype	hip circumference
GCST007059		response, phenotype	antidepressants, symptom improvement
GCST007060		response	ssri
GCST007061		response, phenotype	antidepressants, symptom improvement
GCST007063		phenotype	lean body mass
GCST007064		phenotype	body fat percentage
GCST007065		phenotype	eosinophil count
GCST007066		phenotype	heel bmd
GCST007068		phenotype	mean corpuscular hemoglobin
GCST007074		phenotype	red blood cell distribution width
GCST007078		phenotype	age at onset
GCST007079		phenotype	age at menopause
GCST007080		phenotype	fev1/fec ratio
GCST007081		phenotype	fvc
GCST007082		phenotype	hair color
GCST007083		phenotype	morning person
GCST007085		phenotype	smoking status
GCST007088		background	rheumatoid arthritis
GCST007092		phenotype	hip or knee
GCST007096		phenotype	pulse pressure
GCST007097		phenotype	pulse pressure
GCST007100		background	inhaled corticosteroids
GCST007101		background	seasonality
GCST007102		background	seasonality
GCST007103		phenotype	qrs duration
GCST007104		phenotype	qrs duration
GCST007105		phenotype	qrs duration
GCST007106		response	opioid analgesics
GCST007106		treatment response	opioid
GCST007107		interaction	sodium
GCST007108		interaction	sodium
GCST007109		phenotype	diarrhoea-associated entamoeba histolytica
GCST007110		phenotype	walking duration
GCST007111		phenotype	early onset
GCST007112		phenotype	late onset
GCST007113		phenotype	age of onset
GCST007114		phenotype	cholesterol efflux capacity
GCST007115		phenotype	cholesterol efflux capacity (camp stimulated assay)
GCST007116		phenotype	cholesterol efflux capacity (abca-1 dependent assay)
GCST007117		phenotype	cholesterol efflux capacity (bhk stimulated assay)
GCST007120		pleiotropy	type 2 diabetes
GCST007121		pleiotropy	c-reactive protein
GCST007122		pleiotropy, biomarker	triglyceride
GCST007123		pleiotropy	ldl
GCST007124		pleiotropy, biomarker	hdl
GCST007125		pleiotropy, biomarker	systolic blood pressure
GCST007126		pleiotropy	body mass index
GCST007127		pleiotropy	waist-to-hip-ratio
GCST007128		biomarker	blood protein levels
GCST007129		biomarker	t-tau:beta-amyloid 1-42 ratio (csf)
GCST007130		biomarker	t-tau:beta-amyloid 1-42 ratio (csf)
GCST007131		biomarker	ldl
GCST007132		biomarker	hdl
GCST007133		biomarker	triglyceride
GCST007134		biomarker	total cholesterol
GCST007137		side effect, phenotype	bleeding
GCST007139		phenotype	shingles
GCST007140		biomarker	hdl
GCST007141		biomarker	ldl
GCST007142		biomarker	triglyceride
GCST007143		biomarker	total cholesterol
GCST007145		phenotype	age of onset
GCST007147		background, phenotype	normal aging, lateral ventricular volume
GCST007148		response, biomarker	6-mercaptopurine-treated, erythrocyte thioguanine concentration
GCST007149		response, biomarker	6-mercaptopurine-treated, erythrocyte methylated 6-mercaptopurine metabolite concentration
GCST007150		response, biomarker	6-mercaptopurine-treated, dna-incorporated thioguanine levels
GCST007151		response, biomarker	6-mercaptopurine-treated, dna-incorporated thioguanine to erythrocyte thioguanine ratio
GCST007153		phenotype	delayed reward discounting
GCST007154		phenotype	pediatric
GCST007157		phenotype	corneal
GCST007158		phenotype	refractive
GCST007159		phenotype	corneal
GCST007160		phenotype	refractive
GCST007161		side effect	beta-lactam allergy measurement
GCST007176		phenotype	perceptual rivalry (necker cube stimulus)
GCST007177		phenotype	perceptual rivalry (binocular rivalry task)
GCST007178		phenotype	perceptual rivalry (voluntary modulation strength)
GCST007179		phenotype	fasting glucose in pregnancy (gestational week 14-16)
GCST007180		phenotype	fasting glucose in pregnancy (gestational week 30-32)
GCST007181		phenotype	two-hour glucose in pregnancy (gestational week 14-16)
GCST007182		phenotype	two-hour glucose in pregnancy (gestational week 30-32)
GCST007183		phenotype	general glucose level in pregnancy (gestational week 14-16)
GCST007184		phenotype	general glucose level in pregnancy (gestational week 30-32)
GCST007185		phenotype	timing of glucose curve peak in pregnancy (gestational week 14-16)
GCST007186		phenotype	timing of glucose curve peak in pregnancy (gestational week 30-32)
GCST007187		phenotype	visceral adipose tissue
GCST007188		phenotype	visceral:subcutaneous adipose tissue ratio
GCST007189		phenotype	visceral:total adipose tissue ratio
GCST007190		phenotype	subcutaneous adipose tissue
GCST007191		background	hla-dqb1*06:02 negative
GCST007192		background	kawasaki disease
GCST007193		phenotype	generalised
GCST007194		phenotype	severe
GCST007195		phenotype	slight
GCST007197		phenotype	localised
GCST007198		phenotype	age at diagnosis
GCST007200		side effect	radiation for nasopharyngeal carcinoma
GCST007200		treatment side effect	nasopharyngeal carcinoma - radiotherapy (brain injury)
GCST007202		biomarker	hdl
GCST007203		biomarker	total cholesterol
GCST007204		biomarker	ldl
GCST007206		background	fluorodeoxyglucose uptake in brain
GCST007207		interaction	sex
GCST007210		side effect	red blood cell transfusion for sickle cell anemia
GCST007218		phenotype	qt interval
GCST007220		phenotype	type 2 diabetes
GCST007222		background	schizophrenia
GCST007223		background	type 2 diabetes
GCST007224		background	type 2 diabetes
GCST007226		phenotype	pr interval
GCST007227		phenotype	qrs duration
GCST007229		side effect	thiopurine for crohn's disease
GCST007230		background, phenotype	coronary artery disease
GCST007232		interaction	snp x snp
GCST007234		phenotype	severe
GCST007235		phenotype	ductal adenocarcinoma
GCST007235		stratified	ductal adenocarcinoma
GCST007240		phenotype	obese vs. thin
GCST007241		phenotype	obesity (extreme)
GCST007242		phenotype	normal vs thin
GCST007246		phenotype	vs. type 2 diabetes
GCST007247		background	type 1 diabetes
GCST007250		response	nonunion
GCST007251		phenotype	postburn scar height
GCST007252		phenotype	postburn scar pliability
GCST007254		phenotype	broad depression or major depressive disorder (self-reported)
GCST007255		background	bipolar disorder
GCST007256		phenotype	broad depression or major depressive disorder (recurrent)
GCST007257		phenotype	schizophrenia
GCST007258		side effect	nsaid
GCST007259		side effect	cetuximab for colorectal cancer
GCST007259		treatment side effect	colorectal cancer - cetuximab
GCST007260		biomarker	vitamin b6
GCST007261		biomarker	vitamin b6 (active form pyridoxal phosphate) (csf)
GCST007262		biomarker	vitamin b6 (active form pyridoxal phosphate)
GCST007263		biomarker	vitamin b6 (form ratio) (csf)
GCST007264		biomarker	vitamin b6 (form ratio)
GCST007265		biomarker	vitamin b6 (form ratio)
GCST007266		phenotype	adult
GCST007269		phenotype	pulse pressure
GCST007272		phenotype	pulse pressure
GCST007276		background	b-cell precursor
GCST007278		phenotype	systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies
GCST007279		phenotype	symptom score
GCST007281		interaction, biomarker	physical activity, hdl
GCST007282		interaction, biomarker	physical activity, hdl
GCST007283		interaction, biomarker	physical activity, ldl
GCST007284		interaction, biomarker	physical activity, ldl
GCST007285		interaction, biomarker	physical activity, triglyceride
GCST007286		interaction, biomarker	physical activity, triglyceride
GCST007287		interaction	alcohol consumption
GCST007288		interaction	alcohol consumption
GCST007289		phenotype	vs npdr and no dr
GCST007291		phenotype	vs no dr
GCST007293		phenotype	body fat distribution (arm fat ratio)
GCST007294		phenotype	body fat distribution (trunk fat ratio)
GCST007295		phenotype	body fat distribution (leg fat ratio)
GCST007298		response, biomarker	fenofibrate, triglyceride
GCST007299		biomarker	triglyceride
GCST007300		response, biomarker	fenofibrate, hdl
GCST007301		biomarker	hdl
GCST007302		background	brca2 mutation carriers
GCST007302		stratified	BRCA2 positive
GCST007303		pleiotropy	total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, waist-hip ratio, type ii diabetes mellitus, body mass index, high density lipoprotein cholesterol measurement, coronary artery disease
GCST007304		phenotype	reduced foot dorsiflexion strength
GCST007305		phenotype	white matter hyperintensity volume
GCST007316		response, background	ketamine, bipolar disease
GCST007317		response	ketamine
GCST007318		phenotype	visuospatial domain impairment
GCST007319		phenotype	late onset
GCST007320		background	family history
GCST007321		background	family history
GCST007322		phenotype	general risk tolerance
GCST007323		phenotype	risk-taking tendency (4-domain principal component model)
GCST007324		phenotype	adventurousness
GCST007325		phenotype	general risk tolerance (mtag)
GCST007326		phenotype	number of sexual partners
GCST007327		phenotype	ever vs never smoker
GCST007328		phenotype	drinks per week
GCST007329		phenotype	automobile speeding propensity
GCST007330		phenotype	memory impairment
GCST007332		phenotype	multiple cognitive domain impairments
GCST007333		phenotype	no specific cognitive domain impairment
GCST007334		phenotype	language impairment
GCST007335		phenotype	age at first sexual intercourse
GCST007336		phenotype	age at first birth
GCST007337		phenotype	life satisfaction
GCST007338		phenotype	positive affect
GCST007341		phenotype	well-being spectrum (multivariate analysis)
GCST007344		biomarker	glomerular filtration rate
GCST007345		phenotype	childhood absence epilepsy
GCST007348		phenotype	generalized tonic-clonic seizures
GCST007349		phenotype	lesion negative
GCST007350		phenotype	with hippocampal sclerosis
GCST007351		phenotype	with lesion other than hippocampal sclerosis
GCST007355		response	resistance to antidepressants
GCST007356		response	resistance to antidepressants
GCST007358		response	platinum-based chemotherapy
GCST007359		pleiotropy	type 2 diabetes
GCST007360		response	bronchodilator
GCST007361		background	ankylosing spondylitis
GCST007362		background	with or without ankylosing spondylitis
GCST007363		background, biomarker	anti-mullerian hormone levels in pre-menopausal women of late reproductive age
GCST007365		response	gemcitabine
GCST007366		response	homocysteine level response to multivitamin in cerebral infarction
GCST007367		background	cystic fibrosis
GCST007376		background, biomarker	excessive alcohol consumption, gamma glutamyl transferase
GCST007377		background, biomarker	aspartate aminotransferase levels in excessive alcohol consumption
GCST007378		background, biomarker	aspartate aminotransferase levels in low alcohol consumption
GCST007379		background, biomarker	low alcohol consumption, alanine aminotransferase
GCST007380		background, biomarker	low alcohol consumption, gamma glutamyl transferase
GCST007381		background, biomarker	excessive alcohol consumption, alanine aminotransferase
GCST007382		biomarker	alanine, 20 pfaa adjusted
GCST007382		biomarker	asparagine, 20 pfaa adjusted
GCST007382		biomarker	glutamine, 20 pfaa adjusted
GCST007382		biomarker	glycine, 20 pfaa adjusted
GCST007382		biomarker	l-arginine, 20 pfaa adjusted
GCST007382		biomarker	ornithine, 20 pfaa adjusted
GCST007382		biomarker	phenylalanine, 20 pfaa adjusted
GCST007382		biomarker	proline, 20 pfaa adjusted
GCST007382		biomarker	serine, 20 pfaa adjusted
GCST007382		biomarker	threonine, 20 pfaa adjusted
GCST007383		biomarker	alanine, 1 pfaa adjusted
GCST007383		biomarker	amino acid, 1 pfaa adjusted
GCST007383		biomarker	citrulline, 1 pfaa adjusted
GCST007383		biomarker	glutamine, 1 pfaa adjusted
GCST007383		biomarker	glycine, 1 pfaa adjusted
GCST007383		biomarker	histidine, 1 pfaa adjusted
GCST007383		biomarker	l-arginine, 1 pfaa adjusted
GCST007383		biomarker	leucine, 1 pfaa adjusted
GCST007383		biomarker	lysine, 1 pfaa adjusted
GCST007383		biomarker	methionine, 1 pfaa adjusted
GCST007383		biomarker	phenylalanine, 1 pfaa adjusted
GCST007383		biomarker	proline, 1 pfaa adjusted
GCST007383		biomarker	serine, 1 pfaa adjusted
GCST007383		biomarker	threonine, 1 pfaa adjusted
GCST007383		biomarker	tryptophan, 1 pfaa adjusted
GCST007383		biomarker	tyrosine, 1 pfaa adjusted
GCST007384		biomarker	proline
GCST007385		biomarker	alanine
GCST007385		biomarker	asparagine
GCST007385		biomarker	glutamine
GCST007385		biomarker	glycine
GCST007385		biomarker	histidine
GCST007385		biomarker	l-arginine
GCST007385		biomarker	leucine
GCST007385		biomarker	lysine
GCST007385		biomarker	methionine, 1 pfaa adjusted
GCST007385		biomarker	phenylalanine
GCST007385		biomarker	proline
GCST007385		biomarker	serine
GCST007385		biomarker	threonine
GCST007385		biomarker	tryptophan
GCST007386		biomarker	asparagine
GCST007387		phenotype	never/rarely vs. sometimes/usually
GCST007388		phenotype	never/rarely vs. usually
GCST007389		phenotype	suicide behaviour
GCST007390		phenotype	suicidal ideation/attempts
GCST007392		phenotype	mitochondrial dna copy number (white blood cells)
GCST007393		phenotype	mitochondrial dna copy number
GCST007394		phenotype	mitochondrial dna copy number
GCST007395		phenotype	mitochondrial dna copy number
GCST007396		phenotype	mitochondrial dna copy number (white blood cells)
GCST007397		phenotype	mitochondrial dna copy number (white blood cells)
GCST007398		phenotype	mitochondrial dna copy number (white blood cells)
GCST007399		phenotype	mitochondrial dna copy number
GCST007401		biomarker	factor vii
GCST007402		biomarker	factor vii
GCST007403		interaction	cesarean section
GCST007404		interaction	cesarean section
GCST007405		interaction	cesarean section
GCST007406		phenotype	healthspan
GCST007408		interaction	stressful life events interaction
GCST007409		interaction	stressful life events interaction
GCST007410		interaction	dependent stressful life events
GCST007411		interaction	dependent stressful life events
GCST007412		interaction	independent stressful life events
GCST007413		interaction	independent stressful life events
GCST007415		background	er-positive
GCST007415		stratified	ER-positive
GCST007416		background	er-negative
GCST007417		biomarker	pr negative
GCST007418		phenotype	her2 negative
GCST007419		phenotype	her2 positive
GCST007420		background	pr positive
GCST007420		stratified	PR positive
GCST007421		phenotype	population density of place of residence
GCST007422		phenotype	socioeconomic status of place of residence
GCST007423		response	remission
GCST007424		response	remission
GCST007425		background	rheumatoid arthritis
GCST007426		biomarker	triiodothyronine
GCST007427		biomarker	triiodothyronine/thyroxine ratio
GCST007428		biomarker	thyroxine
GCST007429		phenotype	fvc
GCST007430		phenotype	fev1
GCST007431		phenotype	fev1/fec ratio
GCST007432		phenotype	fev1
GCST007434		background	stage i-iii microsatellite instability low/stable colorectal cancer (time to event)
GCST007434		stratified	colorectal cancer
GCST007436		phenotype	intima media thickness
GCST007437		biomarker	triglyceride
GCST007438		biomarker	hdl
GCST007439		biomarker	aspartate aminotransferase
GCST007440		biomarker	gpt
GCST007441		biomarker	total cholesterol
GCST007442		biomarker	ldl
GCST007445		biomarker	factor viii
GCST007446		biomarker	vwf
GCST007447		biomarker	factor viii measurement, von willebrand factor measurement
GCST007448		phenotype	angle of surface orientation score
GCST007449		phenotype	angle of deformation score
GCST007450		phenotype	deformation magnitude
GCST007451		phenotype	skin, hair and eye pigmentation (multivariate analysis)
GCST007454		phenotype	hair color
GCST007455		phenotype	brightness
GCST007456		phenotype	hue
GCST007457		phenotype	saturation
GCST007458		phenotype	age of initiation
GCST007459		phenotype	cigarettes smoked per day
GCST007461		phenotype	drinks per week
GCST007462		phenotype	age of initiation
GCST007465		phenotype	phoneme awareness
GCST007466		phenotype	word reading
GCST007467		phenotype	word spelling
GCST007468		phenotype	ever regular vs never regular
GCST007469		phenotype	rapid automised naming of digits
GCST007470		phenotype	rapid automised naming of letters
GCST007472		phenotype	drinks per week (mtag)
GCST007473		phenotype	rapid automised naming of pictures
GCST007474		phenotype	ever regular vs never regular
GCST007475		background	er-positive
GCST007475		survival stratified	ER-positive
GCST007476		background	er-negative
GCST007476		survival stratified	ER-negative
GCST007477		phenotype	mortality
GCST007477		survival	
GCST007478		phenotype	non-word reading
GCST007479		phenotype	reading ability (multivariate)
GCST007481		phenotype	heart rate
GCST007482		phenotype	handedness
GCST007483			bmi adjusted
GCST007484			bmi adjusted
GCST007485		background	body height
GCST007486		phenotype	hair color
GCST007487			bmi adjusted
GCST007491			bmi adjusted
GCST007492			bmi adjusted
GCST007493			bmi adjusted
GCST007494			bmi adjusted
GCST007495		background, biomarker	coronary artery disease, glomerular filtration rate
GCST007496			bmi adjusted
GCST007497		phenotype	time to progression
GCST007498		phenotype	time to first abdominal surgery
GCST007499		phenotype	indolent vs progressive
GCST007500			bmi adjusted
GCST007501			bmi adjusted
GCST007502			bmi adjusted
GCST007503			bmi adjusted
GCST007505		stratified	nevus count or cutaneous melanoma
GCST007507		phenotype	lower urinary tract symptoms
GCST007508		background	self-reported childhood asthma in adult smokers
GCST007510		phenotype	cleft lip with or without cleft palate
GCST007511		phenotype	late onset
GCST007512		phenotype	lower urinary tract symptoms
GCST007514		background	hepatitis b
GCST007516			bmi adjusted
GCST007518			bmi adjusted
GCST007519		phenotype	adult
GCST007536		biomarker	urea
GCST007537		phenotype	modic type vertebral endplate changes
GCST007538		biomarker	nre2l2 (nrf2)
GCST007539		response	peg-asparaginase for acute lymphoblastic leukemia
GCST007540		side effect	peg-asparaginase for acute lymphoblastic leukemia
GCST007541		side effect	peg-asparaginase for acute lymphoblastic leukemia
GCST007542		biomarker	interleukin-1 beta
GCST007544		phenotype	total cholesterol
GCST007545		biomarker	triglyceride
GCST007546		biomarker	ldl
GCST007547		pleiotropy, biomarker	hdl
GCST007548		phenotype	uterine fibroid
GCST007549		phenotype	osteolysis in total hip arthroplasty
GCST007550		phenotype	osteolysis in total hip arthroplasty
GCST007553		background	major depressive disorder
GCST007555		phenotype	autism and schizophrenia
GCST007558		response	long-term oxygen therapy
GCST007559		phenotype	sleep duration (short sleep)
GCST007560		phenotype	sleep duration (long sleep)
GCST007561		phenotype	sleep duration
GCST007563		phenotype	asthma, hay fever or eczema
GCST007564		pleiotropy	asthma
GCST007565		phenotype	morning person
GCST007577		background	parental or offspring effect
GCST007578		biomarker	homocysteine
GCST007579		biomarker	folic acid
GCST007580		biomarker	folate in red blood cells
GCST007582		pleiotropy	putamen volume
GCST007583		pleiotropy	nucleus accumbens volume
GCST007584		pleiotropy	thalamus volume
GCST007585		pleiotropy	palladium volume
GCST007586		pleiotropy	intracranial volume
GCST007587		pleiotropy	hippocampal volume
GCST007588		pleiotropy	amygdala volume
GCST007589		phenotype	intracranial volume
GCST007590		phenotype	hippocampal volume
GCST007591		pleiotropy	caudate nucleus volume
GCST007592		phenotype	handedness (left-handed vs. non-left-handed)
GCST007593		phenotype	ambidextrousness
GCST007594		phenotype	handedness (right-handed vs. non-right-handed)
GCST007596		phenotype	adult
GCST007597		phenotype	adult
GCST007598		phenotype	adult
GCST007599		phenotype	adult
GCST007601		phenotype	cigarette pack-years
GCST007602		phenotype	cigarettes smoked per day
GCST007603		phenotype	age of initiation
GCST007605		biomarker	glycated hemoglobin levels
GCST007606		side effect	flucloxacillin
GCST007607		side effect	amoxicillin
GCST007608		side effect	isoxazolyl penicillins
GCST007609		phenotype	resting heart rate
GCST007611		pleiotropy	chronic obstructive pulmonary disease
GCST007612		pleiotropy	coronary artery disease
GCST007613		pleiotropy	chronic obstructive pulmonary disease
GCST007614		biomarker	c-reactive protein
GCST007615		biomarker	c-reactive protein
GCST007616		phenotype	calcaneal bone quantitative ultrasound measurement
GCST007617		interaction	alcohol consumption
GCST007618		interaction	smoking status
GCST007621		phenotype	sensation seeking
GCST007622		phenotype	impulsivity
GCST007623		phenotype	lack of premeditation
GCST007624		phenotype	positive urgency
GCST007625		phenotype	negative urgency
GCST007626		phenotype	lack of perseverance
GCST007627		phenotype	impulsivity (attentional)
GCST007628		phenotype	impulsivity (motor)
GCST007629		phenotype	impulsivity (non-planning)
GCST007631		response	remission
GCST007632		response	remission
GCST007633		response	remission
GCST007634		response	remission
GCST007635		biomarker	fatty acid desaturase enzyme activity in serum
GCST007636		biomarker	fatty acid desaturase enzyme activity in adipose
GCST007637		phenotype	diffusing capacity of the lung for carbon monoxide
GCST007638		biomarker	glycine
GCST007639		phenotype	femoral neck length
GCST007640		phenotype	narrowest width of the femoral neck
GCST007641		phenotype	femoral neck section modulus
GCST007642		phenotype	femoral neck-shaft angle
GCST007643		side effect	gemcitabine for pancreatic cancer
GCST007643		treatment side effect	pancreatic cancer - gemcitabine (high-grade neutropenia)
GCST007644		background, biomarker	renal transplantation (donor effect), glomerular filtration rate
GCST007645		background, biomarker	renal transplantation (recipient effect), glomerular filtration rate
GCST007646		background, biomarker	renal transplantation (donor effect), glomerular filtration rate
GCST007647		background, biomarker	renal transplantation (recipient effect), glomerular filtration rate
GCST007648		background, biomarker	renal transplantation (donor effect), glomerular filtration rate
GCST007649		background, biomarker	renal transplantation (recipient effect), glomerular filtration rate
GCST007650		phenotype	postoperative survival time
GCST007652		phenotype	platelet reactivity and count
GCST007656		pleiotropy	resting heart rate
GCST007657		phenotype	alcohol and nicotine co-dependence
GCST007658		biomarker	triglyceride levels, parental genotype effect
GCST007659		response, biomarker	fenofibrate, triglyceride (parental genotype effect)
GCST007660		response, biomarker	fenofibrate, triglyceride (parental genotype effect)
GCST007661		biomarker	triglyceride
GCST007662		response, biomarker	fenofibrate, triglyceride
GCST007663		response, biomarker	fenofibrate, triglyceride
GCST007664		drug metabolism	anastrozole levels ER positive breast cancer
GCST007664		drug metabolism	plasma anastrozole concentration in er-positive breast cancer
GCST007666		response	antidepressant
GCST007669		phenotype	insulin response
GCST007671		biomarker	fasting blood insulin
GCST007672		phenotype	3-month functional outcome
GCST007673		phenotype	3-month functional outcome
GCST007674		response, phenotype	lacunar ischaemic stroke
GCST007675		phenotype	3-month functional outcome in non-lacunar
GCST007676		phenotype	3-month functional outcome
GCST007677		phenotype	rumination
GCST007678		phenotype	brooding stress response
GCST007679		phenotype	reflection
GCST007680		biomarker	thyroxine, triiodothyronine
GCST007681		biomarker	tshb
GCST007682		biomarker	thyroxine
GCST007683		biomarker	triiodothyronine
GCST007684		response	plasma clozapine-norclozapine ratio in treatment-resistant schizophrenia
GCST007685		response	plasma clozapine levels in treatment-resistant schizophrenia
GCST007686		response	plasma norclozapine levels in treatment-resistant schizophrenia
GCST007687	C535300	phenotype	photic sneeze reflex
GCST007688		biomarker	total cholesterol
GCST007689		biomarker	ldl
GCST007690		phenotype	metabolic coherence
GCST007691		background	femoral neck
GCST007693		phenotype	information processing speed
GCST007695		phenotype	perceptual and visual search speed and executive function
GCST007696		interaction, phenotype	age, information processing speed
GCST007697		interaction	age
GCST007698		interaction, phenotype	age, perceptual and visual search speed and executive function
GCST007701		biomarker	hdl
GCST007702		biomarker	triglyceride
GCST007705		phenotype	pulse pressure
GCST007706		phenotype	mean arterial pressure
GCST007708		phenotype	worry/vulnerability
GCST007711		phenotype	calcification
GCST007712		phenotype	cortical brain region measurements (area, volume and thickness)
GCST007713		phenotype	frontal fibrosing alopecia
GCST007714		phenotype	non-ischemic
GCST007717		biomarker	urinary sodium to potassium ratio
GCST007718		biomarker	urinary albumin to creatinine ratio
GCST007721		biomarker	urinary potassium to creatinine ratio
GCST007725		biomarker	uric acid
GCST007726		phenotype	seropositive for toxoplasma gondii
GCST007727		background	childhood
GCST007727		stratified	childhood
GCST007729		phenotype	small subcortical
GCST007731		phenotype	postoperative survival time
GCST007732		phenotype	asthma, hay fever or eczema
GCST007733		biomarker	uric acid
GCST007736		background, phenotype	primary biliary cholangitis, seropositive for gp210
GCST007737		background, phenotype	primary biliary cholangitis, seropositive for sp100
GCST007739		phenotype	skin reflectance (melanin index)
GCST007740		phenotype	a* coordinate
GCST007741		phenotype	b* coordinate
GCST007742		phenotype	heterochromicity
GCST007743		phenotype	l* coordinate
GCST007745		background	obesity
GCST007746		background	non-obese
GCST007747		background	lower physical activity
GCST007748		background	higher physical activity
GCST007749		background	more-fat diet
GCST007750		background	less-fat diet
GCST007751		background	obesity
GCST007752		background	non-obese individuals
GCST007753		background	higher physical activity
GCST007754		background	lower physical activity
GCST007755		background	more-fat diet
GCST007756		background	less-fat diet
GCST007757		interaction	body mass index
GCST007758		interaction	physical activity
GCST007759		interaction	saturated fatty acids
GCST007760		biomarker	fasting blood insulin
GCST007762		interaction	body mass index
GCST007763		interaction	bmi
GCST007764		interaction	physical activity
GCST007765		interaction	physical activity
GCST007766		interaction	saturated fatty acids
GCST007767		interaction	saturated fatty acids
GCST007768		background	obesity
GCST007769		biomarker	fasting blood insulin
GCST007770		background	higher physical activity
GCST007771		background	lower physical activity
GCST007772		background	more-fat diet
GCST007773		background	less-fat diet
GCST007774		side effect	drug
GCST007775		pleiotropy	brain volume
GCST007776		pleiotropy	brain volume
GCST007777		phenotype	anorexia nervosa, attention deficit hyperactivity disorder, schizophrenia, autism spectrum disorder, mental or behavioural disorder, bipolar disorder, mood disorder
GCST007778		biomarker	urinary sodium to creatinine ratio
GCST007779		side effect	pandemrix
GCST007780		phenotype	age of onset
GCST007781		pleiotropy	bipolar disorder
GCST007782		pleiotropy	schizophrenia
GCST007796		side effect	cisplatin for testicular cancer
GCST007796		treatment side effect	testicular cancer - cisplatin (tinnitus)
GCST007797		phenotype	childhood vs adult
GCST007799		phenotype	adult onset
GCST007800		phenotype	childhood onset
GCST007801		phenotype	sleep duration
GCST007802		phenotype	sleep duration (variability)
GCST007803		phenotype	sleep efficiency
GCST007804		phenotype	sleep (number of episodes)
GCST007805		phenotype	sleep (time to least active 5 hours)
GCST007806		phenotype	sleep (time to most active 10 hours)
GCST007807		phenotype	sleep (time to midpoint)
GCST007808		phenotype	daytime rest
GCST007809		side effect	carbamazepine or oxcarbazepine for epilepsy
GCST007810		side effect, phenotype	carbamazepine or oxcarbazepine for epilepsy, severe
GCST007811		side effect	carbamazepine for epilepsy
GCST007812		side effect	oxcarbazepine for epilepsy
GCST007813		drug metabolism, background	carbamazepine-10,11-diol to carbamazepine ratio, epilepsy
GCST007814		biomarker	sodium
GCST007816		phenotype	trunk fat mass, trunk lean mass adjusted
GCST007817		phenotype	facial attractiveness (male raters)
GCST007818		phenotype	facial attractiveness (female raters)
GCST007819		phenotype	facial attractiveness (male raters)
GCST007820		phenotype	facial attractiveness (female raters)
GCST007821		phenotype	facial attractiveness (female raters)
GCST007822		phenotype	facial attractiveness (male raters)
GCST007823		phenotype	facial attractiveness (male raters)
GCST007825		pleiotropy	fasting blood glucose
GCST007826		pleiotropy	fasting blood insulin
GCST007827		pleiotropy	hdl cholesterol
GCST007830		phenotype	autoantibody against thyroid peroxidase
GCST007831		phenotype	autoantibody against thyroglobulin
GCST007832		biomarker	urinary albumin to creatinine ratio
GCST007836		biomarker	glycine
GCST007837		biomarker	glycine
GCST007838		biomarker	glycine
GCST007840		biomarker	hdl
GCST007846		phenotype	arterial stiffness
GCST007848		biomarker	ldl
GCST007849		biomarker	triglyceride
GCST007850		biomarker	hdl
GCST007851		phenotype	autoantibodies against thyroid peroxidase and thyroglobulin
GCST007856		pleiotropy	advanced adenoma
GCST007857		biomarker	fasting blood insulin, bmi adjusted
GCST007858			bmi adjusted
GCST007859		phenotype	rapid automised naming and rapid alternating stimulus test performance
GCST007860		phenotype	latent naming speed
GCST007861		phenotype	latent naming speed
GCST007862		phenotype	latent naming speed
GCST007863		phenotype	rapid alternating stimulus test for letters/numbers
GCST007864		phenotype	rapid automised naming of letters
GCST007865		phenotype	rapid automised naming of objects
GCST007876		biomarker	glomerular filtration rate
GCST007877		biomarker	creatinine
GCST007878		biomarker	urea
GCST007880		background	attention deficit hyperactivity disorder
GCST007896		phenotype	lymphoma
GCST007897		side effect	anti-tuberculosis drug treatment
GCST007898		biomarker	fasting blood insulin
GCST007900		biomarker	chemerin
GCST007917		biomarker	glomerular filtration rate
GCST007918		biomarker	uric acid
GCST007919		biomarker	creatinine
GCST007921		phenotype	right-sided
GCST007922		response	peptic ulcer and gastro-oesophageal reflux disease agents
GCST007923		response	diabetes agents
GCST007924		response	antithrombotic agents
GCST007925		response	vasodilator agents
GCST007926		response	antihypertensive agents
GCST007927		response	beta blocking agents
GCST007928		response	diuretic agents
GCST007929		response	calcium channel blocker agents
GCST007930		response	renin-angiotensin system agents
GCST007931		response	hmg coa reductase inhibitor agents
GCST007932		response	thyroid agents
GCST007933		response	immunosuppressant agents
GCST007934		response	use of anti-inflammatory and antirheumatic products, non-steroids
GCST007935		response	bone structure and mineralization agents
GCST007936		response	opioid agents
GCST007937		phenotype	aspirin use
GCST007938		response	anilide agents
GCST007939		response	antimigraine agents
GCST007940		response	antidepressant use
GCST007941		response	adrenergics, inhalant agents
GCST007942		response	glucocorticoid agents
GCST007943		response	antihistamine agents
GCST007944		response	antiglaucoma preparations and miotic agents
GCST007945		background, phenotype	high deployment stress exposure, resilience
GCST007946		phenotype	resilience
GCST007947		phenotype	resilience
GCST007948		biomarker	prnp (kanno antigen negativity)
GCST007949		background	type 2 diabetes
GCST007950		background	apol1 risk genotype negative t2d individuals
GCST007951		biomarker	glycated hemoglobin levels
GCST007952		biomarker	glycated hemoglobin levels
GCST007953		biomarker	glycated hemoglobin levels
GCST007954		biomarker	glycated hemoglobin levels
GCST007955		biomarker	ldl and triglyceride
GCST007956		phenotype	maternal
GCST007976		background	cardiac surgery
GCST007977		side effect	cardiac surgery
GCST007978		side effect	cardiac surgery
GCST007979		side effect	cardiac surgery
GCST007980		background	cardiac surgery
GCST007981		background	cardiac surgery
GCST007982		phenotype	sleep duration
GCST007983		phenotype	morning person
GCST007984		phenotype	excessive daytime sleepiness
GCST007986		phenotype	morning person
GCST007987		phenotype	daytime rest
GCST007989		phenotype	facial morphology
GCST007991		phenotype	large artery
GCST007993		phenotype	adult onset
GCST007994		phenotype	age of onset
GCST007995		phenotype	childhood onset
GCST007997		interaction, phenotype	snp x snp, exterme
GCST007999		phenotype	heart rate with reduced ejection fraction
GCST008017		background, phenotype	obesity with metabolic syndrome, bitter
GCST008018		phenotype	obesity with metabolic syndrome, sweet
GCST008019		background, phenotype	obesity with metabolic syndrome, bitter
GCST008020		phenotype	obesity with metabolic syndrome, total
GCST008021		phenotype	obesity with metabolic syndrome, total
GCST008022		phenotype	obesity with metabolic syndrome, umami
GCST008023		phenotype	obesity with metabolic syndrome, sour
GCST008024		phenotype	obesity with metabolic syndrome, salty
GCST008027		phenotype	cigarettes smoked per day
GCST008028		phenotype	cups of coffee per day
GCST008030		biomarker	glomerular filtration rate
GCST008033		biomarker	fasting blood insulin
GCST008034		biomarker	glycated hemoglobin levels
GCST008035		biomarker	hdl
GCST008037		biomarker	ldl
GCST008038		phenotype	mean corpuscular hemoglobin concentration
GCST008042		phenotype	pr interval
GCST008043		phenotype	qt interval
GCST008045		biomarker	total cholesterol
GCST008046		biomarker	triglyceride
GCST008054		phenotype	qrs duration
GCST008055		biomarker	c-reactive protein
GCST008056		interaction	snp x snp
GCST008058		biomarker	glomerular filtration rate
GCST008059		biomarker	glomerular filtration rate
GCST008060		biomarker	glomerular filtration rate
GCST008061		biomarker	glomerular filtration rate
GCST008062		biomarker	blood urea nitrogen levels
GCST008063		biomarker	blood urea nitrogen levels
GCST008066		biomarker	glomerular filtration rate
GCST008067		phenotype	pemphigus foliaceus
GCST008068		phenotype	pemphigus vulgaris
GCST008070		biomarker	hdl
GCST008071		interaction, biomarker	alcohol consumption, triglyceride
GCST008072		interaction, biomarker	alcohol consumption, hdl
GCST008073		interaction, biomarker	alcohol consumption, ldl
GCST008074		interaction, biomarker	alcohol consumption, triglyceride
GCST008075		interaction, biomarker	alcohol consumption, hdl
GCST008076		biomarker	triglyceride
GCST008077		biomarker	ldl
GCST008078		interaction, biomarker	alcohol consumption, ldl
GCST008079		interaction, biomarker	alcohol consumption, ldl
GCST008080		interaction, biomarker	alcohol consumption, triglyceride
GCST008081		interaction, biomarker	alcohol consumption (1df), hdl
GCST008082		interaction, biomarker	alcohol consumption, ldl
GCST008083		interaction, biomarker	alcohol consumption, triglyceride
GCST008084		interaction, biomarker	alcohol consumption (2df), hdl
GCST008085		background, biomarker	current drinkers, hdl
GCST008086		interaction, biomarker	current drinkers, ldl
GCST008087		interaction, biomarker	current drinkers, triglyceride
GCST008097		side effect	bisphosphonate
GCST008098		side effect	bisphosphonate
GCST008099		interaction, phenotype	omega-3 pufa (docosahexaenoic acid), fvc
GCST008100		interaction, phenotype	omega-3 pufa (docosapentaenoic acid), fvc
GCST008101		interaction, phenotype	omega-3 pufa (docosapentaenoic acid), fev1
GCST008102		interaction, phenotype	omega-3 pufa (docosahexaenoic acid), fev1
GCST008104		biomarker	nucleoside diphosphate kinase a
GCST008107		phenotype	refractory to radioiodine
GCST008108		biomarker	n-glycan
GCST008109		biomarker	insulin
GCST008110		phenotype	insulinogenic index
GCST008112		biomarker	insulin
GCST008113		biomarker	insulin
GCST008115		phenotype	bipolar i
GCST008116		phenotype	bipolar ii
GCST008117		phenotype	bipolar type
GCST008118		background	major depressive disorder
GCST008119		background	bipolar disorder
GCST008120		background	schizophrenia
GCST008121		background	major depressive disorder or bipolar disorder
GCST008122		background	schizophrenia or bipolar disorder
GCST008123		background	major depressive disorder or bipolar disorder or schizophrenia
GCST008138		interaction	sex
GCST008141		biomarker	hdl
GCST008147		response, biomarker	allopurinol, uric acid
GCST008148		response, biomarker	allopurinol, uric acid
GCST008149		phenotype	age at menopause
GCST008150		biomarker	triglyceride
GCST008153		phenotype	lean body mass
GCST008156		phenotype	hip circumference, bmi adjusted
GCST008159			bmi adjusted
GCST008161			bmi adjusted
GCST008162		phenotype	hip circumference
GCST008164		biomarker	thyroxine
GCST008165		biomarker	tshb
GCST008166		phenotype	mean corpuscular volume
GCST008167		phenotype	mean platelet volume
GCST008170		biomarker	tg (thyroglobulin)
GCST008171		phenotype	platelet aggregation
GCST008172		biomarker	liver iron
GCST008173		biomarker	gpt
GCST008174		biomarker	aspartate aminotransferase
GCST008175		biomarker	gamma-glutamyl transferase
GCST008177		phenotype	spontaneous
GCST008178		phenotype	early spontaneous
GCST008179		phenotype	moderate-to-late spontaneous
GCST008180		phenotype	spontaneous preterm birth with premature rupture of membranes
GCST008181		phenotype	spontaneous without premature rupture of membranes
GCST008196		biomarker	vcam1
GCST008197		biomarker	interleukin 8
GCST008198		biomarker	vegfa
GCST008199		biomarker	cxcl10
GCST008200		biomarker	interleukin-6
GCST008201		biomarker	interleukin 4
GCST008202		biomarker	e-selectin
GCST008203		biomarker	interleukin 1 receptor antagonist
GCST008204		biomarker	ccl2
GCST008205		biomarker	interleukin 17
GCST008206		biomarker	plasminogen activator inhibitor 1
GCST008207		biomarker	interleukin 1 alpha
GCST008208		biomarker	cd40lg (cd40 ligand) soluble
GCST008209		biomarker	interleukin-1 beta
GCST008210		biomarker	icam-1
GCST008211		biomarker	tnf
GCST008216		phenotype	tumour size
GCST008217		phenotype	age at diagnosis
GCST008218		phenotype	age at diagnosis (< 70 years vs ≥ 70 years)
GCST008219		phenotype	tumour size (< 3 cm vs ≥ 3 cm)
GCST008220		phenotype	tumour stage (tis/t1 vs ta)
GCST008221		phenotype	tumour grade (g3 vs g2/g1)
GCST008222		phenotype	eortc risk category
GCST008223		background	type 2 diabetes
GCST008224		interaction	sex
GCST008228		phenotype	control
GCST008229		interaction	inhaled corticosteroid (1df)
GCST008230		interaction	inhaled corticosteroid (2df)
GCST008232		pleiotropy, biomarker	total cholesterol
GCST008233		pleiotropy, biomarker	ldl
GCST008234		pleiotropy	c-reactive protein
GCST008236		biomarker	c-reactive protein
GCST008237		biomarker	hdl
GCST008238		biomarker	ldl
GCST008239		biomarker	total cholesterol
GCST008240		background, phenotype	never smokers, airflow obstruction (fev1/fvc<70%)
GCST008241		background, phenotype	never smokers, airflow obstruction (fev1/fvc<lower limit of normal)
GCST008242		background, phenotype	ever smokers, airflow obstruction (fev1/fvc<lower limit of normal)
GCST008243		background, phenotype	ever smokers, airflow obstruction (fev1/fvc<70%)
GCST008244		background, phenotype	never smokers, airflow obstruction (fev1/fvc<70%)
GCST008245		background, phenotype	ever smokers, airflow obstruction (fev1/fvc<lower limit of normal)
GCST008246		background, phenotype	never smokers, airflow obstruction (fev1/fvc<lower limit of normal)
GCST008247		background, phenotype	ever smokers, airflow obstruction (fev1/fvc<70%)
GCST008258		phenotype	consumption score
GCST008260		background, biomarker	elevated hscrp, phospholipase a2, membrane associated, c-reactive protein
GCST008261		phenotype	psychological wellbeing (depressiveness)
GCST008262		phenotype	psychological wellbeing index 1 (lack of subjective wellbeing and health)
GCST008263		phenotype	psychological wellbeing index 3 (fatigue and loss of appetite)
GCST008264		phenotype	psychological wellbeing index 12 (lack of enjoying daily life)
GCST008265		phenotype	psychological wellbeing (social role performance and self-confidence)
GCST008266		phenotype	psychological wellbeing (health and vitality)
GCST008267		phenotype	psychological wellbeing index (total score)
GCST008268		side effect	mepolizumab for chronic obstructive pulmonary disease, exacerbation requiring hospitalisation
GCST008269		side effect	mepolizumab for chronic obstructive pulmonary disease, exacerbation
GCST008270		background	trauma-exposed soldiers
GCST008271		side effect	adalimumab for crohn's disease
GCST008272		interaction, background	air pollution (co) in childhood asthma
GCST008273		interaction, background	air pollution (no2) in childhood asthma
GCST008274		phenotype	cerebral microbleed progression
GCST008275		phenotype	cerebral microbleeds
GCST008276		phenotype	corneal resistance factor
GCST008277		phenotype	corneal hysteresis
GCST008278		phenotype	femoral neck size
GCST008279		phenotype	bone size (femur)
GCST008280		phenotype	intertrochanteric region size
GCST008281		phenotype	bone size (hip)
GCST008282		phenotype	bone size (spine)
GCST008283		phenotype	symptom count
GCST008285		phenotype	tolerance
GCST008286		phenotype	withdrawal
GCST008287		phenotype	drinking more than intended
GCST008288		phenotype	desire to cut drinking
GCST008289		phenotype	giving up activities
GCST008290		phenotype	time spent drinking
GCST008291		phenotype	drinking despite problems
GCST008292		response, phenotype	fluticasone propionate/salmeterol, change in quality of life
GCST008293		response, phenotype	fluticasone propionate/salmeterol, trough fev1
GCST008294		response	fluticasone propionate/salmeterol
GCST008295		phenotype	number of decayed, missing and filled tooth surfaces or use of dentures
GCST008296		phenotype	loose teeth
GCST008297		phenotype	loose teeth
GCST008298		phenotype	number of natural teeth
GCST008299		phenotype	decayed and filled tooth surfaces per available tooth surface
GCST008301		phenotype	bleeding gums
GCST008302		phenotype	number of decayed, missing and filled tooth surfaces
GCST008303		phenotype	painful gums
GCST008306		phenotype	dentate gyrus volume
GCST008307		response	belimumab
GCST008308		phenotype	infection persistence (>18 months) in genital human papillomavirus 16 infection
GCST008309		biomarker	cardiac troponin-i
GCST008310		biomarker	cardiac troponin-t
GCST008311		phenotype	sporadic
GCST008312		phenotype	sural nerve amplitude potential
GCST008313		phenotype	sural nerve conduction velocity
GCST008314		response	intravenous immunoglobulin
GCST008315		phenotype	corneal hysteresis
GCST008316		phenotype	corneal endothelial cell size variation coefficient
GCST008317		phenotype	central corneal thickness
GCST008318		phenotype	corneal resistance factor
GCST008319		phenotype	corneal compensated
GCST008320		phenotype	goldman correlated
GCST008321		phenotype	corneal endothelial cell shape (percentage of hexagonally shaped cells)
GCST008324		biomarker	hemoglobin
GCST008327		phenotype	monocyte count
GCST008330		phenotype	mean corpuscular volume
GCST008331		phenotype	mean corpuscular hemoglobin
GCST008332		phenotype	mean corpuscular hemoglobin concentration
GCST008333		phenotype	red blood cell distribution width
GCST008334		phenotype	neutrophil count
GCST008335		phenotype	eosinophil count
GCST008336		phenotype	mean platelet volume
GCST008337		phenotype	multiple
GCST008338		phenotype	multiple
GCST008339		phenotype	corneal endothelial cell density
GCST008356		phenotype	geographic atrophy lesion growth rate
GCST008357		phenotype	mood instability
GCST008358		response, phenotype	cognitive-behavioural therapy, anxiety and major depressive disorders
GCST008359		response	cognitive-behavioural therapy
GCST008360		response	cognitive-behavioural therapy
GCST008361		response	cognitive-behavioural therapy
GCST008363		phenotype	offspring birth weight
GCST008364		pleiotropy	graves disease
GCST008365		pleiotropy	graves disease
GCST008367		phenotype	autoantibodies against thyroid peroxidase and thyroglobulin
GCST008368		phenotype	autoantibody against thyroid peroxidase
GCST008369		biomarker	autoantibody against thyroglobulin
GCST008374		response, background	warfarin maintenance dose, clinical factors adjusted
GCST008375		background	never smokers
GCST008376		background	never smokers
GCST008378		side effect	radiotherapy for prostate cancer, decreased urine stream
GCST008379		response, biomarker	radiotherapy in prostate cancer (overall toxicity)
GCST008380		side effect	radiotherapy for prostate cancer
GCST008381		side effect	radiotherapy for prostate cancer
GCST008382		side effect, phenotype	radiotherapy for prostate cancer, increased urinary frequency
GCST008383		side effect	carbamazepine
GCST008384		side effect	carbamazepine
GCST008385		side effect	carbamazepine
GCST008386		side effect, phenotype	carbamazepine, severe cutaneous adverse reaction
GCST008387		background	schizophrenia
GCST008388		side effect, phenotype	radiotherapy for breast cancer, acute pain
GCST008389		interaction	physical activity
GCST008390		interaction	physical activity
GCST008392		interaction	physical activity interaction
GCST008393		interaction	physical activity interaction
GCST008396		phenotype	years of education
GCST008397		response, phenotype	infliximab, mucosal healing
GCST008398		biomarker	glycated hemoglobin levels
GCST008400		interaction	physical activity (least vs most active quartile)
GCST008401		interaction	physical activity (less vs more active half)
GCST008402		interaction	physical activity (least vs most active quartile)
GCST008403		phenotype	arterial stiffness index
GCST008404		interaction	physical activity (least active quartile vs others)
GCST008405		interaction	physical activity
GCST008406		interaction	physical activity
GCST008407		interaction	physical activity
GCST008408		interaction	physical activity (less vs more active half)
GCST008409		interaction	physical activity (least active quartile vs others)
GCST008410		interaction	physical activity
GCST008411		interaction	physical activity
GCST008412		interaction	physical activity
GCST008413		biomarker	core binding factor
GCST008415		background	cannibis use
GCST008416		phenotype	attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder
GCST008417		phenotype	attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder
GCST008418		phenotype	mean corpuscular hemoglobin concentration
GCST008420		phenotype	mean corpuscular volume
GCST008421		phenotype	monocyte count
GCST008422		phenotype	qrs duration
GCST008423		phenotype	uterine fibroid
GCST008424		phenotype	opioid dependence
GCST008425		phenotype	neutrophil count
GCST008428		phenotype	eosinophil count
GCST008429		biomarker	hemoglobin
GCST008432		phenotype	mean corpuscular hemoglobin
GCST008433		phenotype, biomarker	percutaneous coronary intervention, lipoprotein a
GCST008435		response, biomarker	hepatitis b vaccine, anti-virus surface antigen igg levels
GCST008436		phenotype	non-obstructive
GCST008437		background	hypertension-negative
GCST008438		background	hypertension
GCST008444		biomarker	hdl
GCST008445		biomarker	uric acid
GCST008446		phenotype	alcohol sensitivity (first 5 occasions)
GCST008447		phenotype	alcohol sensitivity (long term)
GCST008456	C536404	phenotype	childhood steroid-sensitive nephrotic syndrome
GCST008457		phenotype	platelet reactivity (collagen-adp)
GCST008458		phenotype	platelet reactivity (collagen-adp)
GCST008460		phenotype	gout vs. hyperuricemia
GCST008461		background, biomarker	coagulation factor v, venous thromboembolism
GCST008462		biomarker	coagulation factor v, venous thromboembolism
GCST008466		biomarker	gpt
GCST008467		background, biomarker	aspartate aminotransferase levels in non-alcoholic fatty liver disease
GCST008469		background	non-alcoholic fatty acid liver disease
GCST008470		interaction	snp x snp
GCST008471		phenotype	disease activity score
GCST008472	C531617	phenotype	sporadic
GCST008473		phenotype	visceral adipose tissue
GCST008475		phenotype	ankle brachial index
GCST008476		background	smokers
GCST008477		background	smokers, bmi adjusted
GCST008478		biomarker	neurological blood protein biomarker levels
GCST008480		phenotype	fev1
GCST008481		phenotype	fev1/fec ratio
GCST008482		phenotype	fvc
GCST008484		phenotype	social and communication disorders checklist score
GCST008487		phenotype	coffee consumption
GCST008488		phenotype	early progression
GCST008490		phenotype	re-experiencing symptoms
GCST008491		background	alzheimer's disease
GCST008492		side effect, phenotype	general, severe cutaneous adverse reaction
GCST008493		phenotype	survival time
GCST008496		phenotype	nicotine dependence
GCST008497		phenotype	change in neurofilament light levels
GCST008498		response, biomarker	meningococcal c vaccine, igg levels
GCST008499		response, biomarker	meningococcal c vaccine, anti-meningococcal c antibody levels
GCST008500		response, biomarker	tetanus vaccine, tetanus toxoid igg levels
GCST008501		response, biomarker	haemophilus influenzae type b vaccine, hib polyribosylribitol phosphate igg concentrations post childhood
GCST008502		phenotype	low susceptibility
GCST008506		interaction	major depressive disorder
GCST008507		interaction	major depressive disorder
GCST008508		interaction	major depressive disorder
GCST008513		phenotype	health literacy
GCST008514		response	peginterferon alfa-2a
GCST008515		background	pre-treatment viral load in hepatitis c virus genotype 3
GCST008516		background	conditioned on rs1426654 and rs35397
GCST008517		response	interferon treatment in hepatitis c virus genotype 3
GCST008520		response	direct-acting antiviral treatment in hepatitis c virus genotype 3
GCST008521		phenotype	bitter beverage consumption
GCST008522		phenotype	bitter alcoholic beverage consumption
GCST008523		phenotype	non-grapefruit juice consumption
GCST008524		phenotype	bitter non-alcoholic beverage consumption
GCST008525		phenotype	artificially sweetened beverage consumption
GCST008526		phenotype	coffee consumption
GCST008527		phenotype	sugar-sweetened beverage consumption
GCST008528		phenotype	sweet beverage consumption
GCST008529		phenotype	tea consumption
GCST008530		phenotype	neuropathy
GCST008531		phenotype	grapefruit juice consumption
GCST008532		phenotype	burning or tingling in extremities
GCST008533		phenotype	decreased fine motor function (eating with utensils)
GCST008534		background	charcot-marie-tooth disease 1a
GCST008535		phenotype	arthritic-like pain
GCST008536		phenotype	scoliosis
GCST008537		phenotype	decreased sensory function
GCST008538		phenotype	balance difficulty
GCST008539		phenotype	foot plantar flexion strength
GCST008540		phenotype	decreased fine motor function (buttons, zippers, fasteners, bottles)
GCST008541		phenotype	foot deformity
GCST008542		phenotype	first dorsal interosseous strength
GCST008543		background	charcot-marie-tooth disease 1a
GCST008544		phenotype	reduced foot dorsiflexion strength
GCST008545		background, phenotype	type 2 diabetes, decreased visual acuity
GCST008546		background	type 2 diabetes
GCST008547		phenotype	time of initiation
GCST008548		phenotype	nicotine dependence
GCST008549		phenotype	mental health study participation (provided email address)
GCST008550		phenotype	mental health study participation (completed survey)
GCST008551		side effect	simvastatin
GCST008552		side effect	statin
GCST008553		side effect	statin
GCST008554		side effect	atorvastatin
GCST008555		phenotype	breakfast cereal skipping frequency
GCST008556		phenotype	breakfast skipping
GCST008557		interaction	dentate gyrus volume
GCST008560		phenotype	propensity-score-matching design
GCST008561		phenotype	psychiatric co-morbidity covariate model
GCST008562		phenotype	psychiatric co-morbidity weighting design
GCST008563		phenotype	including obsessive-compulsive disorder
GCST008564		phenotype	excluding co-morbid schizophrenia
GCST008565		phenotype	excluding adjustment disorder
GCST008568		biomarker	iga
GCST008569		biomarker	composite immunoglobulin trait (iga x igg x igm)
GCST008570		phenotype	iga x igg/igm
GCST008571		phenotype	iga x igg
GCST008572		phenotype	iga/igg
GCST008573		phenotype	iga/igm
GCST008574		phenotype	igg/igm
GCST008575		biomarker	igm
GCST008576		biomarker	igg
GCST008577		background, biomarker	kidney transplantation, tacrolimus trough concentration
GCST008578		side effect	calcineurin inhibitor for kidney transplant
GCST008579		side effect	mycophenolic acid for kidney transplant
GCST008580		side effect	mycophenolic acid for kidney transplant patients (time to event)
GCST008581		side effect	cyclosporine for kidney transplant
GCST008582		side effect	tacrolimus for kidney transplant
GCST008583		interaction, phenotype	major depressive disorder, processing speed
GCST008584		interaction	major depressive disorder
GCST008585		interaction	major depressive disorder
GCST008586		interaction, phenotype	major depressive disorder, processing speed
GCST008589		background	major depressive disorder, processing speed
GCST008590		phenotype	information processing speed
GCST008591		biomarker	triglyceride
GCST008592		biomarker	hdl
GCST008593		biomarker	ldl
GCST008594		biomarker	total cholesterol
GCST008595		pleiotropy	years of educational attainment or schizophrenia
GCST008596		phenotype	opioid overdose severity score
GCST008597		phenotype	fish consumption
GCST008598		phenotype	age >90th survival percentile
GCST008599		phenotype	age >99th survival percentile
GCST008600		phenotype	age >90th survival percentile
GCST008601		phenotype	age >99th survival percentile
GCST008602		phenotype	heel bmd
GCST008604		biomarker	urine specific gravity
GCST008605		phenotype	moderate to severe
GCST008606		phenotype	mild
GCST008608		phenotype	moderate to severe
GCST008609		phenotype	mild
GCST008611		phenotype	moderate to severe
GCST008612		phenotype	mild
GCST008615		biomarker	urinary ph
GCST008616		biomarker	urinary ph
GCST008617		phenotype	moderate to severe
GCST008618		phenotype	mild
GCST008619		biomarker	leukocyte esterase, nitrite
GCST008636		biomarker	cd3-positive t-lymphocyte count
GCST008637		biomarker	cd4-positive t-lymphocyte count
GCST008638		biomarker	cd8-positive t-lymphocyte count
GCST008639		biomarker	cd19-positive b-lymphocyte count
GCST008640		biomarker	cd56-positive nk-lymphocyte cell count
GCST008641		biomarker	c-peptide
GCST008642		biomarker	cerebrospinal fluid ab1-42 levels
GCST008643		phenotype	joint damage
GCST008644		phenotype	celiac disease
GCST008645		phenotype	alcohol dependence or heroin dependence or methamphetamine dependence
GCST008647		biomarker	urinary sodium
GCST008648		biomarker	potassium excretion
GCST008659		background, phenotype	heavy smokers, low fev1 vs high fev1
GCST008660		background, phenotype	never smokers, high fev1 vs average fev1
GCST008661		background, phenotype	heavy smokers, high fev1 vs average fev1
GCST008662		background, phenotype	never smokers, low fev1 vs high fev1
GCST008663		background, phenotype	never smokers, low fev1 vs average fev1
GCST008664		phenotype	fev1, low vs. high
GCST008665		background, phenotype	heavy smokers, low fev1 vs average fev1
GCST008666		interaction, phenotype	smoking status, low fev1 vs high fev1
GCST008667		phenotype	heavy vs never
GCST008669		interaction	occupational exposure
GCST008670		interaction	occupational exposure
GCST008671		interaction	occupational exposure
GCST008672		phenotype	knee pain
GCST008673		biomarker	various
GCST008674		pleiotropy	fasting blood glucose measurement, homa-b, fasting blood insulin measurement
GCST008676		biomarker	ldl
GCST008677		interaction, biomarker	smoking status (current vs non), hdl
GCST008678		interaction, biomarker	smoking status (current vs non), hdl
GCST008679		background, biomarker	current smokers, hdl
GCST008680		background, biomarker	non smokers, hdl
GCST008681		interaction, biomarker	smoking status (ever vs never), hdl
GCST008682		interaction, biomarker	smoking status (ever vs never), hdl
GCST008683		background, biomarker	ever smokers, hdl
GCST008684		background, biomarker	never smokers, hdl
GCST008685		biomarker	hdl
GCST008686		interaction, biomarker	smoking status (current vs non), ldl
GCST008687		interaction, biomarker	smoking status (current vs non), ldl
GCST008688		background, biomarker	current smokers, ldl
GCST008689		background, biomarker	non smokers, ldl
GCST008690		interaction, biomarker	smoking status (ever vs never), ldl
GCST008691		interaction, biomarker	smoking status (ever vs never), ldl
GCST008692		background, biomarker	ever smokers, ldl
GCST008693		background, biomarker	never smokers, ldl
GCST008694		interaction, biomarker	smoking (current vs non-current), triglyceride
GCST008695		interaction, biomarker	smoking (current vs non-current), triglyceride
GCST008696		background, biomarker	smoking, triglyceride
GCST008697		background, biomarker	smoking, triglyceride
GCST008698		interaction, biomarker	smoking (ever vs never), triglyceride
GCST008699		interaction, biomarker	smoking (ever vs never), triglyceride
GCST008700		background, biomarker	smoking, triglyceride
GCST008701		background, biomarker	smoking, triglyceride
GCST008702		biomarker	triglyceride
GCST008703		phenotype	occipital lobe volume
GCST008704		phenotype	parietal lobe volume
GCST008705		phenotype	temporal lobe volume
GCST008706		biomarker	trem2, soluble, csf
GCST008707		phenotype	occipital lobe volume
GCST008709		biomarker	pepsinogen-i measurement
GCST008710		phenotype	parietal lobe volume
GCST008711		phenotype	temporal lobe volume
GCST008712		biomarker	pepsinogen i/ii ratio
GCST008713		phenotype	severe
GCST008715		phenotype	frontal lobe volume
GCST008716		phenotype	seropositive for helicobacter pylori
GCST008717		phenotype	frontal lobe volume
GCST008718		pleiotropy	follicular lymphoma
GCST008719		phenotype	follicular lymphoma
GCST008720		phenotype	follicular lymphoma or systemic lupus erythematosus
GCST008721		pleiotropy	chronic lymphocytic leukemia
GCST008722		pleiotropy	diffuse large b-cell lymphoma
GCST008723		pleiotropy	marginal zone lymphoma
GCST008724		phenotype	chronic lymphocytic leukemia
GCST008725		pleiotropy	rheumatoid arthritis
GCST008726		phenotype	marginal zone lymphoma
GCST008727		phenotype	chronic lymphocytic leukemia or systemic lupus erythematosus
GCST008728		pleiotropy	systemic lupus erythematosus
GCST008729		pleiotropy	systemic lupus erythematosus
GCST008733			bmi adjusted
GCST008735		response	beta blocker, diastolic blood pressure
GCST008736		response	beta blocker
GCST008738		phenotype	accomodative
GCST008741		phenotype	non-accomodative esotropia
GCST008742		phenotype	visceral adipose tissue
GCST008743		phenotype	visceral adipose tissue
GCST008744		phenotype	visceral adipose tissue
GCST008745		background, biomarker	non-diabetics, glomerular filtration rate
GCST008746		background, biomarker	diabetes, glomerular filtration rate
GCST008747		biomarker	glomerular filtration rate
GCST008748		phenotype	epigenetic age acceleration
GCST008752		phenotype	post-term birth
GCST008753		phenotype	early spontaneous
GCST008754		phenotype	spontaneous
GCST008755		response	phenylephrine
GCST008756		drug metabolism, biomarker	cisplatin, platinum
GCST008758		phenotype	pre-treatment viral load
GCST008759		phenotype	intake of total sugars
GCST008760		phenotype	perceived sweetness of sucrose
GCST008761		phenotype	sucrose liking
GCST008762		phenotype	intake of sweets
GCST008763		phenotype	perceived intensity of fructose
GCST008764		phenotype	perceived intensity of neohesperidin dihydrochalcone
GCST008765		phenotype	perceived intensity of aspartame
GCST008766		phenotype	perceived intensity of sweet substances
GCST008767		phenotype	perceived intensity of sucrose
GCST008768		phenotype	perceived intensity of sweet substances
GCST008769		phenotype	perceived intensity of glucose
GCST008770		phenotype	sleep duration
GCST008771		phenotype	age
GCST008773		pleiotropy	birth weight
GCST008774		pleiotropy	birth weight
GCST008775		pleiotropy	birth weight
GCST008776		pleiotropy	birth weight
GCST008777		pleiotropy, biomarker	birth weight, fasting glucose
GCST008778		pleiotropy, biomarker	birth weight
GCST008779		pleiotropy, biomarker	birth weight, glycated hemoglobin levels
GCST008780		pleiotropy, phenotype	birth weight, insulin secretion rate
GCST008781		pleiotropy, phenotype	birth weight, insulin sensitivity
GCST008782		pleiotropy	birth weight
GCST008783		pleiotropy	birth weight
GCST008784		pleiotropy, biomarker	birth weight, ldl
GCST008785		pleiotropy, biomarker	birth weight, hdl
GCST008786		pleiotropy, biomarker	birth weight, total cholesterol
GCST008787		pleiotropy	birth weight, triglyceride
GCST008790		biomarker	urinary albumin to creatinine ratio
GCST008791		phenotype	microalbuminuria
GCST008792		biomarker	urinary albumin-to-creatinine ratio
GCST008793		biomarker	urinary albumin to creatinine ratio
GCST008794		biomarker	urinary albumin to creatinine ratio
GCST008795		phenotype	differential aging in older adults (frontal cortex)
GCST008796		phenotype	differential aging in younger adults (frontal cortex)
GCST008797		phenotype	differential aging (cerebellum)
GCST008798		phenotype	differential aging in older adults (cerebellum)
GCST008799		phenotype	differential aging (frontal cortex)
GCST008800		phenotype	differential aging (frontal cortex)
GCST008801		response	thiopurine-induced myelosuppression in inflammatory bowel disease
GCST008802		phenotype	age of initiation
GCST008803		phenotype	cigarette pack-years
GCST008804		phenotype	cigarettes smoked per day
GCST008805		phenotype	drinks per week
GCST008806		phenotype	age of initiation (ever regular vs never regular)
GCST008807		phenotype	age of initiation
GCST008808		phenotype	cigarette pack-years
GCST008809		phenotype	cigarettes smoked per day
GCST008810		phenotype	age of initiation (ever regular vs never regular)
GCST008811		phenotype	drinks per week
GCST008817		biomarker	bilirubin
GCST008818		phenotype	left-handed vs. non-left-handed
GCST008819		phenotype	left-handed vs. right-handed
GCST008820		phenotype	non-right-handed vs right-handed
GCST008821		biomarker	neurofibrillary tangles
GCST008824		phenotype	subscapular skin fold thickness
GCST008830		biomarker	neurofibrillary tangles
GCST008831		pleiotropy	esophageal adenocarcinoma
GCST008835		phenotype	squamous
GCST008837		biomarker	glomerular filtration rate
GCST008838		phenotype	time to onset
GCST008840		phenotype	depressed mood
GCST008841		phenotype	sleep problems
GCST008842		phenotype	fatigue
GCST008843		phenotype	appetite changes
GCST008844		phenotype	low self-esteem
GCST008845		phenotype	concentration problems
GCST008846		phenotype	psychomotor changes
GCST008850		phenotype	sleep problems
GCST008851		phenotype	fatigue
GCST008852		phenotype	appetite changes
GCST008853		phenotype	low self-esteem
GCST008854		phenotype	concentration problems
GCST008855		phenotype	psychomotor changes
GCST008857		phenotype	anhedonia (ordinal trait)
GCST008858		phenotype	depressed mood
GCST008859		phenotype	anhedonia (binary trait)
GCST008861		phenotype	general cognitive ability
GCST008862		biomarker	triacylglycerol 56:6
GCST008863		biomarker	malate
GCST008864		biomarker	niacinamide
GCST008865		biomarker	sphingomyelin 24:0
GCST008866		biomarker	triacylglycerol 56:2
GCST008867		biomarker	tyrosine
GCST008868		biomarker	xanthine
GCST008869		biomarker	metabolite risk score for predicting weight gain
GCST008870		phenotype	keratinocyte cancer
GCST008873		phenotype	non-lobar
GCST008874		phenotype	lobar intracerebral hemorrhage
GCST008876		phenotype	non-lobar
GCST008877		phenotype	lobar intracerebral hemorrhage
GCST008879		biomarker	17-hydroxyprogesterone (17-ohp) levels
GCST008880		biomarker	aldosterone
GCST008881		biomarker	estradiol
GCST008882		biomarker	cortisol levels (plasma)
GCST008883		biomarker	dehydroepiandrosterone sulphate
GCST008884		biomarker	testosterone
GCST008885		biomarker	progesterone
GCST008886		biomarker	androstenedione
GCST008887		phenotype	systemising
GCST008888		phenotype	systemising
GCST008889		phenotype	systemising
GCST008890		phenotype	social and communication disorders checklist score
GCST008891		phenotype	information processing speed
GCST008894		biomarker	uridine
GCST008895		phenotype	psychotic experience
GCST008896		phenotype	psychotic experience (distressing)
GCST008897		phenotype	psychotic experience (multiple occurrences)
GCST008898		phenotype	adult hearing aid use
GCST008899		phenotype	age-related hearing impairment
GCST008900		phenotype	gut microbiota (alpha diversity)
GCST008901		phenotype	gut microbiota (beta diversity)
GCST008902		phenotype	gut microbiota (bacterial taxa)
GCST008903		phenotype	gut microbiota relative abundance (bacterial taxa)
GCST008907		pleiotropy	brain region volumes
GCST008908		pleiotropy, phenotype	subcortical volume measurements, social disinhibition
GCST008909		pleiotropy, phenotype	subcortical volume measurements, symmetry behavior
GCST008910		pleiotropy	multiple
GCST008912		phenotype	pediatric/youth onset
GCST008913		phenotype	idiopathic osteonecrosis
GCST008915		background	ischemic stroke
GCST008917		phenotype	childhood onset
GCST008918		phenotype	adult onset
GCST008919		phenotype	asthma and attention deficit hyperactivity disorder
GCST008920		phenotype	asthma and anxiety disorder
GCST008921		background	major depressive disorder
GCST008922		biomarker	triglyceride
GCST008923		biomarker	ceramide
GCST008924		biomarker	diglyceride
GCST008925		biomarker	lysophosphatidylcholine
GCST008926		biomarker	lysophosphatidylethanolamine
GCST008927		biomarker	phosphatidylcholine
GCST008928		biomarker	phosphatidylcholine ether
GCST008929		biomarker	phosphatidylethanolamine
GCST008930		biomarker	phosphatidylethanolamine ether
GCST008931		biomarker	phosphatidylinositol
GCST008932		biomarker	esterified cholesterol
GCST008933		biomarker	sphingomyelin
GCST008934		biomarker	sterol
GCST008935		biomarker	ldl
GCST008936		biomarker	hdl
GCST008937		biomarker	triglyceride
GCST008938		biomarker	total cholesterol
GCST008939		background	genotoxic compound exposure
GCST008945		phenotype	genotoxic compound exposure
GCST008946		phenotype	genotoxic compound exposure
GCST008947		background	genotoxic compound exposure
GCST008948		background	genotoxic compound exposure
GCST008949		background	genotoxic compound exposure
GCST008957		biomarker	hormone
GCST008959		biomarker	lipid traits
GCST008960		biomarker	iron
GCST008961		biomarker	c-reactive protein
GCST008963		phenotype	glucose homeostasis
GCST008965		biomarker	liver disease biomarker
GCST008967		drug metabolism	tramadol metabolism
GCST008968		phenotype	clinic systolic blood pressure minus ambulatory systolic blood pressure
GCST008971		biomarker	urate
GCST008972		biomarker	urate
GCST008973		biomarker	urate
GCST008976		pleiotropy	type 2 diabetes or obesity
GCST008979		phenotype	external diameter measurement
GCST008980		phenotype	central pulse pressure measurement
GCST008981		phenotype	stiffness measurement
GCST008982		phenotype	internal diameter measurement
GCST008983		phenotype	circumferential wall stress measurement
GCST008984		phenotype	wall cross sectional area measurement
GCST008985		biomarker	triglyceride
GCST008986		phenotype	mean blood pressure measurement
GCST008987		biomarker	hdl
GCST008988		biomarker	ldl
GCST008989		phenotype	intima media thickness
GCST008990		biomarker	ldl
GCST008992		phenotype	joint damage
GCST008993		phenotype	joint damage
GCST008994			bmi adjusted
GCST008995			bmi adjusted
GCST008999			bmi adjusted
GCST009000		phenotype	seropositive for hepatitis b virus surface antigen (hbsag), viral basal core promoter double mutation
GCST009005	C562388		
GCST009006	C562388		
GCST009007		phenotype	high-grade serous
GCST009016		phenotype	t wave morphology restitution during exercise
GCST009017		phenotype	t wave morphology restitution during recovery from exercise
GCST009018		biomarker	metabolite levels
GCST009022		phenotype	clinical subgroup ad+
GCST009023		phenotype	clinical subgroup ad+
GCST009024		phenotype	clinical subgroup ad+
GCST009025		phenotype	alzheimer’s disease and/or vascular dementia (clinical subgroup vad+)
GCST009026		phenotype	alzheimer’s disease and/or vascular dementia (clinical subgroup vad++)
GCST009027		biomarker	oxytocin
GCST009028		side effect	drug
GCST009032		phenotype	red blood cell distribution width
GCST009034		biomarker	hemoglobin
GCST009035		phenotype	mean platelet volume
GCST009038		phenotype	monocyte count
GCST009040		phenotype	neutrophil count
GCST009041		phenotype	eosinophil count
GCST009042		biomarker	total cholesterol
GCST009043		biomarker	ldl
GCST009044		biomarker	hdl
GCST009045		biomarker	triglyceride
GCST009046		biomarker	aspartate aminotransferase
GCST009047		biomarker	gpt
GCST009048		biomarker	alb
GCST009049		biomarker	alkaline phosphatase
GCST009050		biomarker	gamma-glutamyl transferase
GCST009051		biomarker	bilirubin
GCST009054		biomarker	hemoglobin a1c levels
GCST009059		phenotype	hip circumference
GCST009063		phenotype	mean corpuscular hemoglobin
GCST009064		phenotype	mean corpuscular hemoglobin concentration
GCST009065		phenotype	mean corpuscular volume
GCST009066		phenotype	mosaic loss of chromosome y
GCST009067		phenotype	mosaic loss of chromosome y
GCST009068		phenotype	t wave morphology restitution during exercise
GCST009069		phenotype	t wave morphology restitution during recovery from exercise
GCST009071	C536494	phenotype	uveal melanoma
GCST009072	C536494	phenotype	uveal melanoma (tnm stage 3 or 4 vs tnm stage 1 or 2)
GCST009073	C536494	phenotype	uveal melanoma (tnm stage 3 or 4)
GCST009074	C536494	phenotype	uveal melanoma (tnm stage 1 or 2)
GCST009075	C536494	phenotype	uveal melanoma with epithelioid cells
GCST009076	C536494	phenotype	uveal melanoma with epithelioid cells
GCST009077	C536494	phenotype	uveal melanoma with chromosome 3 loss
GCST009078		phenotype	melanoma
GCST009079	C536494	phenotype	uveal melanoma with any chromosomal aberration
GCST009080		side effect	proton-pump inhibitor
GCST009082		interaction	streptococcus pneumoniae genotype cluster
GCST009084		interaction	streptococcus pneumoniae antigen allele
GCST009088		phenotype	severe
GCST009090		phenotype	thoracic aortic calcification
GCST009091		phenotype	abdominal aortic calcification
GCST009096		phenotype	lifetime smoking index
GCST009099	C563514	response	resistance
GCST009101	C563514	response	resistance
GCST009103	C563514	response	resistance
GCST009105		phenotype	body fat percentage variance
GCST009109		phenotype	hip circumference
GCST009112		phenotype	fvc variance
GCST009113		phenotype	fev1
GCST009114		phenotype	fev1/fec ratio
GCST009115		phenotype	heel bmd
GCST009117		phenotype	fvc
GCST009118		phenotype	fev1
GCST009119		phenotype	fev1/fec ratio
GCST009120		phenotype	heel bmd
GCST009123		phenotype	hip circumference
GCST009125			bmi adjusted
GCST009126		phenotype	body fat percentage
GCST009127			bmi adjusted
GCST009130		phenotype	hospital contact
GCST009132		phenotype	ankle brachial index
GCST009134		phenotype	borderline
GCST009135		phenotype	ankle brachial index
GCST009136		phenotype	ankle brachial index
GCST009137		phenotype	ankle brachial index
GCST009138		phenotype	ankle brachial index
GCST009139		phenotype	ankle brachial index
GCST009140		phenotype	ankle brachial index
GCST009141		phenotype	ankle brachial index
GCST009143		phenotype	hydrolysed wheat
GCST009144		phenotype	disease progression, baseline adjusted
GCST009145		biomarker	total cholesterol
GCST009146		biomarker	total cholesterol
GCST009147		biomarker	ldl
GCST009148		biomarker	hdl
GCST009149		biomarker	triglyceride
GCST009150		biomarker	ldl
GCST009151		biomarker	hdl
GCST009152		biomarker	triglyceride
GCST009153		side effect	chemotherapy for breast cancer
GCST009154		side effect	autoantibody against anoctamin 2
GCST009155	C562388		
GCST009156		phenotype	menorrhagia
GCST009158		phenotype	uterine fibroid
GCST009159		biomarker	protein
GCST009160		biomarker	carotenoid levels
GCST009161		biomarker	diabetes mellitus biomarker
GCST009163		biomarker	hormone
GCST009164		biomarker	inorganic ion
GCST009165		biomarker	lipid or lipoprotein
GCST009166		biomarker	renal system
GCST009168		biomarker	tnf
GCST009169		biomarker	vitamin b12
GCST009170		biomarker	chloride
GCST009171		biomarker	homocysteine
GCST009172		response	pegylated interferon in hbeag-negative hepatitis b
GCST009173		response	pegylated interferon in hbeag-positive hepatitis b
GCST009174		response	pegylated interferon
GCST009175		phenotype	caudal anterior-cingulate cortex volume
GCST009176		phenotype	fusiform gyrus volume
GCST009177		phenotype	entorhinal cortical volume
GCST009178		phenotype	caudal middle frontal gyrus volume
GCST009179		phenotype	pars triangularis volume
GCST009180		phenotype	pars orbitalis volume
GCST009181		phenotype	cuneus cortex volume
GCST009182		phenotype	precuneus cortex volume
GCST009183		phenotype	posterior-cingulate cortex volume
GCST009184		phenotype	inferior parietal cortex volume
GCST009185		phenotype	inferior temporal gyrus volume
GCST009186		phenotype	insular cortex volume
GCST009187		phenotype	lateral occipital cortex volume
GCST009188		phenotype	lingual gyrus volume
GCST009189		phenotype	lateral orbital frontal cortex volume
GCST009190		biomarker	medial orbital frontal cortex volume
GCST009191		phenotype	paracentral lobule volume
GCST009192		phenotype	parahippocampal gyrus volume
GCST009193		phenotype	pars opercularis volume
GCST009194		phenotype	ventral diencephalon volume
GCST009195		phenotype	temporal pole volume
GCST009196		phenotype	pericalcarine cortex volume
GCST009197		phenotype	cortex volume
GCST009198		phenotype	corpus callosum mid-anterior volume
GCST009199		phenotype	precentral gyrus volume
GCST009200		phenotype	whole brain grey matter density
GCST009201		phenotype	sub-cortical grey matter volume
GCST009202		phenotype	rostral middle frontal gyrus volume
GCST009203		phenotype	cerebellum cortex volume
GCST009204		phenotype	intracranial volume
GCST009205		phenotype	supramarginal gyrus volume
GCST009206		phenotype	cerebral white matter volume
GCST009207		phenotype	lateral ventricle volume
GCST009208		phenotype	transverse temporal cortex volume
GCST009209		phenotype	frontal pole volume
GCST009210		phenotype	middle temporal gyrus volume
GCST009211		phenotype	choroid plexus volume
GCST009212		phenotype	isthmus-cingulate cortex volume
GCST009213		phenotype	superior temporal gyrus volume
GCST009214		phenotype	third ventricle volume
GCST009215		phenotype	postcentral gyrus volume
GCST009216		phenotype	corpus callosum central volume
GCST009217		phenotype	corpus callosum mid-posterior volume
GCST009218		phenotype	lateral ventricle temporal horn volume
GCST009219		phenotype	superior frontal gyrus volume
GCST009220		phenotype	corpus callosum anterior volume
GCST009221		phenotype	rostral anterior cingulate cortex volume
GCST009222		phenotype	corpus callosum posterior volume
GCST009236		interaction	early life tobacco smoke exposure
GCST009237		phenotype	childhood onset
GCST009238		interaction	early life tobacco smoke exposure
GCST009239		biomarker	serum metabolite
GCST009240		biomarker	serum metabolite
GCST009241		biomarker	serum metabolite
GCST009242		biomarker	serum metabolite
GCST009243		biomarker	various
GCST009244		biomarker	various
GCST009246		biomarker	trem2, soluble, csf
GCST009248		phenotype	mpo-anca positive
GCST009249		phenotype	anca negative
GCST009253		interaction	smoking status
GCST009254		phenotype	cerebellum white matter volume
GCST009255		phenotype	fourth ventricle volume
GCST009256		phenotype	superior temporal sulcus banks volume
GCST009257		phenotype	caudate nucleus volume
GCST009258		phenotype	nucleus accumbens volume
GCST009259		phenotype	amygdala volume
GCST009260		phenotype	hippocampal volume
GCST009261		phenotype	pallidum volume
GCST009262		phenotype	putamen volume
GCST009263		phenotype	total grey matter volume
GCST009264		phenotype	thalamus volume
GCST009265		phenotype	superior parietal cortex volume
GCST009266		phenotype	decayed and filled deciduous tooth surfaces
GCST009267		phenotype	decayed, missing and filled teeth
GCST009268		phenotype	decayed, missing and filled tooth surfaces
GCST009269		phenotype	decayed and filled deciduous teeth
GCST009276		response	placebo
GCST009277		response	placebo
GCST009278		background	type 1 diabetes
GCST009279		background, phenotype	type 1 diabetes, end-stage renal disease
GCST009280		background, phenotype	type 1 diabetes, end stage renal disease vs non-end stage renal disease
GCST009281		background	type 1 diabetes
GCST009282		background	birth
GCST009283		phenotype	schizophrenia or schizoaffective disorder
GCST009284		background	type 1 diabetes
GCST009285		background, phenotype	end stage renal disease vs macroalbuminuria in type 1 diabetes
GCST009286		background, phenotype	type 1 diabetes, reduced egfr or end stage renal disease
GCST009287		background, phenotype	type 1 diabetes, end stage renal disease vs. normal egfr
GCST009288		background	6 weeks old
GCST009289		background, phenotype	type 1 diabetes, reduced egfr and albuminuria or end stage renal disease
GCST009290		background	3 months old
GCST009291		background	6 months old
GCST009292		background, phenotype	end stage renal disease or albuminuria in type 1 diabetes
GCST009293		background	8 months old
GCST009294		background	1 year old
GCST009295		background	1.5 years old
GCST009296		background	2 years old
GCST009297		background	3 years old
GCST009298		background	5 years old
GCST009299		background	7 years old
GCST009300		background	8 years old
GCST009301		side effect	antipsychotic for schizophrenia or autism
GCST009302		side effect	antipsychotic for schizophrenia
GCST009303		phenotype	abstraction and mental flexibility
GCST009304		phenotype	attention function
GCST009305		phenotype	california verbal learning test score
GCST009306		phenotype	spatial processing
GCST009308		phenotype	emotional recognition
GCST009309		phenotype	face memory
GCST009310		phenotype	sensorimotor dexterity
GCST009311		phenotype	letter-number span reordering
GCST009314		background	cannibis use
GCST009316		biomarker	hdl
GCST009317		biomarker	ldl
GCST009318		biomarker	metabolite levels
GCST009319		side effect, biomarker	thiazide-like diuretic in hypertension, uric acid elevation
GCST009320		phenotype	general cognitive ability
GCST009322		phenotype	numerical cognitive ability
GCST009323		phenotype	figural/spatial cognitive ability
GCST009325		phenotype	include first degree relation
GCST009326		phenotype	stress-related phenotypes
GCST009356		phenotype	nonsyndromic cleft palate
GCST009357		phenotype	nonsyndromic cleft lip
GCST009358		interaction, biomarker	sleep time, triglyceride
GCST009359		interaction, biomarker	sleep time, ldl
GCST009360		interaction, biomarker	sleep time, ldl
GCST009361		interaction, biomarker	sleep time, hdl
GCST009362		interaction, biomarker	sleep time, hdl
GCST009363		interaction, biomarker	sleep time, triglyceride
GCST009364		interaction, biomarker	sleep time, triglyceride
GCST009365		interaction, biomarker	sleep time, ldl
GCST009366		interaction, biomarker	sleep time, ldl
GCST009367		interaction, biomarker	sleep time, hdl
GCST009368		interaction, biomarker	sleep time, hdl
GCST009369		interaction, biomarker	sleep time, triglyceride
GCST009370		biomarker	triglyceride
GCST009371		background	body mass index
GCST009372		background	type 2 diabetes
GCST009373		background	gba carrier
GCST009374		background, phenotype	gba carrier, age of onset
GCST009375		phenotype	mosaic loss of chromosome y
GCST009376		phenotype	cerebral cortex av-45 amyloid
GCST009377		phenotype	volumetric bmd
GCST009378		phenotype	bone mineral content
GCST009380			bmi adjusted
GCST009381		side effect	trastuzumab for cancer
GCST009384		phenotype	longitudinal
GCST009386		interaction	non-traditional parental care
GCST009387		interaction	change in residence
GCST009388		interaction	traumatic experience
GCST009389		interaction	household drinking and illicit drug use
GCST009390		interaction	household tobacco use
GCST009391		biomarker	metabolite
GCST009392		phenotype	left ventricular stroke volume
GCST009393		phenotype	left ventricular mass to end-diastolic volume ratio
GCST009394		phenotype	left ventricular end-systolic volume
GCST009395		phenotype	left ventricular ejection fraction
GCST009396		phenotype	left ventricular mass
GCST009397		phenotype	left ventricular end-diastolic volume
GCST009398		phenotype	former vs current
GCST009399		phenotype	ever regular vs never regular
GCST009400		phenotype	former vs current
GCST009401		phenotype	former vs current
GCST009402		phenotype	ever regular vs never regular
GCST009403		phenotype	ever regular vs never regular
GCST009404		phenotype	optic cup area
GCST009405		phenotype	cigarettes smoked per day
GCST009406		phenotype	cigarettes smoked per day
GCST009407		phenotype	cigarettes smoked per day
GCST009408		phenotype	age of smoking initiation
GCST009409		phenotype	age of smoking initiation
GCST009410		phenotype	age of smoking initiation
GCST009411		phenotype	optic disc area
GCST009412		phenotype	cup-to-disc ratio
GCST009414		phenotype	central corneal thickness
GCST009415		phenotype	intraocular pressure and central corneal thickness (multi-trait analysis)
GCST009416		phenotype	cup-to-disc ratio
GCST009417		phenotype	progression (cd4-positive t-lymphocyte count and viral load)
GCST009419		interaction	sex
GCST009420		phenotype	retinal arteriolar tortuosity
GCST009421		phenotype	maximum retinal arteriolar tortuosity
GCST009422		phenotype	retinal venular tortuosity
GCST009423		phenotype	maximum retinal venular tortuosity
GCST009424		phenotype	central retinal arteriolar equivalent
GCST009425		phenotype	central retinal vein equivalent
GCST009426		phenotype	retinal arteriole-to-venule ratio
GCST009427		phenotype	optic disc radius
GCST009428		interaction	corticosteroid treatment
GCST009429		phenotype	high frequency
GCST009430		phenotype	age-related hearing impairment
GCST009431		phenotype	high minus low frequency
GCST009432		phenotype	low/mid frequency
GCST009434		interaction	hispanic (2df)
GCST009435		interaction	air pollution (2df)
GCST009438		background	alzheimer's disease
GCST009439		phenotype	language
GCST009440		phenotype	attention/processing speed
GCST009441		phenotype	memory
GCST009442		phenotype	executive function
GCST009443		phenotype	visuospatial skill
GCST009444		phenotype	global cognition
GCST009445		side effect	anti-tnf for crohn's disease
GCST009446		phenotype	parental longevity
GCST009447		phenotype	parental longevity
GCST009449		phenotype	parental longevity
GCST009450		phenotype	parental longevity
GCST009456		phenotype	eosinophil count
GCST009457		phenotype	eosinophil count
GCST009458		phenotype	right planum temporale grey matter volume
GCST009459		phenotype	planum temporale asymmetry index
GCST009460		phenotype	left planum temporale grey matter volume
GCST009461		phenotype	apnea hypopnea index, change over time
GCST009462		phenotype	optic disc size
GCST009464		phenotype	facial morphology
GCST009467		biomarker	hemoglobin
GCST009469		biomarker	vitamin b6 (carboxyaldehyde form pyridoxal)
GCST009470		biomarker	vitamin b6 (form ratio)
GCST009471		biomarker	vitamin b6 (active form pyridoxal phosphate)
GCST009472		biomarker	vitamin b6 (catabolic product 4-pyridoxic acid)
GCST009473		biomarker	vitamin b6 (form ratio)
GCST009474		phenotype	central retinal vein equivalent
GCST009475		phenotype	central retinal arteriolar equivalent
GCST009476		biomarker	trem2, soluble, csf
GCST009496		phenotype	onset between ages 58 and 79
GCST009497		phenotype	onset at age over 80
GCST009499		background	birth
GCST009500		background, phenotype	infant head circumference
GCST009507		biomarker	triglyceride
GCST009509		biomarker	hdl
GCST009511		biomarker	fasting blood insulin
GCST009513		phenotype	age of onset
GCST009514		phenotype	recurrence of mild malaria attacks
GCST009515		phenotype	recurrence of malaria infection (mild or asymptomatic)
GCST009516		phenotype	non-del(5q)
GCST009517		phenotype	cerebrospinal fluid neurofilament light levels
GCST009518		phenotype	brain region volumes
GCST009519		phenotype	brain region volumes
GCST009520		phenotype	age-at-onset of spectacle wearing-inferred
GCST009521		phenotype	autorefraction measured
GCST009522		biomarker	inflammatory biomarker
GCST009526		phenotype	impaired activities of daily living
GCST009527		biomarker	hdl
GCST009528		biomarker	hdl
GCST009530		background	childhood
GCST009531		phenotype	body fat percentage
GCST009532		biomarker	leptin
GCST009533		interaction, biomarker	sex, leptin
GCST009536		phenotype	white matter microstructure (mode of anisotropy)
GCST009537		phenotype	white matter microstructure (axial diusivities)
GCST009538		phenotype	white matter microstructure (mean diusivities)
GCST009539		phenotype	white matter microstructure (fractional anisotropy)
GCST009540		phenotype	white matter microstructure (radial diusivities)
GCST009542		interaction, phenotype	cleft lip with or without cleft palate x maternal periconceptional alcohol use interaction (parent of origin effect)
GCST009543		interaction	maternal periconceptional vitamin use (parent of origin)
GCST009544		interaction, phenotype	cleft lip with or without cleft palate x maternal periconceptional smoking interaction (parent of origin effect)
GCST009545		side effect	dimethyl fumarate for relapsing-remitting multiple sclerosis
GCST009546		side effect	dimethyl fumarate for relapsing-remitting multiple sclerosis
GCST009547		phenotype	fibrosis improvement, nonalcoholic steatohepatitis
GCST009548		response	remission
GCST009549		background	nonalcoholic steatohepatitis
GCST009550		background	sickle cell anemia
GCST009551		phenotype	peak height velocity
GCST009552		phenotype	peak weight velocity
GCST009553		phenotype	age at adiposity peak
GCST009554		phenotype	adiposity rebound
GCST009555		phenotype	age at adiposity rebound
GCST009556		phenotype	adiposity peak
GCST009557		phenotype	ventricular enlargement rate
GCST009558		biomarker	ccl19
GCST009559		phenotype	rate of retinal ganglion cell–inner plexiform layer atrophy
GCST009560		phenotype	decreased low contrast letter acuity
GCST009561		biomarker	interleukin 6 receptor subunit alpha
GCST009562		biomarker	cxcl10
GCST009563		biomarker	ccl24
GCST009564		biomarker	mica (mhc class i polypeptide-related sequence a)
GCST009565		biomarker	cd40lg (cd40 ligand)
GCST009566		biomarker	cxcl5
GCST009567		biomarker	kallikrein-11
GCST009568		biomarker	epithelial cell adhesion molecule
GCST009569		biomarker	interleukin 17 receptor b
GCST009570		biomarker	interleukin 12 receptor subunit beta-1
GCST009571		biomarker	vegfd
GCST009572		biomarker	e-selectin
GCST009573		biomarker	mia (melanoma-derived growth regulatory protein)
GCST009576		phenotype	appendicular lean mass
GCST009577		phenotype	appendicular lean mass
GCST009596		phenotype	hand
GCST009600		phenotype	anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or tourette syndrome (pleiotropy)
GCST009601		side effect	adalimumab for hidradenitis suppurativa
GCST009604		phenotype	intrinsic epigenetic age acceleration
GCST009605		phenotype	extrinsic epigenetic age acceleration
GCST009606		pleiotropy	19,155 disease classifications in uk biobank
GCST009607		pleiotropy	major depressive disorder
GCST009608		phenotype	hippocampal atrophy
GCST009610		biomarker	metabolite levels
GCST009611		phenotype	brain age
GCST009612		interaction, biomarker	thiazide or thiazide-like diuretics use, triglyceride
GCST009613		interaction, biomarker	loop diuretics use, hdl
GCST009614		interaction, biomarker	loop diuretics use, ldl
GCST009615		interaction, biomarker	loop diuretics use, triglyceride
GCST009616		interaction, biomarker	thiazide or thiazide-like diuretics use, hdl
GCST009617		interaction, biomarker	thiazide or thiazide-like diuretics use, ldl
GCST009636		phenotype	etv6-runx1 positive
GCST009637		phenotype	high-hyperdiploidy
GCST009639		pleiotropy	bmi
GCST009640		biomarker	urinary albumin to creatinine ratio
GCST009641		biomarker	hemoglobin a1c levels
GCST009642		response, phenotype	n-3 pufa supplementation, insulin sensitivity
GCST009643		response	chlorthalidone
GCST009644		response	chlorthalidone
GCST009645		response	thiazide and thiazide-like diuretics
GCST009646		response	thiazide and thiazide-like diuretics
GCST009647		biomarker	muc16
GCST009648		biomarker	cancer antigen 19.9
GCST009649		biomarker	cancer antigen 15.3
GCST009651		biomarker	alpha fetoprotein
GCST009652		biomarker	alkaline phosphatase
GCST009656		biomarker	hdl
GCST009657		biomarker	triglyceride
GCST009661		biomarker	hdl
GCST009662		biomarker	triglyceride
GCST009664		phenotype	amygdala volume
GCST009666		phenotype	caudate nucleus volume
GCST009667		phenotype	pallidum volume
GCST009668		phenotype	putamen volume
GCST009669		phenotype	thalamus volume
GCST009670		phenotype	nucleus accumbens volume
GCST009671		biomarker	vitamin d (25-hydroxy form)
GCST009672		phenotype	moderate to severe
GCST009673		phenotype	extreme
GCST009674		phenotype	uric acid excretion
GCST009675		biomarker	magnesium excretion
GCST009676		biomarker	calcium excretion
GCST009678		background	schizophrenia or bipolar disorder
GCST009679		phenotype	factor score
GCST009681		biomarker	hemoglobin
GCST009684		background, phenotype	ever smokers, airflow obstruction
GCST009696		biomarker	agrp (agouti-related protein)
GCST009696		biomarker	angiopoietin-1 receptor
GCST009696		biomarker	blood protein levels
GCST009696		biomarker	cadherin-5
GCST009696		biomarker	calcineurin
GCST009696		biomarker	ccl19
GCST009696		biomarker	ccl24
GCST009696		biomarker	ccl4
GCST009696		biomarker	cd40
GCST009696		biomarker	chi3l1 (ykl40)
GCST009696		biomarker	cxcl10
GCST009696		biomarker	cxcl5
GCST009696		biomarker	cxcl6
GCST009696		biomarker	cystatin b
GCST009696		biomarker	epithelial cell adhesion molecule
GCST009696		biomarker	e-selectin
GCST009696		biomarker	fms-related tyrosine kinase 3 ligand
GCST009696		biomarker	galectin-3
GCST009696		biomarker	havcr1 (hepatitis a virus cellular receptor 1)
GCST009696		biomarker	hspb1 (heat shock protein beta-1)
GCST009696		biomarker	ikbkg (nf-kappa-b essential modulator)
GCST009696		biomarker	interleukin 12
GCST009696		biomarker	interleukin 17 receptor b
GCST009696		biomarker	interleukin 17 receptor d
GCST009696		biomarker	interleukin-2 receptor subunit alpha
GCST009696		biomarker	interleukin 6 receptor subunit alpha
GCST009696		biomarker	kallikrein-11
GCST009696		biomarker	mia (melanoma-derived growth regulatory protein)
GCST009696		biomarker	mica (mhc class i polypeptide-related sequence a)
GCST009696		biomarker	mmp10 (matrix metalloproteinase 10)
GCST009696		biomarker	mmp12 (matrix metalloproteinase 12)
GCST009696		biomarker	mmp1 (matrix metalloproteinase 1)
GCST009696		biomarker	mmp7 (matrix metalloproteinase 7)
GCST009696		biomarker	monocyte chemotactic protein 1
GCST009696		biomarker	myeloperoxidase
GCST009696		biomarker	pecam1 (platelet endothelial cell adhesion molecule)
GCST009696		biomarker	resistin
GCST009696		biomarker	st2 protein
GCST009696		biomarker	stem cell factor
GCST009696		biomarker	thbd (thrombomodulin)
GCST009696		biomarker	tnfsf10 (tnf-related apoptosis-inducing ligand)
GCST009696		biomarker	tnfsf8 (tumor necrosis factor ligand superfamily member 8)
GCST009696		biomarker	vascular endothelial growth factor receptor 2
GCST009697		phenotype	brainstem volume
GCST009698		biomarker	acylcarnitine
GCST009698		biomarker	ceramide
GCST009698		biomarker	glycine
GCST009698		biomarker	metabolite
GCST009698		biomarker	methionine
GCST009698		biomarker	proline
GCST009698		biomarker	serine
GCST009698		biomarker	sphingolipid
GCST009698		biomarker	sphingomyelin
GCST009699		biomarker	uric acid
GCST009703		biomarker	urinary arsenic
GCST009704		phenotype	maternal nondisjunction of chromosome 21 (mi error vs fathers)
GCST009705		phenotype	maternal nondisjunction of chromosome 21 (mi error vs fathers)
GCST009706		phenotype	maternal nondisjunction of chromosome 21 (mi error vs fathers)
GCST009707		phenotype	maternal nondisjunction of chromosome 21 (mi error vs fathers)
GCST009708		biomarker	sclerostin
GCST009709	C536404	phenotype	childhood steroid-sensitive nephrotic syndrome
GCST009710	C536404	phenotype	childhood steroid-sensitive nephrotic syndrome
GCST009711	C536404	phenotype	childhood steroid-sensitive nephrotic syndrome
GCST009716		phenotype	eczema, allergic rhinitis, asthma
GCST009717		phenotype	eczema, allergic rhinitis
GCST009721		side effect	anthracycline for cancer
GCST009723		phenotype	cup-to-disc ratio, vertical disc diameter adjusted
GCST009724		phenotype	cup-to-disc ratio
GCST009727		phenotype	longitudinal brain connectivity change (characteristic path length)
GCST009728		phenotype	longitudinal brain connectivity change (global efficiency)
GCST009729		phenotype	longitudinal brain connectivity change (transitivity)
GCST009730		phenotype	longitudinal brain connectivity change (louvain modularity)
GCST009731		background, biomarker	cardiovascular risk, blood protein levels
GCST009731		biomarker	adm (pro-adrenomedullin)
GCST009731		biomarker	advanced glycation end-product
GCST009731		biomarker	agrp (agouti-related protein)
GCST009731		biomarker	angiopoietin-1 receptor
GCST009731		biomarker	beta-nerve growth factor
GCST009731		biomarker	cathepsin d
GCST009731		biomarker	cathepsin l1
GCST009731		biomarker	ccl16
GCST009731		biomarker	ccl3
GCST009731		biomarker	ccl4
GCST009731		biomarker	chi3l1 (ykl40)
GCST009731		biomarker	cx3cl1
GCST009731		biomarker	cxcl1 (growth-regulated alpha protein)
GCST009731		biomarker	cxcl6
GCST009731		biomarker	cystatin c
GCST009731		biomarker	dickkopf-related protein 1
GCST009731		biomarker	e-selectin
GCST009731		biomarker	follistatin
GCST009731		biomarker	galectin-3
GCST009731		biomarker	gdf15
GCST009731		biomarker	havcr1 (hepatitis a virus cellular receptor 1)
GCST009731		biomarker	hspb1 (heat shock protein beta-1)
GCST009731		biomarker	interleukin 16
GCST009731		biomarker	interleukin 18
GCST009731		biomarker	interleukin 1 receptor-like 1
GCST009731		biomarker	interleukin 27 receptor subunit alpha
GCST009731		biomarker	interleukin 6 receptor subunit alpha
GCST009731		biomarker	interstitial collagenase
GCST009731		biomarker	kallikrein-11
GCST009731		biomarker	kallikrein-6
GCST009731		biomarker	kit ligand
GCST009731		biomarker	macrophage colony stimulating factor
GCST009731		biomarker	macrophage metalloelastase
GCST009731		biomarker	mmp10 (stromelysin-2)
GCST009731		biomarker	mmp3 (stromelysin-1)
GCST009731		biomarker	mucin-16
GCST009731		biomarker	myeloperoxidase
GCST009731		biomarker	nppb (natriuretic peptide b)
GCST009731		biomarker	osteoprotegerin
GCST009731		biomarker	pappa (pappalysin-1)
GCST009731		biomarker	pecam1 (platelet endothelial cell adhesion molecule)
GCST009731		biomarker	pgf (placenta growth factor)
GCST009731		biomarker	platelet-derived growth factor receptor beta
GCST009731		biomarker	pro-interleukin-16
GCST009731		biomarker	renin
GCST009731		biomarker	spon1 (spondin-1)
GCST009731		biomarker	thbd (thrombomodulin)
GCST009731		biomarker	tissue factor
GCST009731		biomarker	tnfsf11 (tumor necrosis factor ligand superfamily member 11)
GCST009731		biomarker	tnfsf14 (tumor necrosis factor ligand superfamily member 14)
GCST009731		biomarker	tumor necrosis factor receptor superfamily member 1b
GCST009731		biomarker	tumor necrosis factor, receptor superfamily, member 5
GCST009731		biomarker	tumor necrosis factor receptor superfamily member 6
GCST009731		biomarker	xpnpep2 (xaa-pro aminopeptidase 2)
GCST009733		biomarker	urinary metabolite levels
GCST009734		phenotype	severe
GCST009735		biomarker	urinary metabolite modules (eigenmetabolites)
GCST009736		biomarker	interleukin 18
GCST009737		phenotype	intima media thickness
GCST009738		phenotype	intima media thickness (maximum)
GCST009739		phenotype	intima media thickness
GCST009739		phenotype	intima media thickness (mean-maximum)
GCST009756		biomarker	sphingolipid d18:1/d18:2 ratio
GCST009759		phenotype	nasal type
GCST009780		phenotype	visceral fat, circulating phospholipid pc(16:0/2:0) and white matter microstructure (shared variance)
GCST009796		phenotype	cessation
GCST009797		phenotype	heavy vs. light/non-drinkers
GCST009799		phenotype	drinkers vs non-drinkers
GCST009800		phenotype	drinks per week
GCST009801		phenotype	coffee
GCST009802		phenotype	green tea
GCST009803		phenotype	milk
GCST009806		phenotype	natto
GCST009807		phenotype	tofu
GCST009808		phenotype	fish intake
GCST009809		phenotype	small whole fish
GCST009812		phenotype	inattention symptoms
GCST009816		phenotype	childhood
GCST009817		side effect	clozapine for schizophrenia
GCST009818		phenotype	severity
GCST009819		phenotype	compulsion score
GCST009820		phenotype	obsession score
GCST009821		response, biomarker	statin, ldl cholesterol
GCST009835		interaction, response	antihypertensive drug treatment (left ventricular mass interaction)
GCST009836		interaction, response	antihypertensive drug treatment (relative wall thickness interaction)
GCST009839		phenotype	chronic
GCST009840		background	type 2 diabetes
GCST009841		phenotype	childhood onset
GCST009842		phenotype	adult onset
GCST009843		pleiotropy, phenotype	fasting blood glucose, nonatopic
GCST009845		phenotype	nonatopic
GCST009848		pleiotropy	fasting glucose
GCST009850		phenotype	atopic
GCST009852		phenotype	exposure
GCST009856		phenotype	leukocyte
GCST009857		pleiotropy	type 2 diabetes
GCST009858		phenotype	bmi adjusted
GCST009859		pleiotropy	type 2 diabetes
GCST009862		pleiotropy, phenotype	waist-to-hip ratio, atopic, bmi adjusted
GCST009865		pleiotropy, phenotype	waist-to-hip ratio, adult onset, bmi adjusted
GCST009866		pleiotropy	bmi
GCST009867			bmi adjusted
GCST009868		pleiotropy	bmi
GCST009870		phenotype	calcific
GCST009873		pleiotropy	
GCST009878		phenotype	poor prognosis
GCST009880		response, background, biomarker	niacin, statin, hdl cholesterol
GCST009881		response, background, biomarker	niacin, statin treatment, lipoprotein a
GCST009885		biomarker	3-ureidopropionate (saliva)
GCST009885		biomarker	creatinine (saliva)
GCST009885		biomarker	dimethylglycine (saliva)
GCST009885		biomarker	urate (saliva)
GCST009888		phenotype	autoantibody against thyroid peroxidase and/or thyroglobulin
GCST009890		phenotype	parental lifespan
GCST009892		phenotype	bone measurement
GCST009892		phenotype	hip bone mineral density
GCST009892		phenotype	spine bone mineral density
GCST009892		phenotype	spine bone size
GCST009893		biomarker	carnitine
GCST009893		biomarker	creatine
GCST009893		biomarker	dimethylglycine
GCST009893		biomarker	glycine
GCST009893		biomarker	lysine
GCST009893		biomarker	proline
GCST009893		biomarker	pyruvate
GCST009893		biomarker	serum metabolite
GCST009893		biomarker	valine
GCST009894		biomarker	il6st (soluble gp130)
GCST009897		phenotype	reading disability
GCST009917		biomarker	ldl cholesterol
GCST009918		biomarker	hdl
GCST009919		biomarker	total cholesterol
GCST009920		biomarker	triglyceride
GCST009921		phenotype	carotid artery intima media thickness
